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ABSTRACT: 
The stargazer mutant mouse is an animal model of human absence epilepsy and 
cerebellar ataxia. The stargazer mutation results in the complete ablation of 
expression ofTARPy2, an AMPA receptor (AMPAR) auxiliary subunit. Results 
ofthe current study provide evidence for the involvement ofTARPy2 in the 
regulation of expression and trafficking of specific GABAA receptor (GABAR) 
subtypes in the cerebellum and hippocampal formation. 
Expression of total GABARs (y2 and o-containing) in stargazer cerebellum was 
found to be reduced to 70 ± 1 00/o of control levels. In situ eHJ muscimol 
autoradiography revealed that this loss of GABARs was entirely restricted to the 
cerebellar granule cell (CGC) layer. Total numbers ofy2-containing GABARs 
were only slightly reduced in the stargazer cerebellum (90 ± 6% of control 
levels), which was entirely attributable to a reduction in the benzodiazepine-
insensitive (BZ-IS) subtype ofy2 containing GABARs, conferred by a.6~y2 
receptors which are located entirely within the CGC layer (to 78 ± 10% of 
control levels). The benzodiazepine-sensitive subtype of GABAR, largely 
represented by a.1 ~y2 receptors, was unaffected. This data implied that the 
extrasynaptic a.6~o GABARs were dramatically affected by the mutation. This 
was further supported by semi-quantitative immunoblotting analysis which 
demonstrated a reduction in GABAR a.6 and o subunit expression to 39 ± 22% 
and 36 ± 21% of control levels respectively. 
Cultured cerebellar granule cells (CGCs) from control (AMP AR and kainate 
receptor-competent) and stargazer (AMPAR-incompetent but kainate receptor-
competent) mice were employed as a model system to investigate how the 
stargazer mutation evoked aberrant a.6~o GABAR expression and trafficking. 
The studies described herein demonstrated that AMP AR activation resulted in L-
type voltage-gated calcium channel-dependent up-regulation ofGABAR o 
subunit expression and cell surface trafficking which was not detected in CGCs 
derived from stargazer animals. This offers a partial explanation for the 
abnormalities observed in vivo. 
This investigation also provides evidence of a switch in GABAR expression in 
response to hyper-excitability in the dentate gyrus of the stargazer mutant, where 
a combination of in situ autoradiographical, immunohistochemical and 
immunoblotting analyses indicated that a.4J3y2 GABARs arose at the expense of 
the a.4J3o subtype. Hence, there is a potential switch from extrasynaptic 
GABARs in favour of synaptic GABARs, which may reflect an adaptive 
response to high frequency spike-wave discharges that enter the DG in the 
stargazer mutant. 
Overall the results of this study support the hypothesis that neural networks in 
both the cerebellum and the hippocampus are able to undergo homeostatic 
GABAergic plasticity in response to alterations in excitatory inputs. 
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CHAPTER 1. INTRODUCTION 
1.1. Epilepsy 
Epilepsy is the commonest type of neurological disorder, affecting approximately 
1% of the population (Letts eta/., 1998; Brodie eta/., 2005). Epilepsies are a 
heterogeneous group of disorders chamcterised by recurrent spontaneous seizures. 
Seizures can be classified depending on the pattern of neuronal involvement and the 
clinical features of the seizure. The two main classes of seizure are partial and 
generalised. Partial seizures originate in a focal region of the cortex and are divided 
into those that impair consciousness (complex partial) and those that do not (simple 
partial). Generalised seizures can be characterised by widespread involvement of the 
cortical regions and usually involve an impairment of consciousness. Subtypes of 
generalised seizures include absence, myoclonic, clonic, tonic and atonic seizures 
(Brodie eta/., 2005). 
Absence seizures commonly affect children and manifest as a sudden onset of 
staring and impaired consciousness with or without eye blinking and a chamcteristic 
electroencephalogmm (EEG) demonstrates a 3 Hz spike-wave pattern (Brodie eta!., 
2005). A number of mouse mutants show characteristics of absence epilepsy with 
ataxia and a form of spike-wave discharge associated with behavioural arrest (Letts 
eta/., 1998). A number of these mutants possess mutations in genes encoding 
calcium channel subunits, including tottering (alA subunit mutation), leaner (alA 
subunit), ducky (a2/o2 subunit), lethargic ((34 subunit mutation) and stargazer, 
(putative calcium channel y2 subunit mutation) (Letts eta/., 1998; Sharp eta/., 
2001). 
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Epilepsy results from an imbalance between excitatory and inhibitory 
neurotransmission, which can occur as a consequence of an increase in excitatory 
neurotransmission, via glutamate receptors or a deficiency in inhibitory 
neurotransmission mediated by GABA receptors. Here follows an introduction to 
excitatory (Non-NMDA: AMPA and Kainate) receptors and inhibitory (GABAA) 
receptors in terms of their structure and function in the central nervous system 
(CNS) which is essential for the understanding ofthe work herein. 
1.2. y-Aminobutyric Type A (GABAA) Receptors 
1.2.1. Structure of the GABAA Receptor (GABAR) 
In the central nervous system, the principal mediator of inhibitory neurotransmission 
is the GABA receptor. GABA receptors can be subdivided into GABAA (ligand-
gated chloride ion channel receptors), GABAs (G-protein coupled receptors) and 
GABAc (ligand-gated ion channel receptors) receptors. The GABAA receptor 
(GABAR) is a member of the superfamily ofligand-gated ion channels which also 
includes the nicotinic acetylcholine receptor (nAChR), the glycine receptor (GlyR) 
and the 5-hydroxytryptamine receptor (5HT3) (Sieghart eta/., 1999). 
The GABAA receptor is a hetero-pentameric glycoprotein which is encoded by a 
family of 18 separate genes, grouped according to their sequence homology, a (1-6), 
~ (1-4), 'Y (1-4), o, E, 7t and e. p (1-3) form GABAc receptors which are prominent in 
the retina (Barnard eta/., 1998). Each GABAR subunit consists of four putative 
transmembrane (TM) domains, a large extracellular N-terminus, an extracellular C-
terminus and a large intracellular loop between TM3 and TM4 domains (figure 1.1. ). 
The subunit composition of the GABAR determines the pharmacological and 
electrophysiological properties and the cellular location of the receptor. The 
predominant subunit combination in the brain exists in a pentameric organisation, 
consisting of2a., 2rJ and a y2 subunit. The major GABAR subtypes in the 
cerebellum include a.1 rJxy2, representing approximately 400/o of the total GABAR in 
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the brain, a.6~xy2 (7%), a.1a.6~xy2 (22%), a.6~xB (18%) and a.1a.6~xo (10%) 
(McKernan and Whiting, 1996; Poltl eta/. , 2003). 
A 
B 
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Figure 1.1. Structure of a GABAA Receptor 
A : Structure of a GABAR subunit, consisting of four transmembrane domains with 
extracellular amino and carboxy termini . A long intracellular loop links 
transmembrane domains 3 and 4. 
B: Structure of a GABAA receptor, composed of a pentameric arrangement of 
GABAR subunits, most commonly, 2a., 2~ and either a y orB subunit. 
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The genes encoding the GABAR subunits have been demonstrated to occur in 
clusters of3-4 genes at each locus on the chromosome. Each cluster contains genes 
of the a., f3 andy or & subunit classes, corresponding to GABAR composition. 
GABAR subunits a.2, a.4, f31 and y1 occur on human chromosome 4 (4p13-q11), 
subunits a.1, a.6, (32 and y2 have been mapped to human chromosome 5 (5q34-q35), 
a.5, (33 and y3 subunits are localised on human chromosome 15 (15q 11-q 13), while 
the GABAR 8 subunit has been mapped to human chromosome 1 (1p) (For review 
see Barnard eta/., 1998) 
1.2.2. Expression of GABAR subunits 
The expression of GABAR subunits is regulated in a tempoml and spatial manner, 
which allows for a potentially diverse population of pentameric receptors. The 
matumtion of the cerebellum involves the migmtion of cerebellar gmnule cells from 
the external to the internal gmnule cell layer. Precursor cells in the germinative 
zones of the outer surface of the cerebellum (EGL) begin to divide and become post-
mitotic in the first postnatal weeks (Qiao eta/., 1996, 1998; Mellor eta/., 1998). The 
cerebellar granule cell precursors migrate along Bergmann glial cell processes to 
pass through the molecular and Purkinje cell layers and finally come to rest in the 
internal granule cell layer (IGL) where the cells mature and extend dendritic 
processes (Gao et al., 1995). 
During the development of the cerebellum the expression of GAB AA receptor 
subunits change. Dividing precursor cells and post-mitotic, premigmtory cells 
express a.2, a.3, (33, y1 and y2 subunits, which are replaced by a.1, a.6 and 8 subunits 
as cells reach the IGL (Laurie eta/., 1992; Mellor eta/., 1998). This switch in 
GABAA receptor subunit expression occurs at approximately postnatal day 6-7 (P6-
7) (Laurie et al., 1992). Therefore, the expression level of the a.6 subunit provides a 
marker ofthe level of maturity ofthe cerebellum (figure 1.2.). 
In the hippocampus, in contrast to the cerebellum, the predominant expression of 
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adult GABAR subunits is established from the early embryonic stage (Laurie eta/., 
1992). Increases in GABAR a.l, a.2, a.5, J31, J33, y2 and 8 are observed from 
embryonic day 14-19 (E14-E19) to adult age. Continuous low levels of expression 
ofGABAR a.3 and J32 subunits have been reported from E19-adult age. In contrast, 
GABAR y1 subunit mRNA expression levels decrease after P6, while y2 mRNA 
levels peak around P6 and a.3, a.4, J31 and y3 subunit mRNA levels peak at P12 
(Laurie eta/., 1992) (figure 1.2.). 
The cerebellum demonstrates a diverse range of GABAR subunit 
immunoreactivities. The granule cell layer has been reported to express high levels 
of GABAR a.1, J32, J33 and 8 subunit protein. Most notably, the GABAR a.6 subunit 
is expressed solely in the cerebellar granule cell (CGC) layer. Staining for other 
GABAR, a.2, a.3, a.4, a.5, J31, yl and y3 are absent or are observed at low levels in 
the cerebellum (Pirker eta/., 2000). The Purkinje cell layer demonstrates high levels 
of a.l, J32 and y2 immunoreactivity. Staining in the molecular layer for GABAR a.2, 
a.3, a.5, J31, J32, y2 and y3 has been reported to be mostly diffuse. Dendrites 
demonstrate high levels of a.l immunoreactivity, while J32 subunit expression is 
observed in single perikarya (Pirker eta/., 2000). 
Abundant staining for the GABAR a.1, a.2, a.4, a.5, J31, J32, J33 and y2 subunits were 
reported in the hippocampus by Pirker eta/., in 2000. High levels of GABAR a.l, 
J32 and y2 subunits were observed in the stratum oriens and radiatum of the CAl and 
CA3, while immunoreactivity for the a.2, a.4 and 8 subunits was reported in the 
dentate gyrus molecular layer. Moderate staining for the a.l, J31, J32, J33 and y2 
subunits were also reportedly noted in the molecular layer. GABAR J32 subunit 
staining is equally distributed in the Ammon's hom, J33 subunit immunoreactivity 
has been reported to be enriched in the CAl and CA3, with J31 subunit expression 
concentrated in the CA2 (Sperk eta/., 1997; Pirker eta/., 2000). Intemeurons in the 
polymorph cell layer of the dentate gyrus were shown to be labelled with a. I, a.3, J31, 
J32, y2 and 8 subunit-specific antibodies (summarised in table 1.1.). 
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Figure 1.2. Developmental expression profiles ofGABAR subunits in the 
cerebeUum and hippocampus from embryonic (E) to postnatal (P) to adult age 
White bar: No expression, Light grey bar: Low expression, Grey bar: Medium 
expression, Black bar: High expression (Laurie eta/., 1992). 
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Table 1.1. Expression of the GABAR subunits in the adult cerebellum and 
hippocampus 
GABAR CEREBELLUM HIPPOCAMPUS 
SUBUNIT CGC ML PL DG CAl CA3 
a.l -H- -H- -H- + -H- + 
a.2 - + - -H- + + 
a.3 - + - + - -
a.4 - - - -H- + -
a.5 - + + + -H- + 
a.6 +-H- - - - - -
131 - + - + + -
132 -H- -H- -H- + -H- ++ 
133 +-H- - - -H- -H- ++ 
yl - - + - - -
y2 ++ -H- ++ -H- ++ ++ 
y3 - + + - - -
0 +-H- - - ++ - -
-:No expression,+: Low expression,++: Moderate expression, +-H-: High 
expression. CGC: Cerebellar granule cell layer, DG: Dentate gyrus, ML: Molecular 
layer, PL: Purkinje cell layer. 
Adapted from Pirker et al., 2000 
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1.2.3. GABAR trafficking and targeting 
GABAR constitutively recycle between the cell surface and microtubule-dependent 
perinuclear endosomal compartment by clathrin-dependent mechanisms (Tehrani et 
al., 1997; Connolly eta/., 1999a; Moss and Smart, 2001; Kneussel eta/., 2002). 
Assembly of GABAR subunits is reported to occur in the endoplasmic reticulum 
(ER), involving interactions with chaperone molecules such as calnexin and Ig 
binding protein (BiP), molecules which hold glycoproteins in the ER until folding 
and assembly is complete (Connolly eta/., 1996a). Heterologous expression of 
GABAR subunits has demonstrated that expression of GABAR at the cell surface 
requires the combination of an a and a f3 subunit in the presence or absence of a y 
subunit to produce GABA-gated currents (Connolly eta/., 1996a, 1996b, 1999). 
Localisation ofGABAR to the synapse is controlled by association ofGABAR with 
interacting proteins such as gephyrin and GABAA receptor-associated protein 
(GABARAP). Gephyrin is a ubiquitous protein which binds to polymerised tubulin, 
acting as a scaffolding protein shown to co-localise with the GABAR a2, f32/3 and 
y2 subunits, to stabilise yrcontaining GABAR at postsynaptic sites (Kneussel eta/., 
1999, 2001; Sassoe-Pognetto and Fritschy, 2000; Kittler et al., 2001a; Jacob eta/., 
2005). Studies on gephyrin-deficient mice (geph-t-) demonstrated a complete loss of 
synaptic y2 subunit-containing GABAR (Kneussel eta/., 1999). 
GABARAP shares sequence homology with GATE16, a protein which participates 
in vesicular membrane transport through interaction with N-ethylmaleimide-sensitive 
factor (NSF), a protein critical for vesicular fusion. GABARAP is enriched in the 
trans-golgi network and has previously been proposed to facilitate intracellular 
transport from the Golgi apparatus to synaptic sites (Wang and Olsen, 1999; Chen et 
a/., 2000; Kittler eta/., 2001 ). 
The G@AR y2 subunit is_ mostly disp~nsable for as~embly and membrane insertion 
of functional GABAR, but is essential for accumulation of GABAR at synapses, and 
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for the recruitment of gephyrin to postsynaptic sites. Keller eta/., in 2004 reported a 
novel y2 subunit interacting protein, the Golgi-specific DHHC zinc finger protein 
(GODZ), a member of the superfamily ofDHHC cysteine-rich domain membrane 
proteins, which have been characterised as palmitoyltransferases. GODZ interacts 
with a cysteine-rich 14 amino acid domain which is conserved in the cytoplasmic 
loop (TM3-4) ofthe GABAR y1-3 subunits. Co-expression ofGODZ and GABAR 
in HEK-293 cells resulted in the palmitoylation of the GABAR y2 subunit in its 
cytoplasmic domain. This highlights a novel post-translational modification selective 
for y subunit-containing GABAR important for the regulation of trafficking in the 
secretory pathway (Keller eta/., 2004). 
Rathenberg et al., in 2004 identified a role for palmitoylation ofGABAR in the 
synaptic clustering of GABAR containing the y2 subunit in cultured hippocampal 
neurons. More recently, the roles of distinct domains of the GABAR y2 subunit have 
been identified in mediating clustering and synaptic function ofGABAR and 
gephyrin (Alldred eta/., 2005). Analysis ofGABAR a2/y2 chimeras where 
extracellular, transmembrane and intracellular domains of the y2 subunit were 
replaced with homologous domains from the a.2 subunit were employed to determine 
the domains of the y2 subunit that critical for GABAR clustering and synaptic 
function. Transfection of the above chimeric constructs into GABAR y2 subunit 
knockout (y2-t-) neurons revealed that the fourth transmembrane domain of the y2 
subunit is necessary for postsynaptic clustering of GABARs, whereas the fourth 
transmembrane domain and the cytoplasmic loop contribute to the recruitment of 
gephyrin to the postsynaptic membrane. 
GABAR expression and function can be modulated by phosphorylation. GABAR 
phosphorylation can act to cause diverse functional effects, from enhancement to 
inhibition of function depending on the receptor subunit composition and the 
location of the phosphorylation site within the subunit (Lin eta/., 1996; McDonald et 
iii., 1998). GABAR p 1-3 and y2 subunits are targets for cAMP-"depehdent protein 
9 
kinase A, protein kinase C, cGMP-dependent protein kinase and 
calcium/calmodulin-dependent protein kinase II (CaMKII) (Krishek et al., 1994; 
McDonald et al., 1994; McDonald eta/., 1998). 
GABAR ~subunits play a unique role in function modulation, as they possess 
conserved sites for protein kinase A (PKA) phosphorylation (McDonald et al., 1998). 
Expression of GABAR with varying ~ subunits in human embryonic kidney cells 
293 (HEK-293) cells revealed that phosphorylation ofserines 408 and 409 enhanced 
GABA-activated currents, while phosphorylation of the ~1 subunit at serine 409 
acted to reduced GABA-activated currents. In contrast the ~2 subunit was not 
affected by PKA phosphorylation (McDonald et al., 1998). The GABAR ~ subunit 
therefore plays a critical role in the modulation of GABAR function. Furthermore, 
the GABAR ~ subunit is not only essential for the cell surface targeting of functional 
GABAR but also for the targeting of GABAR to cellular locations (Connolly eta!., 
1996a, 1996b ). Expression of GABAR containing the ~3 subunit were shown to 
target to the basolateral domain ofmadin-darby canine (MDCK) cells, analogous to 
the somatodendritic surface of neurons, via the apical surface, corresponding to 
axonal surfaces in neurons. In contrast, GABAR containing the ~2 subunit were 
targeted directly to the basolateral domain (Connolly et al., 1996b ). 
Heterologous expression systems have provided evidence that protein kinase C 
(PKC) activity can interfere with recycling of receptors to the cell surface from late 
endosomes (Brandon et al., 1999; Connolly et al., 1999; Moss and Smart, 2001 ). 
Furthermore, GABAR ~ subunits have been reported to be phosphorylated by PKC-
dependent signalling pathways to modulate neuronal GABAR function in neurons 
(Poisbeau et al., 1999). 
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Figure 1.3. Constitutive recycling ofGABAR to the cell surface 
Proteins reported to interact with GABARs to influence cellular trafficking are Plic-1 
which interacts with a. and f3 subunits of GABAR acting to limit the degradation of 
GABAR by the proteosome, thereby acting to increase GABAR surface expression 
(Bedford eta/., 2001). GABAA receptor interacting fuctor-1 (GRIF-1) is a 913 amino 
acid protein identified by the yeast-2 hybrid system to specifically interact with the 
GABAR f32 subunit and kinesins to function in trafficking f32 subunit-containing 
GABAR to the synapse along microtubules (Beck eta/., 2002; Brickley eta/., 2005). 
Huntingtin-associated protein 1 has recently been identified as a protein important in 
the modulation of synaptic GABAR number by inhibiting receptor degradation and 
facilitating receptor recycling (Kittler eta/., 2004). 
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1.2.4. Localisation of GABAR to synaptic and extrasynaptic sites 
In cerebellar granule cells (CGCs}, two types ofGABAA receptor-mediated 
inhibition exist, phasic and tonic (Brickley et al., 1996, 1999; Nusser eta/., 1998). 
GABAR have been shown to be segregated to synaptic and extrasynaptic sites to 
mediate phasic and tonic inhibition depending on their subunit composition. Nusser 
eta/., in 1998 reported that y2 subunit containing GABAR were enriched in 
GABAergic Golgi synapses, while GABAR containing the 8 subunit were present on 
the extrasynaptic, somatic and dendritic membranes in CGCs. 8-containing GABAR 
have been proposed to mediate tonic inhibition, as a result of their characteristic 
pharmacological properties and extrasynaptic location. 8 subunit-containing GABAR 
have distinct properties in that they do not desensitise in the presence of GABA 
while they display a high affinity for the ligand. 8 subunit-containing GABAR also 
confer a small single channel conductance and a long open time of the channel 
(Nusser eta/., 1998; Brown eta/., 2002). 
In hippocampal neurons 8 subunit-containing GABAR, are targeted to perisynaptic 
domains where they respond to overspill ofGABA from the synapse (Wei eta/., 
2003). With the exclusive non-synaptic presence of the subunit, it is a prime 
candidate for the mediation of tonic inhibition, to regulate passive membrane 
properties (Nusser eta/., 1998). 
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Table 1.2. Properties of y2 and 8 subunit-containing GABAR 
RECEPTOR PROPERTY GABAR y2 SUBUNIT GABAR 8 SUBUNIT 
Cellular Localisation Synaptic Extrasynaptic/Perisynaptic 
Single Channel 30ps 22ps 
Conductance aJ(31y2 a1(318 
(Nusser eta/., 1998) 
Channel open time 5 msec 400msec 
(Nusser eta/., 1998) a1(31y2 a1(318 
Desensitisation in the Fast Slow 
presence of GABA 10 msec 5-8 msec 
(Nusser eta/., 1998) 
Sensitivity to zinc High Low 
(Brown eta/., 2002) 1Cso=2.0 ~ 1Cso=3.1 ~ 
a4(33y2 a4(338 
Affinity for GABA ECso=l3 ~ ECso=0.27 ~ 
(Nusser eta/., 1998) a1(33y2 a6(338 
Sensitivity to THDOC=297% THDOC=524% 
neurosteroids potentiation potentiation 
(Brown eta/., 2002) a4(33y2 a4(338 
Phasic inhibition in CGCs has been attributed to the activation of synaptic a.1J3y2, 
l4J3rz and a.tl4f3rz receptors, in response to synaptic release ofGABA (Sieghart et 
a/., 1999). Phasic inhibition, in the form of postsynaptic currents, involves the 
synchronous opening of 18-32 synaptic GABAR. In contrast, tonic inhibition 
involves the persistent opening of several GABAR channels, providing a background 
level of inhibition within a CGC (Nusser eta/., 1998). Figure 1.4. depicts the 
arrangement of the cerebellar circuitry and the cellular localisation ofGABAR 
subtypes either synaptically or extrasynaptically. 
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1.2.5. Modulation of GABAR function 
GABAA receptors can be modulated by a number of different ligands including 
benzodiazepines, barbiturates, anaesthetics, convulsants and neurosteroids, which 
bind to distinct sites on the receptor to alter the ability ofGABA to open the GABAR 
cr channels. 
Benzodiazepines (BZ) are commonly used for their anxiolytic, sedative and 
anticonvulsant properties. Benzodiazepines bind to the GABAA receptor on allosteric 
sites to modulate GABA-mediated cr ion flow and hence inhibitory 
neurotransmission in the CNS. A BZ agonist acts as a positive modulator of the 
GABAR, to increase the frequency of opening of the cr channel, increase net cr ion 
flux and hence potentiate inhibitory neurotransmission (Rogers eta/., 1994). 
Conversely, a classical BZ antagonist, such as Ro15-1788 (flumazenil), acts to 
prevent the binding ofbenzodiazepine agonists to the receptor, with no intrinsic 
activity of its own. Inverse agonists act as negative modulators, to decrease the 
opening frequency ofthe channel (Turner eta/., 1991; SmartT., 1998). Ro15-4513 is 
a partial inverse agonist at GABAR, which has high affinity for the a.4 and a.6 
GABAR subunits and proconvulsant properties (Barnard et al., 1998). 
Sieghart et al., in 1987 reported that BZ pharmacology can be divided into two 
classes of binding site, benzodiazepine-sensitive (BZ-S) which can be blocked by 
diazepam and benzodiazepine-insensitive (BZ-IS) which are unaffected by BZ 
binding. It is the subunit composition of the GABAA receptor that confers its 
pharmacology. The combination ofa.1, a.3, a.5, J3 and y2 subunits confers 
benzodiazepine sensitivity. The BZ-IS subtype of receptor is a subpopulation of 
receptors located predominantly in the cerebellum, with minor populations in the 
hippocampus and cortex. Turner et al., in 1991 proposed that BZ-IS receptors are 
composed of a.4 or a.6, J3 and y2 subunits. The a. subunit thus influences the 
receptor's benzodiazepine pharmacology. Type I pharmacology is indicative of 
a.1J3y2, present in the adult cerebellum. Type ll pharmacology is conferred by the a.2, 
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a.3 and a.5 subunits and is the predominant subtype expressed in the developing 
cerebellum. 
It is possible to distinguish between y2 and cS-subunit containing GABAR in the 
cerebellum by using a combination ofradioligands in binding studies.[~] Rol5-
4513 binds to y2-containing GABARonly, while, eHJ muscimol has high affinity 
for both y2 and cS-containing receptors. Therefore, by difference analysis, it is 
possible to determine contributions of both y2 and cS-containing GABAR to a 
receptor population. 
Brown eta/. in 2002 characterised the pharmacological differences between human 
a.4f33cS and a.4f3312 GABAR in a stable cell line (mouse L9-tk) cells). cS-containing 
GABAR were shown to exhibit a higher sensitivity for GABA when compared to Yr 
containing receptors, but also cS-containing receptors had a higher efficacy for GABA 
partial agonists, piperidine-4-sulphonate (P4S) and 4,5,6,7-tetrahydroisothiazolo-
[5,4-c]pyridin-3-ol (THlP). It was also proposed that cS-containing receptors have a 
greater sensitivity to lanthanum (a cation) than yrcontaining receptors and a low 
sensitivity for zinc. The cS subunit has been proposed to confer slow desensitization 
to GAB A, insensitivity to modulation by benzodiazepine ligands and enhanced 
sensitivity to neurosteroids (Spigelman eta/., 2002, 2003; Stell and Mody, 2003). 
1.3. Non-NMDA Receptors: a.-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic 
(AMP A) Receptors and Kainate Receptors 
Non-NMDA receptors mediate fast excitatory neurotransmission in the central 
nervous system (CNS). a.-amino-3-hydroxy-5-methylisoxazole-4-propinoic acid 
receptors (AMPAR) are heterotetrameric structures composed ofGluRl-4 subunits 
(also known as GluRA-D). Kainate receptors consist ofGluR5-7 and KAI-2 subunits 
(For review see Bettler and Mulle, 1995). Each subunit consists of a large 
eXtraCellular amino terminal domain, four membrane-associated domains where the 
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second transmembrane domain forms a re-entrant loop, to result in an intracellular 
carboxy terminus (see figure 1.5.). 
The extracellular and transmembrane domains of the AMP AR subunits are similar, 
sharing 68-74% amino acid identity, while the intracellular C-terminal tail is distinct 
between subunits, forming splice variants (Song and Huganir, 2002). The GluR1, 
GluR4 and GluR2L possess long cytoplasmic tails, while the predominant splice 
variant of the GluR2 subunit, GluR3 and the alternative splice form of GluR4 which 
is predominant in the cerebellum, possess short cytoplasmic tails (For review see 
Malinow and Malenka, 2002). 
AMP AR are dynamic in their association with the post-synaptic density in that they 
are able to translocate into and out of the postsynapse. Modulation of AMPAR 
synaptic transmission underlies forms of synaptic plasticity, examples of which are 
long-term potentiation (LTP) and long-term depression (LTD), models oflearning 
and memory (Malenka and Nicoll, 1999; Malinow and Malenka, 2002; Song and 
Huganir, 2002). 
Proteins which interact with AMP AR can be separated into two groups, those that 
contain postsynaptic density-95, discs large, zonula occludens (PDZ) domains and 
those that interact via non-PDZ domains (Braithwaite eta/., 2000; Henley, 2003). 
Association of AMP AR with interacting proteins, via the C-terminal tail is important 
for AMP AR trafficking-dependent forms of plasticity, providing a mechanism for 
clustering of ion channels and receptors at the plasma membrane and also to direct 
kinases and phosphatases towards their substrates (Braithwaite eta/., 2000; Chen et 
a/., 2000; Henley, 2003). Proteins important in signalling, trafficking and targeting 
belong to the PDZ protein superfamily which bind with high affinity to short PDZ-
binding motifs in the intracellular domain of the AMPAR subunits (Kittler and Moss, 
2001b). 
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Figure 1.5. Structure of an AMP A receptor 
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A: Structure of an AMP AR subunit, consisting of four membrane-associated 
domains with extracellular amino terminus and intracellular carboxy terminus. 
B: Structure of an AMP A receptor, composed of a tetrameric arrangement of 
AMPAR subunits, ofGluR1 -4. 
Glutamate receptor interacting protein (GRIP) was the first protein shown to interact 
with AMP AR by yeast two-hybrid analysis. GRIP is a 130 kDa protein which 
contains seven PDZ domains, the third, fifth and sixth of which bind to the C-termini 
of the AMP AR GluR2 and GluR3 subunits (Dong eta/., 1997). AMP A receptor 
binding protein (ABP) shares a 64-93% homology in PDZ domains to GRIP. ABP 
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similarly contains seven PDZ domains, of which the third, fifth and sixth PDZ 
domains interact with the C-termini of GluR2 and GluR3 (Srivastava eta/., 1998). 
The exact function of GRIP I ABP is not fully resolved, although it has been proposed 
to serve a scaffolding function, stabilising AMPAR at the synapse (Liu and Cull-
Candy, 2005). 
Protein interacting with C-kinase (PICK 1) is a further PDZ-containing protein which 
has been shown to interact with AMPAR GluR2, GluR3 and GluR4 subunits via a 
single PDZ domain within its structure (Dev eta/., 1999; Xia eta/., 1999). PICK1 is 
a postsynaptic scaffold protein which in heterologous expression systems has been 
shown to aggregate AMPAR (Bredt and Nicoll, 2003). 
Synapse associated protein of97 kDa (SAP97) is a member of the synapse 
associated protein family, which includes SAP90 (PSD-95), chapsyn110 (PSD-93) 
and SAP1 02, which have been shown to interact with NMDA receptor subunits 
(Henley, 2003). SAP97 is the only PDZ protein currently known to interact directly 
with the C-terminus of the AMPAR GluR1 subunit (Sans eta/., 2001 ). It has been 
proposed that SAP97 has a role in AMP AR targeting and acts to cluster GluR1-
containing AMP AR, but not in endocytosis, and therefore may fulfil a chaperone 
function (Braithwaite eta/., 2000; Sans eta/., 2001; Henley, 2003). 
Non-PDZ protein interactions with AMP AR include N-ethylmaleimide-sensitive 
factor (NSF) which binds to the C-termini of GluR2 and GluR3 subunits, acting to 
play a role in regulating membrane insertion and stabilisation of AMP AR 
(Nishimune eta/., 1998; Song eta/., 1998). Neuronal activity-regulated pentraxin 
(Narp) is a neuronal immediate early gene product, forming a member of a secretory 
family of proteins, the pentraxins. Narp interacts with all AMP AR subunits via the 
extracellular domain ofthe subunit, acting to increase synaptic clustering of AMPAR 
(Henley, 2003; Bredt and Nicoll, 2003). 4.1 proteins are a family of cytoskeletal 
coll_lp~nents. 4.1 Nand 4.1 G interact with the C•terrninus of the GluRl subunit at the 
synapse. It has b~~n proposed that the 4.1 proteins acHo provide a link between 
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GluR1 and the actin cytoskeleton (Shen eta/., 2000). Lyn is a src-family non-
receptor protein tyrosine kinase, which couples to the AMP AR GluR2 and GluR3 
subunits to initiate signalling via the mitogen-activated protein kinase (MAPK) 
signalling cascade. This in tum activates transcription ofDNA encoding brain-
derived neurotrophic factor (BDNF) which has been shown to be involved in 
synaptic plasticity and the development of the nervous system (see section 1.4.4.1) 
(Hayashi eta/., 1999). 
Table 1.3. Summary of AMPAR interacting proteins 
INTERACTING INTERACTING DOMAIN AMPAR SUBUNIT 
PROTEIN 
SAP-97 PDZ GluR1 
GRIP PDZ GluR2, GluR3 
ABP PDZ GluR2, GluR3 
PICK1 PDZ GluR2, GluR3, GluR4 
NSF Non-PDZ GluR2, GluR3 
Narp Non-PDZ GluR1, GluR2, GluR3, 
GluR4 
4.1N Non-PDZ GluR1 
4.1G Non-PDZ GluR1 
Lyn Non-PDZ GluR2, GluR3 
The first transmembrane AMP AR interacting protein identified was stargazin, the 
protein mutated in the stargazer mutant mouse (Letts eta/., 1998). 
1.4. The stargazer mutant mouse 
The stargazer mutant mouse is an animal model of human absence epilepsy and 
cerebellar ataxia. The stargazer mutation arose spontaneously in the NJ inbred 
mouse line at The Jackson Laboratory, Maine, USA, and was recognised by its 
distinctive head tossing and ataxia. The recessive mutation was mapped to mouse 
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chromosome 15 and was determined to result from a 6 kb early viral transposon 
insertion into intron 2 of the stargazin gene (Noebels eta/., 1990; Letts eta/., 1998). 
The insertion of the transposon results in the premature transcriptional arrest of the 
stargazin gene which encodes a membrane-spanning protein, stargazin of323 amino 
acids with a molecular weight of36-41 kDa (Letts eta/., 1998; Sharp eta/., 2001). 
Stargazin mRNA distribution was determined by RT -PCR to be brain-specific, no 
expression was observed in heart, spleen, lung, liver, skeletal muscle, kidney or testis 
(Letts eta/., 1998). High levels of expression were observed in the cerebellum, 
olfactory bulb, cerebral cortex, striatum, pons, thalamus, CA3 and dentate gyrus of 
the hippocampus (Letts eta/., 1998; Klugbauer eta/., 2000; Sharp eta/., 2001 ). 
Stargazin protein was determined to share a similar putative secondary structure with 
they subunit of skeletal muscle voltage-dependent calcium channel, y1, comprising 
four transmembrane domains and cytosolic amino and carboxy termini. A 25% 
sequence identity in primary structure was also observed between the two proteins. 
Heterologous expression of stargazin demonstrated that the protein had relatively 
minor effects on P/Q, L-and T-type calcium channel kinetics and cell surface 
trafficking (Letts eta/., 1998; Klugbauer eta/., 2000; Rousset eta/., 2001; Green et 
a/., 2001 ). Stargazin was therefore proposed to be a neuronal counterpart of the 
skeletal muscle-specific calcium channel subunit, y1 and was termed y2 (Letts eta/., 
1998). 
1.4.1. The CACNG family of y subunits 
Voltage-dependent calcium channels are heteromultimeric complexes of a.1, (3, a.28 
andy subunits which assemble in a 1:1:1:1 subunit stoichiometry. The a.1 subunit 
forms the central pore of the channel and thereby determines the major function of 
the channel. All auxiliary subunits act to modulate the voltage-dependence and 
kinetics of the channel (Burgess eta/., 1999; Chu eta/., 2001 ). The discovery of 
stargazin expanded the calcium channel y subunit family to include a neuronal-
specific y subunit, in contrast to the skeletal muscle-specific y1. To date, a total of 
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eight calcium channel y subunits have been identified y1-y8 (genes: CACNG1-8), 
which have distinct tissue distributions in mouse and human, summarised in table 
1.3. (Burgess et al., 1999 (human y2, y3, y4, y5); Klugbauer eta/., 2000 (mouse y3, 
y4, y5); Moss eta/., 2001 (y7); Chu eta/., 2001 (rat y6, y7, y8)). Chu eta/., in 2001 
suggested that the calcium channel y subunit family could be functionally subdivided 
into two groups, based on sequence similarity, tissue distribution and evolutionary 
relationships. The first group ofy subunits are those that could act as auxiliary 
subunits to associate with calcium channels (y1 and y6). A second subgroup are those 
that have a role in mediating protein trafficking, such as y2 in targeting AMP AR to 
postsynaptic sites via an interaction with PDZ proteins. Analysis of sequence 
similarity within the y subunit family identified a common PDZ binding domain at 
the C-terminus ofy2, y3, y4 and y8, which are also robustly expressed in the brain. 
Adapted from: Qiao and Meng, 2003 
Figure 1.6. Phylogenetic tree of the putative calcium channel y subunit family 
Common branching points represent shared ancestor sequences. Pairs indicate 
higher sequence identity than to other members of the family. Shaded area indicates 
members of the transmembrane AMP A receptor regulatory protein (T ARP) family 
(Burgess eta/., 1999;Klugbauereta/., 2000;Chuetal., 2001;Mosseta/., 2001; 
Tomita et al., 2003). 
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Table 1.4. The CACNG fiunily of calcium channel subunit mRNA and protein expression 
y1 y2 y3 y4 y5 y6 y7 y8 
Distribution: Cerebellum - +++ - + - - ++ -
Cerebral cortex 
- +++ +++ +++ - - ++ ++ 
Hippocampus - ++ + +++ - - ++ +++ 
Midbrain 
-
++ ++ +++ 
- - - -
Striatum - ++ ++ +++ - - - -
Thalamus - ++ + + - - ++ -
Heart 
- - - -
+ +++ + -
Liver 
- - - - +++ - - -
Lung 
- - - - + + + -
Kidney - - - - ++ - - -
Skeletal muscle +++ -
- -
+ ++ 
- -
Testes - - - - + - - + 
References: Chu eta/., Klugbauer Klugbauer Klugbauer Klugbauer Chu eta!., Chu eta!., Chu eta/., 
2001 eta/.,2000 eta!., 2000 eta/.,2000 eta!., 2000 2001 2001. 2001 
Sharp et Sharp et Sharp et Moss et Tomita et 
a!., 2001 a/., 2001 a/., 2001 a/., a!., 2003 
2002 
--- --- -- -- -~ 
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1. 4. 3. Transmembrane AMP A receptor regulatory proteins (T ARPs) 
Tomita eta/., in 2003 defined the proposed subgroup of calcium channel subunits, as 
a family of transmembrane AMP A receptor regulatory proteins (T ARPs ). The 
identification of a calcium channel subunit as a member ofthe TARP family was 
based on the ability of the subunit to rescue glutamate-evoked responses in stargazer 
cerebellar granule cells (CGCs), CGCs that fail to express AMPAR at the cell 
surface as a result of ablation of stargazin expression. Subsequently, stargazin (y2), 
y3, y4 and y8 were identified as members of the TARP family (Tomita eta/., 2003). 
Mapping ofTARP isoform mRNA and protein distribution by a combination of in 
situ hybridisation and western blotting techniques demonstrated that T ARPs had 
overlapping distributions in the brain, such that one cell type could possess a number 
ofTARP isoforms (see table 1.1.). Furthermore, immunogold and 
immunofluorescence methods using pan-T ARP antibodies revealed the selective 
location ofT ARPs at punctate sites on dendrites corresponding to excitatory 
synapses, evidenced by overlap of staining with AMP AR GluR2 subunit and 
postsynaptic density protein of95 kDa (PSD-95) (Tomita eta/., 2003). 
Immunoprecipitations of Triton X-1 00 soluble brain extracts further confirmed the 
association ofTARPs with AMPAR Stargazin co-immunoprecipitated with 
AMPAR GluRl, 2 and 4 subunits in control cerebellum, y3 co-associated with 
AMP AR subunits in cortex, y4 in neonatal forebrain, and y8 in hippocampus (See 
chapter 7; Tomita eta/., 2003; Rouach eta/., 2005). 
1.4.3.1. Stargazin (T ARPy2) 
Stargazin, also known as T ARPy2, whose expression is completely ablated in 
stargazer mutant mice, possesses four putative transmembrane domains and 
cytosolic N and C-termini. The C-terminus contains a PDZ binding motif (-
RRTTPV), a protein-protein interaction motif which interacts with PSD-95 at the 
synapse. 
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Chen eta/., in 2000 identified two mechanisms by which T ARPy2 functions to 
control AMP A receptor number at the synapse. T ARPy2 regulates the delivery of 
AMP AR to the membrane surface, a function which does not require the PDZ-
domain of the protein. Stargazer cerebellar granule cells express reduced levels of 
AMPARsubunits GluR2 and 4 (Ives eta/., 2004), furthermore, functional receptors 
are not delivered to the cell surface. Transfection ofT ARPy2 into these cells 
restored normal AMPAR function (Chen eta/., 2000a). 
The second mechanism of AMP AR trafficking for which stargazin is responsible is 
the synaptic targeting of AMP AR. Deletion of the final four amino acids of the C-
terminal tail ofTARPy2 protein (stargazinAC) disrupted the association ofTARPy2 
with PSD-95, indicating a critical role for the PDZ domain ofT ARPy2 in the 
synaptic clustering of AMP AR (Chen eta/., 2000). Chimeric analysis, by 
systematically switching sections of the y5 structure with T ARPy2 domains 
identified the first intracellular loop and intracellular tail ofT ARPy2 critical in 
AMPA trafficking, more specifically, C-terminal residues 212-268 (Tomita eta/., 
2004). 
In support ofthe role ofTARPy2 in the synaptic targeting of AMPAR to the cell 
surface, Schnell eta/., in 2002, demonstrated that overexpression ofT ARPy2 
resulted in a selective increase in extrasynaptic AMP AR excitatory postsynaptic 
currents (EPSCs ). Clustering of these receptors at the synapse required increased 
expression of the synaptic anchor, PSD-95. Transfection of the stargazinAC clone, 
lacking the PDZ domain, into slice cultures resulted in decreased clustering of 
AMP AR and decreased AMP AR EPSCs (Schnell eta/., 2002). 
Vandenberghe eta/., in 2005a identified TARPy2 as an auxiliary AMPAR subunit in 
cerebellar extracts. T ARPy2 was shown to associate with all four AMP AR subunits, 
but only within a tetrameric receptor structure, no free T ARPy2 was detected in 
cerebellar extracts. Hence, two receptor populations were identified, a functional 
form which is associated with T ARPy2, and an apo-form which lacks T ARPy2. 
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AMPAR of the stargazer mutant cerebellum show an immature endoplasmic 
reticulum-type of glycosylation pattern, consistent with a role forT ARPy2 in the 
transport of AMP AR from the endoplasmic reticulum (ER). Furthermore, in a later 
study, Vandenberghe and coworkers revealed that the unfolded protein response is 
up-regulated in stargazer CGCs, a homeostatic pathway that up-regulates genes 
encoding ER chaperones such as lg binding protein (BiP), to prevent accumulation 
of unfolded and unassembled proteins in the ER, indicating a role forT ARPy2 in ER 
processing of AMP AR (Vandenberghe eta/., 2005b). 
Synaptic plasticity involves protein phosphorylation cascades that alter the number 
of AMP AR at the synapse. The cytosolic C-terminus ofT ARPy2 contains a number 
of serine, threonine and tyrosine residues that may act as substrates for 
phosphorylation. Interestingly, the PDZ domain ofthe TARPy2 C-terminal tail 
overlaps with the consensus sequence for phosphorylation by protein kinase A 
(PKA). TARPy2 is basally phosphorylated at a critical threonine residue (T321) by 
PKA in the brain (Choi eta/., 2002). As a consequence ofphosphorylation, 
TARPy2 selectively loses its interaction with PSD-95. Choi eta/., in 2002 
demonstrated that mutations mimicking phosphorylation at T321 disrupted 
interactions with PSD-95 and synapse-associated protein of97 kDa (SAP-97) both 
in the yeast 2-hybrid system and biochemical associations and clustering ofT ARPy2 
and PSD-95 in heterologous cells. Furthermore, a T ARPy2 phosphomimic (Thr 
321 ~ Glu) transfected into cultured hippocampal neurons acted to reduce the 
frequency and amplitude of AMP AR-mediated EPSCs ( Chetkovich eta/., 2002). 
In contrast, Tomita et al., in 2005a proposed that only serine residues of the C-
terminal tail ofTARPy2 are phosphorylated in cultured cerebrocortical neurons. The 
group demonstrated that phosphorylation ofT ARPy2 was dynamically regulated by 
activation of calcium-calmodulin kinase ll (CaMKII) and protein kinase C (PKC) to 
induce phosphorylation, whereas activation of protein phosphatases, PPI and PP2B 
dephosphorylate serine residues. Phosphorylation ofT ARPy2 facilitates synaptic 
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trafficking of AMP AR to the surface through interaction with PDZ proteins. 
Furthermore, phosphorylation ofTARPy2 was found to be important in hippocampal 
long-term potentiation (L TP), while dephosphorylation mediates long-term 
depression (LTD) (Tomita eta/., 2005a). 
1.4.4. The phenotype of the stargazer mutant mouse 
The phenotype of the stargazer mutant appears at postnatal day 14, and manifests in 
cerebellar ataxia, impaired eye-blink conditioning responses and a characteristic 
head toss, from which the mutant was named (star-gazing) (Qiao eta/., 1996; 1998). 
At PIS, the mutant begins to exhibit spontaneous bilaterally symmetrical 6-7 Hz 
spike-wave discharges at a frequency of -150 per hour which originate in the 
reticulothalamocortical circuit, acting to persistently activate neocortical and 
hippocampal networks (Qiao and Noebels, 1993). 
1.4.4.1. Cerebellum 
The ataxia observed in the stargazer mutant on a flat surface has been reported to be 
mild in the hind limbs, without obvious forelimb involvement, with a normal 
righting response (Qiao eta/., 1996). Stargazer mice are severely impaired in motor 
coordination and balance. In motor coordination and balance tests on a stationary 
balance rod, all stargazer mice tested fell off the rod after <5 seconds either when 
initiating movement or when the rod was rotated slowly. In contrast, all control mice 
tested were able to remain on the rod for the entire duration of the experiment (60 
seconds) (Qiao eta/., 1996). Classical eyeblink conditioning is a form of 
sensorimotor learning that depends on the cerebellum and therefore allows for the 
determination of changes in cerebellar function that can be correlated with 
biochemical abnormalities (Thompson, 1990). The stargazer mutant is severely 
impaired in the acquisition of eye blink conditioning when compared to control 
littermates (Qiao eta/., 1998). 
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The cerebellum of the stargazer mutant has been reported to be mildly hypoplastic in 
that the net wet tissue weight of the stargazer cerebellum was reduced by 14%. Qiao 
eta/., in 1996 reported no major cytoarchitectural abnormalities in the stargazer 
cerebellum, with a well defined laminar cortical structure and cerebellar foliation, 
indicating a generalised reduction in all anatomical elements, rather than a specific 
structural abnormality. However, an increased number of external granule cells were 
observed in the stargazer cerebellum at P15 (226% of controls), where granule cells 
demonstrated elongated oval shaped nuclei with few scattered lumps of coarse 
chromatin around the nuclear membrane, characteristic of migrating, immature 
CGCs (Qiao eta/., 1998). 
Neurotrophic factors play an important role in the development of the nervous 
system and have been implicated in the proliferation, migration, differentiation and 
maturation of cerebellar granule cells (Segal et al., 1992~ Gao et al., 1995~ Das eta/., 
2001~ Borghesani eta/., 2002). The family ofneurotrophins include nerve growth 
factor (NGF), brain-derived neurotrophic factor (BDNF) and the neurotrophins 3 
and 4/5 (NT -3, NT -4/5). The neurotrophins have different spatiotemporal expression 
patterns in the developing brain. Das eta/., in 2001 proposed different roles for 
neurotrophic factors in cerebellar development, where in early development, these 
factors regulate the proliferation, differentiation and survival ofCGCs. Whereas, in 
adulthood, their role becomes more functional in the regulation, maintenance and 
survival of CGCs. 
Interestingly, levels ofbrain-derived neurotrophic factor (BDNF) mRNA were 
reported to be reduced by 70% in the whole stargazer cerebellum, with a near total 
ablation ofBDNF mRNA expression in the cerebellar granule cell layer at P15, 
coincident with the onset of ataxia (Qiao eta/., 1996). Levels of neurotrophins NT -3 
and nerve growth factor (NGF) and BDNF TrkB receptor mRNA and protein were 
found to be normal in the stargazer cerebellum. However, a reduction in constitutive 
and NT -4/5 induced tyrosine phosphorylation ofPLCy1, a trkB signal transduction 
protein, suggested a deficit in trkB signalling in the stargazer mutant cerebellum 
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(Qiao eta/., 1998). 
A number of abnormalities in excitatory and inhibitory neurotransmission in the 
stargazer cerebellum have been reported, which could underlie the cerebellar ataxia 
and deficits in motor learning observed in the mutant (Qiao eta/., 1998). Excitatory 
postsynaptic currents (EPSCs) at mossy fibre-granule cell synapses are devoid of the 
AMP AR-mediated fast component of excitatory neurotransmission, without a 
significant change in the N-methyl-D-aspartate receptor (NMDAR) mediated slow 
component. This abnormality was proposed by Hashimoto and co-workers in 1999 
to result from defects in postsynaptic AMP AR function rather than a failure of 
presynaptic glutamate release. Characterisation of AMP AR subunit rn.RNA and 
protein expression levels in control and stargazer mice has produced conflicting 
evidence. Hashimoto et al. in 1999 state that expression of the four AMP AR subunit 
mRNAs are comparable with those found in wild type mice, as revealed by in situ 
hybridisation. In contrast, Ives et al. in 2004 report differences in AMP AR subunit 
protein expression levels in stargazer mice, particularly in GluR2 expression. 
Chen et al. in 2000 implicated T ARPy2, the mutated protein, in the regulation of the 
cell surface expression and synaptic targeting of AMP AR. Hence, AMP AR are not 
expressed at the cerebellar granule cell surface as a result of the failure in receptor 
trafficking and anchoring in the membrane through the interaction of the carboxyl 
terminus with PDZ domains ofPSD-95, a postsynaptic density protein (see section 
1.4.3.1.). 
Abnormalities in the inhibitory GABAR profile of the stargazer mouse have also 
been reported by Thompson eta/., in 1998. During the maturation of the cerebellum, 
expression of the GABAR subunits is subject to temporal regulation, such that there 
is a switch in expression of subunits, from a2/a3 to a6 and 8 (Laurie et al., 1992). 
Subsequently, the GABAR a6 and 8 subunits can be used as markers of maturity in 
the cerebellum. Thompson eta/., in 1998 reported a dramatic reduction in 
expression of the GABAR a6 and (33 subunits in the stargazer mutant cerebellum, 
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by western blot analysis (to 23 ± 8% and 38 ± 12% of control levels respectively). 
Furthermore, the benzodiazepine-insensitive subtype ofeH] Ro15-4513 binding 
was reduced to 3 8 ± 10% of control levels, indicating a loss of a6f33y2 GABAR in 
the stargazer mutant. 
1.4.4.2. Hippocampus 
In contrast to cerebellar granule cells, granule cells of the dentate gyrus (DG) are not 
electrically silent in the stargazer mutant. The stargazer mutant exhibits spontaneous 
bilaterally symmetrical 6-7 per second spike-wave discharges in cortical and 
hippocampal brain areas, which represent ~20% of total waking 
electroencephalographic (EEG) activity (See figure 1.7.; Qiao & Noebels, 1993). 
Onset of seizure activity has been shown to occur between postnatal days 16-18 
(P16-18), with a frequency of~ 150 bursts per hour (Qiao & Noebels, 1993). The 
spike-wave pattern of generalised synchronous activity has been shown to generate 
primarily in the thalamus and neocortex to activate synaptically linked brain areas, 
such as the hippocampus via the dentate gyrus. 
Accumulation of continuous seizure activity has been shown to correlate with an 
increase in mossy fibre sprouting in the inner molecular-granule cell layer of the 
dentate gyrus, which occurs at 4-6 weeks following seizure onset (Qiao & Noebels, 
1993). In contrast to convulsive seizure models such as kainic acid treatment, 
kindling and pentylenetetrazole (PTZ) which are associated with cellular injury, 
death and gliosis (Nahm & Noebels, 1998), no significant cell death of granule cells 
in the dentate gyrus (DG), CA3 pyramidal cells or hilar polymorph cells was noted 
following non-convulsive seizures in the stargazer mutant (Qiao & Noebels, 1993). 
Chronic depolarisation in convulsive seizure models also results in an adaptive 
modification of inhibitory neurotransmission to balance increased excitation, 
manifesting in alterations in the function, pharmacology, targeting and clustering of 
GABAR (Brooks-kayal eta/., 1998; Clark, 1998; Cohen eta/., 2003; Peng eta/., 
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2004). No abnormalities in GABAR expression have been reported in the stargazer 
DG to date. However, a number of convulsive seizures have also been reported to 
induce rearrangements in the GABAR expression proftles in the hippocampus. The 
rat model of mesial temporal lobe epilepsy has been reported to result in an increase 
in spontaneous miniature inhibitory postsynaptic currents (miPSCs) in dentate 
granule cells of epileptic rats compared to controls, suggesting an increase in 
GABAR number (Brook-kayal eta/., 1998~ Shumate eta/., 1998~ Cohen eta/., 
2003). Furthermore, GABA responses were found to demonstrate minimal 
augmentation by zolpidem and increased blockade of the GABA response by zinc in 
epileptic rats (Brook-kayal eta/., 1998~ Cohen eta/., 2003). This alteration in 
GABA responses was reported to be paralleled by a reduction in GABAR a.1 
subunit expression (54% of controls), responsible for the reduction in amplification 
of GABA responses to zolpidem and increases in GABAR a.4 (175% of controls) 
and o (225% of controls) subunit mRNA expression, conferring increased sensitivity 
to zinc blockade (Brook-kayal eta/., 1998). 
In the pilocarpine model oftemporallobe epilepsy, Peng eta/., in 2004 reported a 
reduction in GABAR o subunit protein in the molecular layer of the dentate gyrus, 
while a time-dependent increase in GABAR o subunit immunoreactivity was noted 
in the many GABAergic intemeurons. In the same temporal lobe epilepsy model, 
Leroy eta/., in 2004 demonstrated a 40% increase in GABAR-mediated IPSCs and a 
reduction in the effectiveness of diazepam (65% compared to controls) at increasing 
the decay time ofGABAR-mediated miPSCs 24-48 hours after pilocarpine 
treatment. Furthermore, a loss of neurosteroid sensitivity was reported, 
corresponding to a decrease in a.4J3o GABAR 
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B 
c 
OML 
IML 
GC 
Hilar mossy cells 
1 stglstg 1 
1 stg/stg 1 
OML 
IML 
Mossy fibre sprouting 
>---ERC 
Hilar mossy cells 
Figure 1.7. Effects of the stargazer mutation on the dentate gyrus circuitry 
A: Structure ofthe hippocampus. DG: Dentate gyrus, G: Granule cell layer, H: 
Hilus, ML: Molecular layer, 
B: Representative EEG traces from control and stargazer hippocampal brain areas, 
demonstrating spontaneous bilaterally symmetrical 6-7 per second spike-wave 
discharges in the stargazer mutant mouse (Qiao and Noebels., 1993) 
C: Schematic representation of cellular differences between control and stargazer 
dentate gyri (DG). ERC: Entorhinal cortex, GC: Granule cell, IML: Inner molecular 
layer, OML: Outer molecular layer, P: Pyramidal cell. (Lynd-Balla eta/., 2004). 
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In contrast to decreased BDNF mRNA expression and trkB signalling in stargazer 
cerebellar granule cells (CGCs), the dentate granule cells (DGCs) of the stargazer 
mutant are subject to intermittent elevated BDNF expression (Chaftez eta/., 1995 ~ 
Nahm and Noebels., 1998). Koyama eta/., in 2004 identified a role for BDNF 
signalling in the induction of mossy fibre sprouting. Activation of trkB signalling in 
the hippocampus has been shown to influence the maturation of GABAergic factors 
in cultured hippocampal neurons, including increased expression of GABAR J3213 
subunits (Yamada eta/., 2002), increased GABAR cluster number and synaptic 
localisation (Elmiariah eta/., 2004), as well as increased PKC phosphorylation, 
surface expression of GABAR J33 subunit containing receptors (Jovanovic eta/., 
2004). 
1.5. Aims of the study 
Thompson eta/., in 1998 reported differences in the GABAR receptor complement 
expressed in the cerebellum of the stargazer mutant mouse. The abundance of total 
specific [:n] Ro15-4513 binding sites was not found to differ significantly between 
control and stargazer mice. However, determination of the contribution ofBZ-S and 
BZ-IS subtypes of receptor to the total receptor population indicated a reduction in 
the BZ-IS subtype of receptor to 38 ± 10% of control levels. The GABAR a6 
subunit-containing receptors are the principal contributors to this receptor 
subpopulation (Sieghart eta/., 1987). This decrease in BZ-IS binding correlated with 
the reported decrease in the expression of the GABAR a6 subunit to 23 ± 8% in the 
stargazer mutant cerebellum as determined by western blot analysis. The previous 
study did not use the appropriate background strain of mouse (C57BU6J) compared 
to the C3B6Fe +strain used in the current study. Furthermore, the full complement of 
GABARs were not investigated, the study favoured the y2-subunit containing 
GABARs, without investigating the extrasynaptic, B subunit-containing GABARs. A 
mechanistic explanation for the abnormalities in GABAR expression in the stargazer 
mutant was also not offered in the previous study. 
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Therefore, the aim of the current study was to determine the effects of the stargazer 
mutation on the complete GABAR complement in the stargazer mutant, using the 
appropriate background strain, with a particular focus on the expression and 
trafficking of the extrasynaptic GABAR 8 subunit. 
In the first instance, the GABAR subunit expression was to be determined 
quantitatively in control and stargazer cerebellum by western blotting and qualitative 
differences in distribution ofGABAR subunits by immunohistochemical mapping 
using subunit-specific antibodies. Furthermore, radioligand binding techniques were 
to be employed to control and stargazer cerebellar membranes and tissue sections to 
determine the extent of any GABAA receptor deficits in the stargazer mutant. 
Following in vivo characterisation of GABAR abnormalities in the stargazer mutant 
cerebellum, cerebellar granule cells were to be employed as a dynamic model 
system with which the trafficking and targeting of the GABAR 8 subunit could be 
studied in vitro. Furthermore, to determine the effects of excitatory inputs on 
GABAR subunit expression by the comparison of GABAR expression in control 
('AMPAR and kainate receptor-competent') and stargazer ('AMPAR-incompetent') 
CGCs by western blotting and radioligand binding techniques. 
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CHAPTER 2. MATERIALS AND METHODS 
2.1. MATERIALS 
Laboratory reagents purchased were of the highest quality available from VWR 
(Leicestershire, UK) or Sigma (Poole, Dorset, UK) with exceptions listed below. 
2.1.1. Radiochemicals 
eH] Muscimol (29.5 Ci/mmol) and eH] Ro15-4513 (20.0 and 28.3 Ci/mmol) 
were obtained from PerkinElmer Lifesciences (Boston, MA). Ro 15-1788 and 
Flunitrazepam were a gift from Hoffmann LaRoche (Basle, Switzerland). 
Zolpidem was obtained from Tocris (Bristol, UK). eH] Flunitrazepam (91 
Ci/mmol) and eH] Hyperfilm were purchased from Amersham Pharmacia 
(Aylesbury, Buckinghamshire, UK). Ecoscint and Decon 90 were obtained from 
National Diagnostics Ltd. (Hull, UK). 
2.1.2. Antibodies 
Anti-GABAR a1 (1-14Cys) subunit specific antibody used in 
immunohistochemical assays was provided by Professor F.A. Stephenson 
(School ofPharmacy, London, UK). Anti-GABAR a4 (1-14) (Ebert eta/., 1996), 
P1 (350-375) (Jechlinger eta/., 1998), P2 (351-405) (Jechlinger eta/., 1998), p3 
(345-408) (Slany eta/., 1995), & (1-44) (Jones eta/., 1997) and 12 (319-366) 
(Tretter eta/., 2001) subunit-specific antibodies were provided by Professor W. 
Sieghart (Brain Research Institute, University of Vienna, Austria). Affinity 
purified C-terminal anti-T ARPy2 (Cys DSLHANT ANRR TTPV), anti-T ARPy8 
(MESLKRWNEERGLW Cys) (Payne eta/., 2006 (in preparation)), anti-
NMDAR NR1 (17-35), anti-GABAR a.1 (1-15cys) (Thompson eta/., 2000) used 
in lmrimnoblots and anti-GABAR a6 (1-15cys) (Ives eta/., 2002) subunit-
specific antibodies were prepared in the laboratory as previously described by 
Pollard eta/., 1993. Anti-neuron-specific enolase (NSE) antibody was obtained 
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from Affiniti Research Products Ltd. (Nottingham, UK). Anti-~-actin antibody 
was obtained from Sigma. Anti-AMP AR GluR2 and anti-AMP AR GluR4 were 
obtained from Santa Cruz Biotechnology (Autogen Bioclear, calne, Wiltshire, 
UK). Anti-AMP AR GluR1 was provided by Cambridge Research Biochemicals 
(Billingham, UK). 
2.1.3. PCR reagents 
100 bp DNA ladder, Taq polymerase, and deoxynucleotides (dATP, dGTP, 
dCTP and dTTP) were obtained from Promega (Southampton, Hampshire, UK). 
Sequence specific primers were synthesised by Invitrogen (Paisley, UK). 
2.1.4. CeU Culture 
Modified Eagle Medium (MEM) + Earles salts - L-glutamine, Neurobasal A 
medium and B-27 supplement were obtained from Invitrogen/Gibco (Paisley, 
UK). Foetal calf serum was purchased from Perbio (Cheshire, UK). Sulfolink 
NHS-SS-biotin was obtained from Pierce (Chester, Cheshire, UK). Poly-L-
lysine, insulin, FDU, nifedipine and streptavidin beads were obtained from 
Sigma (Poole, UK). Kainic acid, CNQX and verapamil were purchased from 
Tocris (Bristol, UK). Transferrin was obtained from Calbiochem (Darmstadt, 
Germany). L-glutamine was obtained from ICN (Ohio, USA). 
2.1.5. Miscellaneous 
Horseradish peroxidase-linked anti-rabbit secondary antibody, Horseradish 
peroxidase-linked anti-mouse secondary antibody, and ECL Hyperfilm, were 
purchased from Amersham Pharmacia (Aylesbury, Buckinghamshire, UK). 
Horseradish peroxidase-linked anti-goat secondary antibody was obtained from 
Pierce (Chester, Cheshire, UK). Vecta-stain Elite ABC kits (avidin-biotin-
peroiidase method) were-ptitchased from Vector Laboratories (Peterborough, 
UK). Prestained precision protein standards (10-250 kDa) were obtained from 
Bio-rad (Hertfordshire, UK). Nuclei lysis solution and protein precipitation 
solution were purchased from Promega (Southampton, Hampshire, UK). 
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2.2. ANIMALS 
Wild type (C3B6Fe+, +/+),heterozygous (C3B6Fe+, +/stg) and homozygous 
stargazer mutant mice (C3B6Fe+, stg/stg) were obtained from heterozygous 
breeding pairs originally obtained from The Jackson Laboratory (Bar Harbor, 
ME) and bred in the University ofDurham vivarium on a 12 hour light/dark 
cycle with food and water freely available. All procedures were conducted 
according to the Animals (Scientific Procedures) Act 1986. 
2.3. LADORA TORY SOLUTIONS 
Phosphate buffered saline 4 mM Na2HP04, 1.7 mM KH2P04, 137 mM NaCI, 
(PBS) 107 mM KCl, pH 7.4 
Tris buffered saline (TBS) 50 mM Tris, 0.9% NaCI, pH 7.1 
2x Electrode buffer 10 mM Tris, 800 mM Glycine, 0.2% SDS pH 8.8 
2x Transfer buffer 25 mM Tris, I 00 mM Glycine, 20% Methanol 
3x Sample buffer 20 mM Dithiothreitol (DTT), 30 mM NaH2P04, 300/o 
Glycerol, 0.05% bromophenol blue, pH 7.4, 7.5% 
SDS 
lx Solubilising buffer 50 mM Tris, 2 mM EDT A, 2% SDS pH 6.8 
lOx TBE 0.9 M Tris, 0.9 M boric acid, 40 mM EDTA, pH 8.0 
SS buffer 137 mM NaCl, 5.3 mM KCl, 0.17 M Na2HP04, 0.22 
(Hall R.A., Soderling T.R., M KH2P04, 10 mM HEPES, 33 mM glucose, 44 mM 
1997) sucrose, pH 7. 3 
Luminol 1.25 mM in 0.1 M Tris-HCl, pH 8.5 
P-coumaric acid 68 mM 
Lowry reagent A 
Lowry reagent B 
Lowry reagent C 
6 x Loading buffer 
2% sodium carbonate, 0.1 M NaOH, 0.5% SDS 
2% sodium potassium tartrate 
1% copper sulphate 
0.25% bromophenol blue, 30% glycerol, 60 mM 
EDT A, pH 8.0 
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2.4. GENOMIC SCREENING OF MICE 
2.4.1. Background 
Adult (2-6 months) and neonate (P3-4) mice are routinely screened for 
possession of the mutated stargazin gene, in order to classify each animal as a 
control mouse (+/+:+/stg) or stargazer mutant (stg/stg). Genomic DNA is 
extracted from tail biopsy, PCR amplification of specific sequences is undertaken 
using sequence-specific primers (See section 2.4.3.). Amplification products are 
separated by agarose gel electrophoresis, stained with ethidium bromide and 
viewed using a UV transilluminator. 
The screening of adult mice is important for the pairing ofheterozygous (+/stg) 
mice for the maintenance of the stargazer breeding program, but also 
experiments to determine differences in GABAR between heterozygous ( +/stg) 
and wild type ( +/+) animals hinges on the accurate genotyping of the mice. It is 
necessary to screen neonate mice for primary cerebellar granule cell culture, as 
the characteristic phenotype of the stargazer does not become apparent until P14. 
Figure 2.1. is an example of a PCR screen carried out on neonates, which were 
later used for primary cerebellar granule cell culture, demonstrating the 
characteristic amplification products of heterozygote (300 bp and 600 bp bands), 
wild type (600 bp) and stargazer (300 bp) animals. 
2.4.2. Genomic DNA extraction from tail biopsy 
Tail biopsies (-2-3 mm) were taken from adult (2-6 months) or neonate mice 
(P3-4) and transferred to 1.5 ml eppendorfs. In order to allow the correct 
identification of mice after genotyping, in the case of the adult mice, different 
combinations of ear punches were made and noted, whereas for neonates, toe 
clips were taken. 
Per biopsy, 500 J.d nuclei lysis solution (Promega) was combined with 120 J.1l 0.5 
M EDT A, pH 8 at 4°C. 600 J!l, or 360 J.1l for neonate samples, of this solution 
was added to each tail biopsy. 17.5 J.1l (10.5 J.d for neonates) of20 mg/ml 
38 
Proteinase K was then added to the samples, vortexed and incubated at 55°C 
overnight to digest constituent proteins. 
Protein precipitation solution (200 J.11 for adult samples or 120 ~I for neonates) 
was added to each sample and incubated on ice for 5 minutes, following which, 
samples were centrifuged at 11 400 g for 5 minutes using a bench top (Eppendorf 
5415C) microfuge. The resultant supernatant was retained and 600 ~I (360 ~I for 
neonates) isopropanol was added in order to precipitate DNA and samples were 
centrifuged at 11 400 g for 1 0 minutes. The pellet was washed with 100 ~I 70% 
ethanol and centrifuged for a further 5 minutes at 11 400 g. The dried pellet was 
resuspended in 80 !J.l (40!J.l for neonates) deionised water and incubated at 65°C 
for 45-60 minutes in order to dissolve DNA. DNA samples were stored at -20°C 
until required. 
2.4.3. Primers 
Oligonucleotide primers for the amplification of the stargazin gene were: 
109F: 5'-CATTTCCTGTCTCATCCTTTG-3', 
EHt7: 5'-ACTGTCACTCTATCTGGAATC-3', 
EtNOR: 5' -GCCTTGATCAGAGTCACTGTC-3' 
(Letts eta/., 1998) 
2.4.4. Genomic PCR amplification 
PCR reactions were carried out in a total volume of 25 111. Each reaction 
contained final concentrations of 
3 units Taq Polymerase, 
15 mMMgCh, 
25 pmoles EtNOR, 
50 pmoles 109F, 
50 pmoles EHt7, 
2.5 mM dNTPs, 
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2.5 ~l Mg-free 10 x reaction buffer (500 mM KCl, 100 mM Tris-HCl, 1% Triton 
X-100) 
13.4 ~ dH20 
1 ~ genomic DNA. 
PCR reactions containing control DNA samples(+/+, +/stg and stg/stg) were 
included in each PCR, in order to correctly identify the genotype of test samples. 
Contamination ofPCR solutions was monitored by including a PCR reaction 
containing deionised water as a 'no DNA' control. The amplification protocol 
was carried out using an applied biosystems GeneAmp 2700 PCR machine as 
follows: 
95°C - 5 minutes 
94°C- 1 minute 
55°C- 2 minutes 
72oC- 2 minutes 
}30 cycles 
Resultant PCR products were stored at -20°C until required. 
2.4.5. Agarose gel electrophoresis 
5 ~ of each amplification product was diluted in 5~1 dH20 and 2J.Ll 6x loading 
buffer. 100 bp DNA ladder (4 ~)was diluted in 6 ~l deionised water and 2~ 6x 
loading buffer and loaded on the gel in order to size sample DNA fragments. 
Products were resolved on 1.5% agarose gels (1.2 g agarose in 80 ml 1 xTBE 
buffer) for -45 minutes at 90 mV using a Bio-rad electrophoresis power pac. 
DNA was stained with ethidium bromide (0.2% v/v) for 10-15 minutes, followed 
by de-staining in deionised water for ten minutes. Gels were analysed using the 
Quantity one (4.0.3) software for the GelDoc system (Bio-Rad, Hertfordshire, 
UK). 
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A 
ETn Etn-OR 
Stargazin Gene 
B 
c 
600 
300 
1 09F ----. +----- EHt7 
AMPLICONS: 1 09F + EHt7 = 600 bp 
Etn-OR + EHt7 = 300 bp 
M +/stg +/+ stg/stg 1 2 3 4 5 6 
FIGURE 2.1. GENOMIC PCR SCREENING OF TAIL BIOPSIES 
A : Schematic representation of the stargazin gene indicating the site of 
transposon insertion (6 kb) in stargazer mice. Boxed areas represent 
exons, with shaded regions on the stargazin gene representing coding 
exons. (Letts et al., 1998). ETn: Early transposon insertion. 
B: Amplicons resulting from the amplification of DNA extracted from 
tail biopsy with sequence specific primers, to produce bands of 600 bp 
and 300 bp. 
C: M is 100 bp DNA ladder. Lane 1 is a 'no DNA' control lane. Lane 3 
represents a heterozygote (300 and 600 bp). Lanes 2 and 6 represent wild 
type mice (600 bp). Lanes 4 and 5 represent stargazer mice (300 bp). 
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2.5. PREPARATION OF CEREBELLAR MEMBRANE HOMOGENA TES 
FOR RADIOLIGAND BINDING 
Cerebellar membrane preparations were carried out according to the method of 
Mehta and Ticku (1999) with modifications. Cerebella were dissected from adult 
(2-6 months old) +/+: +/stg and stg/stg mice, flash frozen in liquid nitrogen, to 
avoid ice crystal formation and stored at -80°C. 
Cerebella were rapidly thawed, weighed and suspended in a minimum of 10 
volumes of ice-cold buffer to wet tissue weight (50 mM Tris-Citrate, pH 7 .1, 1 
mM EDT A, 1 mM EGTA, 2 mM Benzamidine, 0.02% (w/v) Sodium azide), 
usually -20 ml per 10 cerebella. Protease inhibitors were then added to the tissue 
to prevent proteolytic degradation, which included 1 mM Phenylmethylsulphonyl 
Fluoride (PMSF), 2 ~g/ml Aprotinin, 1 ~g/ml Leupeptin and 1 ~g/ml Pepstatin 
A. The tissue was homogenised (10 strokes) in a 50 ml homogeniser tube, using 
a Potter glass/Teflon homogeniser. The homogenate was then transferred to 
Beckman centrifuge tubes and balanced against each other with ice-cold buffer. 
The tissue was centrifuged at 78 000 g for 40 minutes at 4°C in a Beckman L-70 
ultracentrifuge using a 70. 1 Ti rotor. The resultant supernatant was discarded and 
the pellet re-suspended in -30 ml ice-cold buffer, including protease inhibitors as 
above. 
Following homogenisation ( 10 strokes) the homogenate was transferred to 
centrifuge tubes and balanced using ice-cold buffer. The tissue was then re-
centrifuged at 45 000 g for 35 minutes at 4°C using a JA20 rotor in a high speed 
centrifuge (Beckman JS-HC or JS-HS). The resultant pellet was re-suspended in 
~30 ml buffer including protease inhibitors, homogenised (10 strokes), flash 
frozen in liquid nitrogen and stored at -20°C overnight. 
The tissue samples were then thawed quickly in warm water, balanced using ice-
cold buffer and centrifuged at 45 000 g for 35 minutes at 4°C. The supernatant 
was discarded and the resultant pellet was re-suspended, homogenised and 
centrifuged as above. The final pellet was suspended in -5 ml ice-cold buffer, 
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aliquoted into 1 ml samples and stored at -80°C until required. An aliquot was 
removed for protein determination using the Lowry assay with bovine serum 
albumin (BSA) as a standard. 
2.6. SOLUBILISA TION OF CEREBELLAR MEMBRANES FOR 
IMMUNOBLOTTING 
Cerebella were dissected from adult mice, flash frozen in liquid nitrogen and 
stored at -80°C until required. Each cerebellum was homogenised (10 strokes) 
individually in a 2 ml homogeniser tube using a potter glass/Teflon homogeniser 
in 2 x Solubilising buffer ( 100 mM Tris, 4 mM EDTA including protease 
inhibitors Aprotinin (4 ~g/ml), Leupeptin (2 ~g/ml) and Pepstatin A (2 ~g/ml)). 
An aliquot of homogenate was removed for protein determination by Lowry 
assay. Following which, an equal volume of 4% Sodium dodecyl sulphate (SDS) 
was added to the remaining material and incubated at room temperature for 30 
minutes with agitation. The homogenate was triturated with a 0.8 mm diameter 
needle in order to shear genomic DNA. Samples were flash frozen in liquid 
nitrogen and stored at -80°C until required. 
2. 7. SOLUBILISA TION OF DENTATE GYRI FOR IMMUNOBLOTTING 
Adult mice were deeply anaesthetised, perfused with PBS-nitrite (0.1% w/v) plus 
protease inhibitors and forebrain were dissected out and stored at 4°C (see 
section 2.14.2). 200 ~m coronal sections were cut using a vibrating microtome 
and dentate gyri were dissected out using a light microscope at 4°C. 250 J!l1x 
solubilising buffer was added to each dentate gyrus in a 1.5 ml eppendorf and 
incubated at room temperature for 30 minutes with agitation. Constituent DNA 
was then sheared by trituration of the homogenate with a 0.8 mm diameter 
needle. Samples were assayed by the method of Lowry, to determine protein 
concentrations (see section 2.8.) and samples were precipitated and resuspended 
in 2x sample buffer to give a final concentration of 1 mg/ml for western blot 
analysis (see section 2.10.). 
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2.8. LOWRY ASSAY FOR PROTEIN CONCENTRATION 
DETERMINATION 
Protein concentration was determined by the method ofLowry eta/., (1951) 
using bovine serum albumin as the standard protein. A stock solution ofBSA (1 
mg/ml) was serially diluted in deionised water to yield concentrations of 5, 10, 
20 and 40 Jlg/ml, which were used as a range of standard protein concentrations 
to construct a standard curve. Lowry reagent A, B and C were mixed in a ratio of 
50:1:1 to form lowry reagent D. 1 mllowry reagent D was added to a total 
volume of200 Jll of sample (10-20 Jll) and water (180-190 Jll) and incubated for 
10 minutes at room temperature. Samples were assayed in duplicate. 100 Jll 
Lowry reagent E (1 part Folins ciocalteau reagent and 1 part water) was added to 
each sample and incubated at room temperature for 30 minutes. The OD at 750 
nm was determined for each sample, using a spectrophotometer, employing the 
'0 Jlg/ml BSA' sample as a blank. A standard curve for BSA was constructed to 
allow the determination of sample unknown protein concentrations. 
2.9. PROTEIN PRECIPITATION BY THE CHLOROFORM METHANOL 
ME mOD 
4 volumes of methanol, 1 volume of chloroform and 3 volumes of deionised 
water ( dH20) were added to 1 volume of sample. The preparation was then 
vortexed for 10 seconds and centrifuged for 1 minute at 11 400 g. Following 
centrifugation, the preparation was seen to form three layers, the protein present 
within the mixture forming a solid interface between two liquid layers. The top 
liquid layer was discarded and 3 volumes of methanol were added to the 
remaining preparation. The preparation was then gently agitated in order to mix 
the component layers and centrifuged for two minutes at 11 400 g. The 
supernatant was removed and discarded and the resultant pellet was allowed to 
air_-:dry. Once dry, the pellet was suspended in 2x sample buffer to yield a final 
protein concentration of 1 mg/ml, heated for 5 minutes at 95°C and stored at 
-20°C until required. 
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2.10. SODIDM DODECYL SULPHATE-POLYACRYLAMIDE GEL 
ELECTROPHORESIS (SDS-PAGE) AND IMMUNOBLOTTING 
Polyacrylamide gel electrophoresis was performed in 10% polyacrylamide slab 
mini-gels, loading 10 ~g protein and fractions thereof per gel lane (Thompson et 
al., 1998). 
2.10.1. Solutions 
3.5% Stacking gel 
10 ml total volume: 
10% Resolving gel 
(Makes 10 gels) 
Blocking buffer 
Incubation buffer 
0.09% Acrylogel-3 
0.125 M Tris-HCl, pH 6.8 
0.1% SDS 
1 mg/ml Ammonium Persulphate 
(APS) 
10 ~ TEMED 
7.61 ml dH20 
29.63 ml dH20 
25.2% Acrylogel-3 
24~TEMED 
25.1% Running Buffer 
(1.5 MTris, 8 mMEDTA, 0.4% SDS, 
pH 8.8 in 100 m1 dH20) 
1 mg/ml AMPS 
5% Dried skimmed milk powder 
0.2% Tween 20 in PBS 
2.5% Dried skimmed milk powder in 
PBS 
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2.10.2. Preparation of 10% resolving gels 
1 Ox8 em glass plates, alumina plates and 1 mm spacers were rinsed with 100% 
ethanol, once with acetone and allowed to dry. Plates were then assembled in a 
1 0-gel caster. 10% resolving gel solution was prepared as in section 2.11.1 and 
poured into the gel caster to a volume -2-3 em from the top of the gel caster. 150 
Jll water saturated butanol was added to the surface of each gel to prevent 
dehydration and allowed to polymerise for 1 hour at room temperature. Gels 
were wrapped individually in tissue and stored at 4°C in a 25% running buffer 
solution until use. 
2.10.3. SDS-PAGE 
A 10% resolving gel was clamped into a Hoefer Mighty Small II vertical slab gel 
unit. 3.5% stacking gel solution was prepared (see section 2.10.1.) and degassed 
for 10 minutes. 10 Jll TEMED was added to the stacking gel solution and poured 
above the resolving gel. A 0. 75 mm 10 well comb was inserted into the stacking 
gel and allowed to polymerise. -200 ml 1 x electrode buffer was poured behind 
the gel and in the base of the unit to -1 em height. The comb was removed and 
wells were washed by expelling electrode buffer into the wells using a Hamilton 
syringe to remove excess gel. 10 Jll (10 Jlg) protein sample or prestained protein 
standards (10-250 kDa) was loaded per gel lane using a hamilton syringe. 
Electrophoresis was carried out using an Amersham pharmacia power pac 
E300/E301 at 80V for -45 minutes to allow protein samples to move through the 
stacking gel and then proteins were resolved at 1 OOV for -90 minutes. 
2.10.4. Immunoblotting 
Once SDS-PAGE was complete, components of the transfer cassette were 
equilibrated in 1 x transfer buffer. The transfer cassette was assembled in the 
following order: sponge, 1 piece ofwhatman 3MM filter paper, resolving gel, 
nitrocellulose membrane, whatman paper and sponge. All components were 
assembled submerged in transfer buffer and care was taken to ensure no air 
46 
became trapped within the transfer layers. Once assembled, the transfer cassette 
was placed in a Hoefer TE series transphor unit containing 1x transfer buffer at 
room temperature and proteins were transferred to nitrocellulose membrane for 2 
hours at 50 V. 
Following transfer of proteins to nitrocellulose, the membrane was incubated in 
blocking buffer (see section 2.10.1.) for 1 hour at room temperature with gentle 
shaking. Primary antibody was diluted in incubation buffer (see section 2.10.1.) 
and the nitrocellulose membrane was incubated in a 50 ml falcon tube overnight 
at 4°C in primary antibody (see table 2.1. for antibody concentrations). 
Table 2.1. Primary antibody concentrations used for immunoblotting 
ANTIBODY CONCENTRATION 
(pglml) 
Anti-GABAR a1 (1-14Cys) 0.25-1 
Anti-GABAR a4 (1-14) 0.5 
Anti-GABAR a6 (1-15cys) 2-4 
Anti-GABAR P2 (351-405) 0.5 
Anti-GABAR P3 (345-408) 0.5 
Anti-GABAR o (1-44) 1 
Anti-GABAR y2 (319-366) 1 
Anti-NSE 1:100 000 
Anti-P-actin 1:2000 
Anti-AMP AR GluR2 1:250-500 
Anti-NMDAR NR1 (17-35) 1 
Anti-stargazin C-terminus 1-4 
peptide sequence (Cys-
DSLHANT ANRRTTPV) 
Anti-TARP y8 (1-14cys) 4 
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After incubation in primary antibody, the nitrocellulose membrane was washed 
three times in wash buffer (see section 2.10.1) and incubated in horseradish 
peroxidase linked secondary antibody (anti-rabbit (1: 1000) or goat (1 :4000)) 
diluted in incubation buffer, for 1 hour at room temperature with gentle shaking. 
On completion of blocking non-specific binding sites, the nitrocellulose 
membrane was washed three times in wash buffer and twice in PBS, before 
allowing the membrane to dry. Prestained protein standards were marked with 
diluted horseradish peroxidase linked secondary antibody (1: 1 00), to allow sizing 
of proteins on the membrane. 
The enhanced chemiluminescence (ECL) western blotting system was used to 
detect immunoreactive species on hyperfilm. Processing of membrane involved 
incubation in a solution of 1.25 M luminol (10 ml), 68 mM p-coumaric acid (120 
J.d) and 30% H20 2 (6.67Jll) for 1 minute. On removal of reagent, the membrane 
was wrapped in clingfilm and exposed to Hyperfilm ECL for 1-5 minutes. 
Immunoreactive species were detected using Kodak GBX developer and films 
fixed for -5 minutes. Band intensity was quantified using Image J software. 
2.10.5. Analysis of immunoblots 
The intensity of immunoreactive bands were quantified using ImageJ software. 
lmmunoblots were scanned using a flatbed scanner at high resolution (minimum 
600 dpi). Values of mean gray-scale intensity were determined for each 
immunoreactive band from which mean background intensity was subtracted. 
Values are expressed as a ratio of mean intensity for the protein of interest over 
mean intensity for f3-actin. 
2.11. RADIOLIGAND BINDING ASSAYS 
eH] Ro 15-4513 and eH] Muscimol binding assays were conducted on cerebellar 
membrane homogenates prepared as described in section 2.5. (Thompson et al., 
1998). 
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eH] Ro15-4513 
Binding buffer 
10 mM Tris-HCl, 
150 mMNaCl, pH 
7.4 
Wash buffer 
10 mM Tris-HCl, 50 
mM NaCl, pH 7.4 
2.11.1. [3H] Ro15-4513 
eH] Muscimol 
Binding buffer 
50 mM Tris-Citrate, 
pH7.1 
Wash buffer 
5 mM Tris-Citrate, 
pH7.1 
The radio ligand concentration range for saturation analyses for eHJ Ro 15-4513 
was 0.3125-40 nM. Non-specific binding was determined in the presence of 
Ro15-1788 (10 !J.M), a benzodiazepine receptor antagonist. eHJ Ro15-4513 
binding in the presence of flunitrazepam ( 1 0 J.LM), a benzodiazepine full agonist, 
defined benzodiazepine-insensitive (BZ-IS) binding sites and hence 
benzodiazepine-sensitive (BZ-S) sites could be determined by subtraction of the 
BZ-IS binding sites from total eHJ Ro15-4513 specific binding sites. 
2.11.2. Zolpidem displacement of eHJ Ro15-4513 
A concentration of eH] Ro 15-4513 of 10 nM was used for zolpidem 
displacement of eHJ Ro 15-4513 binding, which was co-incubated with varying 
concentrations of zolpidem. Half log dilutions of zolpidem were employed 
ranging from 1 nM to 10 J.!M. Levels of total, BZ-S and BZ-IS eHJ Ro 15-4513 
binding were determined as in section 2.11.1., in order to determine the levels of 
displacement ofBZ-S binding in the presence ofzolpidem. 
2.11.3. eu] Muscimol 
T~e radioligand concentration range employed for eH] Muscimol was 0.~-40 
nM. Non-specific binding sites were defined in the presence of0.2 mM GABA. 
Experimental protocols were similar for both radioligands. The total assay 
volume per reaction was 0.5 ml, comprising binding buffer, radioligand and 
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membrane preparation. Each radioligand concentration was tested in triplicate 
and incubated in the presence of radio ligand for an hour on ice. Following which 
the reaction was terminated by rapid filtration through Whatman GF IB filter 
paper pre-soaked in 0.03% Polyethylenimine, using a Brandel Cell Harvester. 
Filters were washed three times with -3 ml wash buffer and allowed to dry. 
Filters were then transferred to scintillation vials with 4 ml scintillation fluid 
(Ecoscint) and subjected to scintillation counting for 3 minutes per sample. 
2.11.4. Data analysis for saturation binding curves 
Saturation binding curve data was analysed using GraphPad Prism 3.0 by non-
linear regression and one-site binding hyperbola. Ko values were calculated 
according to the following equation: 
Y = Specific bound eH] ligand 
X = Concentration of eH] ligand 
Y =BMAXX 
KD+X 
BMAX = Maximum number of binding sites 
Ko = Dissociation constant from saturation binding of eH] ligand 
For Rosenthal transformations, saturation data was fit by linear regression to the 
line, using GraphPad Prism 3.0: 
F(x)=ax+b 
F(x) = Specific bound eH] ligand/Free eH] ligand 
A= Slope- (1/Ko) 
X = Specific bound eH] ligand 
B =x-axis 
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2.12. RECEPTOR AUTORADIOGRAPHY 
2.12.1. Receptor autoradiography to tissue sections 
Sucrose-perfused (1 0% sucrose in PBS) adult whole mouse brain was frozen in 
isopentane over liquid nitrogen (3 minutes, -40°C) and sectioned (16 11m) in the 
horizontal plane using a cryostat at -21 °C. Sections were immediately transferred 
to polysine coated slides (BDH). Two control and two stargazer sections were 
thaw mounted onto each slide, dried for a minimum of 12 hours, desiccated and 
stored at -20°C until required. 
Slides were incubated in pre-incubation buffer for 15-20 minutes at 4°C. 
Following which, the slides were transferred into radioligand-containing or non-
specific binding buffer (see table 2.2.) at 3 minute intervals and incubated for a 
total of 1 hour at 4°C. Slides were removed from ligand-containing buffer in the 
same order and immersed in three changes of wash buffer for 15 seconds, 
followed by 1 wash in dH20, all at 4 °C. Slides were then dried under a stream of 
cool air to remove any excess buffer and hence prevent ligand dissociation and 
allowed to dry at room temperature overnight. Once dry, the slides were secured 
into a hypercassette and exposed to eHJ Hyperfilm for 2 weeks to 2 months 
depending on ligand employed. 
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Table 2.2. Summary of component buffers for eH] Receptor Autoradiography 
PREINCUBATION LIGAND- NON- WASH 
BUFFER CONTAINING SPECIFIC BUFFER 
BUFFER BINDING 
BUFFER 
("B] 50 mM Tris-HCI, 50 mM Tris- 50 mM Tris- 10 mM Tris-
Fluoitrazepam pH7.4 HCI, HCI, HCI, pH 7.4 
120mMNaCl pH 7.4 pH7.4 
120 mMNaCI 120 mMNaCI 
5 nM eHJ 5 nMeH] 
Flunitrazepam Flunitrazepam 
10 lJ.M Ro15-
1788 
[3H] 0.31 M Tris- 0.31 MTris- 0.31 M Tris- 10 mM Tris-
Muscimol acetate, pH 7.1 acetate, acetate, HCI, pH 7.4 
pH7.1 pH7.1 
20 nm eH] 20 nm eH] 
Muscimol Muscimol 
1 mMGABA 
r'HJ 50 mM Tris-HCI, 50 mM Tris- 50 mM Tris- 10 mM Tris-
Ro15-4513 pH7.4 HCI, pH 7.4 HCI, pH7.4 HCI, pH 7.4 
120 mMNaCI 120mMNaCI 120 mMNaCI 
zonMeH] zonMeHJ 
Ro15-4513 Ro15-4513 
(10 lJ.M 10 lJ.M Ro15-
flunitrazepam) 1788 
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2.12.2. Quantification of receptor autoradiograpbs 
The level of radioactivity in the different brain areas were compared in control 
and stargazer tissue sections using ImageJ software. Autoradiographs were 
scanned using a flatbed scanner at high resolution (1200 dpi). A standard curve 
was constructed by analysis of gray-scale intensity of radioactive standards of 
known concentrations, exposed on each autoradiograph to be analysed. 
Calibration standards ranged from 0.1-109.4 nCi/mg. 5-10 measurements of 
gray-scale intensity were taken from within each brain structure to be analysed of 
6 comparable sections per mouse strain to yield a mean intensity. Mean film 
background values were subtracted from mean intensities. The amount of 
radioactivity associated with each brain structure could then be determined from 
the standard curves and compared by student's t-test with p<0.05 considered to 
be statistically significant. 
2.13. IMMUNOillSTOCHEMISTRY 
2.13.1. Solutions 
Phosphate buffered saline (PBS) and 
NaN02 (0.1% w/v), pH 7.4 
4% paraformaldehyde in 0. 1 M 
phosphate buffer 
137mMNaCl 
107mMKCl 
4 mM Na2HP04 (anhydrous) 
1. 7 mM KH2P04 
0.1% w/v NaN02 
500/o (v/v) 0.2 M Phosphate buffer 
50% (v/v) 8% Paraformaldehyde 
2.13.2. Perfusion fixation and tissue sectioning 
A deeply anaesthetised mouse (100 J.11 per 100 g Pentobarbital (Euthatal)) is 
assessed by failed nictating reflex and pressure-induced retraction of the hind 
limb and pinned out with its ventral surface uppermost. The ribcage is exposed 
and retracted to reveal the heart. A 25 gauge microlance is pushed into the left 
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ventricle through which is perfused, via a peristaltic pump, ice-cold 0.1 M 
sodium phosphate buffer (pH 7.4) containing 0.1% (w/v) sodium nitrite. The 
right atrium is cut under slight positive pressure from the perfusate and the 
animal is exsanguinated in this manner for 5 minutes (~25 ml buffer). The 
perfusate is exchanged for freshly prepared, ice-cold fixative (normally 4% 
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 for immunohistochemical 
studies). The fixation procedure is continued for 20 minutes (100 ml fixative) 
after which the brains are dissected out and immersed in fixative at 4 oc 
overnight. For light microscopic studies, brains are cryoprotected by sucrose 
infiltration. Fixed, PBS-washed brains are transferred to 10% (w/v) sucrose in 
PBS, pH 7.4 for 48 hours prior to sectioning. The sucrose solution is replaced 
every 12 hours. 
Perfusion-fixed adult whole brain was frozen in isopentane over liquid nitrogen 
(1 minute, -70°C) and sectioned (30 J..lm) using a cryostat (-21°C). Sections were 
stored in PBS/0.02% NaN3 until required. 
2.13.3. Antigen retrieval 
Prior to immunohistochemical staining for the GABAR o subunit, free floating 
sections were processed by antigen retrieval methods initially characterised by 
Jiao eta/., ( 1999), in order to increase receptor staining while reducing 
background staining. Following incubation in 20% methanol, 20% H202 in TBS, 
as in the immnuohistochemical staining procedure, sections were incubated in 
0.05 M sodium citrate, pH 8.6 for 30 minutes at room temperature and then 
heated to 90°C for 70 minutes. Sections were allowed to cool to room 
temperature and washed in TBS before further immunohistochemical processing. 
2.13.4. Immunostaining 
Brain sections were immunostained using the Vecta-stain Elite ABC kit (avidin-
biotin-peroxidase method). Residual paraformaldehyde was quenched by 
incubation of:freely floating sections in(0.2%w/v) TBS-glycine, pH 7.4 for 30 
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minutes at room temperature. Non-specific binding sites were blocked with 1 00/o 
w/v goat serum in (0.2% v/v) TBS-Triton X-1 00 (TBS-T), incubated for 1 hour 
at room temperature with agitation. Sections were incubated in primary antibody 
diluted in PBS-goat serum (1% v/v) overnight at 4°C. 
Table 2.3. Primary antibody concentrations used for immunohistochemistry 
ANTIBODY CONCENTRATION 
(J.Lg/ml) 
Anti-GABAR a1(1-14cys) 0.25 
Anti-GABAR a4 (1-14) 0.5 
Anti-GABAR a6 (1-15cys) 0.25 
Anti-GABAR ~1 (350-375) 1 
Anti-GABAR ~2 (351-405) 0.5 
Anti-GABAR ~3 (345-408) 0.5 
Anti-GABAR o (1-44) 0.25 
Anti-GABAR y2 (319-366) 2 
Anti-stargazin C-terminus 0.5 
peptide sequence 
(Cys-DSLHANT ANRRTTPV) 
Following incubation in primary antibody, sections were allowed to equilibrate 
to room temperature for 1 hour in primary antibody, washed 3 times ( 5 minute 
washes) with TBS-T and incubated for 2 hours with anti-rabbit biotinylated 
secondary antibody, diluted in TBS-goat serum (1% v/v). Sections were then 
washed 3 times with TBS-T and incubated at room temperature for 1 hour with 
ABC reagent (5 ml TBS, 100 J!1 Solution A, 100 J!1 Solution B). Following 
which, sections were washed 3 times with TBS-T, twice with TBS and incubated 
with Horseradish peroxidase substrate (0.0667% (v/v) Hydrogen peroxide, 3,3-
diaminobenzidine (0.5 mg/ml) in TBS) until an optiro.-al signal was !lChieved _(-2-
4 minutes). HRP substrate was then removed, sections washed 2 times with 
deionised water and mounted on a glass slide using DPX mountant. 
55 
Sections were imaged using a Nikon DXM 1200 camera and Nikon diaphot 300 
microscope at x 400 and x 1000 magnifications. 
2.14. PRIMARY CEREBELLAR GRANULE CELL CULTURE 
2.14.1. Solutions 
H-EBSS 
Sol. 1H 
Trypsin 
Dilute DNAse I and trypsin inhibitor 
Concentrated DNAse/trypsin inhibitor 
Culture media 
138.3 mM NaCl, 5.4 mM KCl, 25 mM 
HEPES, 4.2 mM NaHC03, 1 mM 
NaH2P04.H20 
50 ml H-EBSS, 7.3 mM Glucose, 3 
mglml Bovine Serum Albumin (BSA) 
fraction V, 0.5 ml MgS04 (3.82% w/v) 
10 ml Sol.1H, 2.5 mg Trypsin 
10 ml Sol. 1H, 1.6 ml concentrated 
DNAse/Trypsin inhibitor 
10 ml Sol. 1H, 0.1 ml MgS04, 1300 
kunitz units DNAse I, 8 mg Trypsin 
inhibitor 
100 ml MEM containing 1 00/o foetal calf 
serum, 2 mM glutamine, 0.5 mglml 
gentamycin, 2.5 ml 1.33M glucose, 0.025 
mglml insulin, 0.01 mglml transferrin 
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2.14.2. Cell Culture 
(Adapted from Dutton, 1990) 
All cell culture techniques were conducted using aseptic technique using a 
category 2 Telstar laminar flow hood, with autoclaved instruments and solutions. 
All solutions employed for the culture of primary neurons were sterile filtered 
through 0.2llm membrane filters before use. 
24 hours before culturing neurons, 3 5 mm Petri dishes were treated under sterile 
conditions with poly-L-lysine (50 llg/ml in deionised water (dH20), 2 ml per 35 
mm dish). Excess poly-L-lysine was aspirated on the day of the culture, dishes 
were washed three times with sterile dH20 and allowed to dry. 
Cerebellar granule cells were cultured from 5-7 day old (P5-P7) mouse neonates. 
Cerebella were dissected out under sterile conditions, the meninges were 
removed to minimise contamination of the culture with non-neuronal cells and 
the tissue was transferred to sol. 1H (see section 2.14 .1. ). Upon completion of the 
dissections, excess sol. 1H was aspirated from the tissue and the cerebella were 
cut into blocks using two scalpel blades. The material was then transferred into 
trypsin solution (10 ml) and incubated at 37°C for 15 minutes with gentle 
agitation, in order to break down the tissue further. Dilute DNAse I and Trypsin 
inhibitor were then added to the tissue to breakdown DNA and inhibit the action 
of the trypsin. The material was then centrifuged at 200 g for 2 minutes at 4 oc 
and the supernatant was aspirated to leave the cell pellet. 
Approximately 5 ml Concentrated DNAse/Trypsin inhibitor was added to the 
pellet and the material was triturated approximately 30 times using a sterile, 
siliconised, heat-polished glass pipette, until a homogenate was obtained. The 
upper cell suspension was retained and the remaining concentrated 
DNAse/Trypsin inhibitor was added to the undissociated tissue and re-triturated. 
Any further cell suspension was added to the original retained material. The cell 
suspension was overlaid over 4% BSA (5 ml) and centrifuged at 500 g for 5 
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minutes at 4°C. The supernatant was aspirated and the remaining pellet was 
resuspended in 1 0 ml culture media. Cell numbers were counted on a 
haemocytometer and cells were resuspended in an appropriate volume to plate at 
a density of3.0x106 cells per 35 mm dish in a volume of3 mls. 
Cells were then incubated at 37°C, 5% COi/95% air. After 48 hours, cells were 
treated with Fluoro-2-deoxyuridine (80 J.!M) to suppress the proliferation of non-
neuronal cells. 
2.14.3. Drug treatment of cultured cerebellar granule cells 
24 hours after plating (1 DIV), cerebellar granule cells were treated with 100 J.1M 
kainic acid (30 ~of 10 mM stock per 35 ml culture dish), an ionotropic 
glutamate receptor agonist, in order to activate AMP A receptors within the 
culture and hence allow us to study the effects of depolarisation on the cultured 
cells. Alternatively, cells were treated with KCl (30 ~of 2M stock per 35 mm 
dish), to increase the extracellular potassium concentration to 25 mM and hence 
depolarise the cells by altering electrochemical and potassium ion concentration 
gradients. 
In order to study the possible mechanisms by which depolarisation by kainic acid 
influences GABAA receptor expression profiles, cells were treated with 10 J.1M 
nifedipine (3 ~ of20 mM stock in DMSO) or 10 J.1M verapamil (3 J.ll of20 mM 
stock in DMSO), L-type calcium channel blockers, to determine if calcium entry 
though L-type calcium channels was an important factor in GABAA receptor 
expresston. 
2.14.4. Harvesting of cultured cerebellar granule cells 
Each 35 mm culture dish of cells to be harvested was washed three times in SS 
buffer (3 mls) and solubilised in 500 J.ll 1x solubilising buffer. Cells were scraped 
into the solubilising buffer, transferred into 1.5 ml eppendorfs, flash frozen in 
liquid nitrogen and stored at -20°C until required. 
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2.15. CELL SURFACE BIOTINYLATION 
(Adapted from Archibald eta/., 1998) 
Quenching buffer 192mM Glycine, 4% sucrose in 50 mM 
TBS, pH 8.0 
Lysis buffer 0.1mM PMSF, 10 J.lg/ml aprotinin, 
leupeptin, pepstatin A, 2mM EDTA in 
TBS, pH 8.0 
+ 1% SDS 
+ 1% triton x-100 
7 DIV cerebellar granule cells 35 mm dishes were washed three times (1 ml) 
with ice cold PBS+ 4% sucrose, pH 8.0 and incubated for 15 minutes at 4°C 
with 1 mglml EZ-link Sulfo-NHS-SS-biotin in cold PBS + 4% sucrose with 
gentle agitation (0.5 ml per 35 mm dish). Cells were washed once with ice cold 
PBS+ 4% sucrose and incubated for 10 minutes at 4°C with quenching buffer. 
Cells were washed twice in cold PBS + 4% sucrose. Cells were solubilised in 
166 J.lllysis buffer + 1% SDS and samples were made up to 1 ml total volume 
with 833 J.lllysis buffer+ 1% Triton x-100. Samples were incubated with 100 J.ll 
of 50% slurry of streptavidin beads for 2 hours at 4°C with agitation. Samples 
were centrifuged at 10 000 g for 1 min and the supernatant retained as the 
unbound fraction, or intracellular component. Streptavidin beads were washed 
once with 1 mllysis buffer+ 1% triton x-100 and centrifuged for 1 min at 10 000 
g. Followed by a further two washes with lysis buffer alone. Sample bound to the 
beads was eluted with 50 J.11 2x sample buffer by heating at 95°C for 5 minutes. 
Streptavidin beads were centrifuged at 10 000 g for 1 minute and the supernatant 
retained as the bound fraction or surface protein. Samples were subjected to 
western blot analysis (see section 2.1 0.) to allow for the quantification of surface 
versus intracellular protein. 
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2.16. RADIOLIGAND BINDING TO CULTURED CEREBELLAR 
GRANULE CELLS 
Radio ligand binding was conducted on 7 DIV cultured cerebellar granule cells 
using eH] Ro 15-4513 and eH] muscimol at a concentration of 40 nM for each 
ligand. Briefly, cell culture dished were washed rapidly three times with 3 ml SS 
buffer and incubated in 1 mlligand for 1 hour at 4°C. Following incubation in 
ligand, dishes were washed a further three times with 3 ml SS buffer rapidly, to 
avoid ligand dissociation and allowed to dry at room temperature. 1 ml 0.2 M 
NaOH was applied to each dish and incubated overnight at room temperature 
with gentle agitation. The reaction was neutralised with 100 J..Ll 2 M HCI and 
incubated at room temperature for 30 minutes with agitation. 700-800 J..Ll sample 
was added to 4 ml scintillation fluid and subjected to scintillation counting for 3 
minutes per sample. A further 100 J.1l of each sample was ali quoted for lowry 
assay. 
2.17. STATISTICAL ANALYSES 
Statistical analyses were performed using GraphPad Prism version 3. 0 and 
Microscoft Excel, using an unpaired student's t-test with p<0.05 considered to be 
statistically significant. 
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CHAPTER 3. GABAA RECEPTOR SUBUNIT PROTEIN 
EXPRESSION IN THE STARGAZER MUTANT MOUSE 
3.1. INTRODUCTION 
Previous work by Thompson eta/. in 1998 identified a series of cerebellar 
GABAA receptor abnormalities in the stargazer mutant. These included specific 
down-regulation of expression of the GABAR a.6 and J33 subunits whilst a.1 and 
J32 subunits appeared to be relatively spared. Since the GABAR a.6 subunit is 
one marker of cerebellar granule cell maturation this data might imply that the 
stargazer cerebellum is restrained in an immature state (see section 1.2.2.). 
The initial studies conducted by Thompson et al., 1998 were limited by (i) the 
availability of a sufficient number of animals to conduct a comprehensive 
analysis; (ii) access to an appropriate background strain of mice for control 
experiments and, (iii) high quality subunit-specific antibodies with which to 
screen all GABAA receptor subunits of interest (Thompson eta/., 1998). 
Therefore, the aim of this chapter was to re-evaluate and extend the previous 
observations by Thompson eta/., in 1998 using an appropriate background strain 
and to further comprehensively characterise the expression of all the principal 
GABAA subunits and receptors in the cerebellum of the stargazer mutant mouse. 
Immunohistochemistry was used to investigate, qualitatively, the distribution of 
the GABAA receptor subunits in the cerebellum of the stargazer mutant mouse 
and secondly to quantify the levels of expression of these subunits by semi-
quantitative immunoblotting. The C3B6Fe + mouse strain was utilised in the 
current study, as opposed to the C57BL/6J strain used in initial studies, as the 
stargazer mouse strain is essentially raised on the C3B6Fe+background. This 
allowed us to determine whether the previously reported effects were due to 
mouse strain variability or as a consequence of the stargazer mutation. 
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3.2. RESULTS 
3.2.1. Immunohistochemical mapping of GABAA receptor subunits in adult 
control (+/+:+/stg) and stargazer (stg!stg) cerebellum 
Paraformaldehyde perfusion-fixed (4% w/v) horizontal and sagittal mouse brain 
sections (30 J.lm) were immunohistochemically stained by standard methods (see 
section 2.14), using GABAR subunit-specific antibodies, in order to map the 
distribution of each receptor subunit in control and stargazer cerebellum. For 
each antibody employed, a range of concentrations of primary antibody (0.125-2 
J.lg/ml), were applied to a number of sections in order to determine the optimum 
concentration of antibody to achieve the optimal specific signal, with a minimum 
level of non-specific staining. (See table 2.3. for concentrations of antibody 
employed.) Controls performed included sections probed with secondary 
antibody only to determine non-specific binding of the secondary antibody and 
sections stained with diaminobenzidine (DAB) without primary or secondary 
antibodies to determine non-specific binding of DAB. 
3 .2.1.1. GABAA receptor subunit a.1 
Immunostaining for the GABAR a.l subunit was observed in all layers of the 
cerebellar structure to varying degrees, with the predominant immunoreactive 
staining found in the cerebellar granule cell and Purkinje cell layers (figure 3.1.). 
Weaker immunostaining was observed in the basket and stellate cells of the 
molecular layer. No qualitative difference in levels of immunostaining for the a.1 
subunit was detected in control and stargazer sections (n=S-8 sections from n=3 
mice per strain). 
3.2.1.2. GABAA receptor subunit a.6 
Intense immunoreactivity for the GABAR a.6 subunit was observed in the 
cerebellar granule cell layer of the cerebellum in control brain sections. No 
specific immunostaining was detected-in eitlier the molecular or Purkinj e cell 
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Figure 3.1. Immunohistochemical mapping of the GABA A receptor at subunit 
in adult mouse cerebellum 
A&B: +/+:+/stg and stg/stg whole cerebella respectively 
C&D: +/+:+/stg and stg/stg cerebella respectively at x40 magnification 
E&F: +/+:+/stg and stg/stg cerebella respectively at x 100 magnification 
Note the intense staining in the granule cell layer (GL), Purkinje cell layer (PL) 
and the molecular layer (ML) in both control and stargazer cerebella. 
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Figure 3.2. Immunohistochemical staining of GADA A receptor a.6 subunit 
in adult mouse cerebellum 
A&B: +/+:+/stg and stg/stg brain sections respectively at x40 magnification 
C&D: +/+:+/stg and stg/stg brain sections respectively at x l 00 magnification 
Note the decrease in intensity of staining in the granule cell layer (GL) of the 
stargazer tissue section. ML: Molecular Layer, PL: Purkinje Cell Layer. 
layers. A dramatic decrease in immunostaining was noted in the cerebellar 
granule cell layer of stargazer sections when compared to controls, in all 
cerebellar folia (figure 3.2.) (n=5-8 from n=3 mice per strain) 
3.2.1.3. GABAA receptor subunit J32 
Strong immunoreactivity for the GABAR J32 subunit was observed in the 
cerebellar granule cell layer and to a lesser extent in the Purkinje cell layer 
and the basket and stellate cells of the molecular layer (n=5-8, from n=3 
mice per strain). The level of immunostaining was greatly reduced 
uniformly in all cerebellar folia in stargazer tissue sections (figure 3.3.). 
3.2.1.4. GABAA receptor subunit J33 
Tissue sections probed with anti-GABAR J33 subunit specific antibody (0.5 
l-tg/ml) displayed strong immunoreactivity in the cerebellar granule cell 
layer and to a lesser extent in the Bergmann glia cell bodies and processes in 
the molecular layer. No specific immunostaining was observed in the 
Purkinje cell layer (n=5-8 from n=3 mice per strain). The level of 
immunostaining was greatly reduced uniformly in all cerebellar folia in 
stargazer tissue sections when compared to control sections (figure 3.4.). 
3.2.1.5. GABAA receptor subunit y2 
Various levels of immunostaining were observed in the cerebellar layers of 
control and stargazer tissue sections when probed with anti-GABAR y2 
subunit specific antibody (2 l-tg/ml). The most intense immunostaining was 
detected in the Purkinje cell layer, with strong immunoreactivity also in the 
granule cell layer and Purkinje cell dendrites of the molecular layer (n=5-8 
from n=3 mice per strain). No obvious differences in intensity of staining 
were observed in control and stargazer sections (figure 3.5.) 
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Figure 3.3. Immunohistochemical mapping of GADA A Receptor ~2 Subunit 
in Adult Mouse CerebeUum 
A&B: +/+:+/stg and stg/stg whole cerebella respectively 
C&D: +/+:+/stg and stg/stg cerebella respectively at x40 magnification 
E&F: +/+:+/stg and stg/stg cerebella respectively at xlOO magnification 
Note the reduction in staining in the granule cell layer (GL) of stargazer 
tissue sections. ML - Molecular Layer, PL - Purkinje Cell Layer 
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Figure 3.4. Immunohistochemical mapping of GABA A receptor ~3 subunit in 
adult mouse cerebellum 
A&B: +/+:+/stg and stg/stg whole cerebella respectively 
C&D: +/+:+/stg and stg/stg cerebella respectively at x40 magnification 
E&F: +/+:+/stg and stg/stg cerebella respectively at xlOO magnification 
Note the reduction in intensity of staining in the granule cell layer (GL) in the 
stg/stg cerebellum. ML: Molecular Layer, PL: Purkinje Cell Layer 
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Figure 3.5. Immunohistochemical mapping of the GADA A receptor y2 subunit 
in adult mouse cerebellum 
A&B: +/+:+/stg and stg/stg whole cerebella respectively 
C&D: +/+:+/stg and stg/stg cerebella respectively at x40 magnification 
E&F: +/+:+/stg and stg/stg cerebella respectively at x 100 magnification 
Note the intense staining in the Purkinje cell layer (PL) and to a lesser extent in 
the granule cell layer (GL) and molecular layer (ML). 
3 .2.1. 6. GABAA receptor subunit a 
Tissue sections probed for the localisation of the GABAR a subunit (0.25 
~g/ml) demonstrated the most intense immunoreactivity in the cerebellar 
granule cell layer, with no specific immunostaining present in the Purkinje 
cell or molecular layers. The level of immunostaining was dramatically 
reduced in the stargazer tissue sections when compared to controls (n=S-8 
from n=3 mice per strain) (figure 3.6.). 
The distribution of GABAR subunits studied were as expected from 
previous observations (Pirker eta/., 2000) and were compatible in both 
+/+:+/stg and stg/stg. However, immunohistochemical staining revealed an 
overall qualitative decrease in the expression of the GABAR subunits a6, 
f32, f33 and a uniformly in all cerebella folia of the stargazer cerebellum. 
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A +/+:+/stg 8 stg!stg 
Figure 3.6. Immunohistochemical mapping of the GADA A receptor 8 subunit in 
adult mouse cerebellum 
A&B: Whole brain sections for +/+:+/stg and stg/stg mice respectively 
C&D: +/+:+/stg and stg/stg cerebella respectively at x40 magnification 
E&F: +/+:+/stg and stg/stg cerebella respectively at x l 00 magnification 
Note the decrease in intensity of staining in the granule cell layer (GL) of the stg/stg 
cerebellum. ML: Molecular Layer, PL: Purkinje Cell Layer 
Table 3 .1. Immunohistochemical mapping of GABAR subunits in the adult mouse cerebellum 
GABAR PURKINJE GRANULE CELL MOLECULAR LAYER STAINING 
SUBUNIT CELL LAYER INTENSITY 
LAYER IN 
STARGAZER 
SECTIONS 
Purkinje cell Granule cells Basket cells Stellate cells Bergmann glial cell Bergmann glial cell COMPARED 
bodies bodies processes TO 
+/+:+/stg stglstg +/+:+/stg stglstg +/+:+/stg stglstg +/+:+/stg stglstg +/+:+/stg stglstg +/+:+/stg stglstg CONTROLS 
a.1 +++ +++ +++ +++ ++ ++ ++ ++ - - - - = 
a.6 - - +++ + - - - - - - - - ~~ 
~2 + + ++ + + + + + - - - - ~ 
~3 - - ++ + - - - - ++ ++ + + ~ 
y2 +++ +++ ++ ++ + + - - + + - - = 
B - - +++ + - - - - - - - - ~~ I 
+:Weak staining++: Moderate staining+++: Strong staining-: No specific staining 
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3.2.2. Quantitative comparison of the expression of GABAA receptor 
subunits in adult mouse cerebellum by semi-quantitative immunoblotting 
For each GABAR subunit to be studied, a range of protein concentrations of 
control and stargazer cerebellar membranes ( 0. 125-10 J.lg) were subjected to 
immunoblotting and signals detected by the enhanced chemiluminescence (ECL) 
system. Immunoblots were exposed to hyperfilm ECL for most commonly 30 
seconds, 1 minute and 2 minutes. The resultant immunoreactive bands were 
quantified by computer-assisted densitometry using ImageJ software in order to 
determine within which range of protein amounts the level of signal achieved 
was linear, i.e. the signal doubled when double the amount of protein was loaded. 
An amount of control and stargazer protein which fell within the linear range for 
each antibody was then loaded on subsequent sodium dodecyl sulphate- ·,. 
polyacrylamide gel electrophoresis (SDS-PAGE) gels to compare three separate 
control cerebella with three stargazer cerebella (see section 2.10.). 
In order to normalise for the exact levels of protein loaded per SDS-PAGE gel 
and allow for the direct comparison of separate cerebella, the linear range forJ3-
actin was determined. A J3-actin value for each separate control and stargazer 
cerebellum was determined in order to report the expression levels of each 
subunit as a ratio of protein ofinterest:J3-actin signal. 
3 .2.2.1. GABAA receptor subunit a 1 
The linear range of protein for the GABAR a 1 subunit was determined to lie 
between 2.5 and 5 J.lg for control cerebella and between 5 and 10 J.lg for stargazer 
cerebella (see figure 3. 7.). Therefore, a comparison of 5 J.lg of each control and 
stargazer cerebellum was made by semi-quantitative immunoblotting using anti-
- -a:1-subunit specific antibody at 3 J.lg/ml. 
No significant difference in the expression levels of the GABAR al subunit was 
observed between control and stargazer cerebella. 
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Figure 3.7. Determination oftbe linear range for cerebeDBar 
expression levels of GABAA receptor al subunit in control 
(+/+:+/stg) and stargazer (stglstg) mutant mice 
A: Western blot analysis of serially diluted +:+/+/stg and stglstg 
cerebellar membrane homogenates probed with anti-GABAR al subunit 
antibody at a concentration of 1 ~mi. n=3, immunnoblotting repeated 
twice. 
B: Line graph showing the increasing intensity of immunoreactive band 
with increasing protein concentration by western blotting, quantified 
using ImageJ software (see section 2.10.5). Dotted lines indicate the 
linear range for +/+:+/stg and stglstg membrane homogenates. The 
circled protein concentrations were used for subsequent comparison of 
control and stargazer cerebellar membranes. 
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1Fngunre 3.8. Qunsntnll'ication ofr cerebeHDar expressimn Bevens o1r GABAJR 
all sa.nllnmmnt in conntroR (+/+:+/stg) anull stargazer (stg/stg) mice 
A: Western blot analysis of three control and three stargazer cerebella 
probed with anti-GABAR al subunit antibody at a concentration of3 
!J.g/ml. 
B: Bar graph illustrating the relative levels of al subunit expression in 
control and stargazer cerebellum, expressed as a ratio of a 1/~-actin. 
Values are mean± SEM ofn=3, immunoblotting repeated twice. Results 
indicate no significant reduction in al subunit expression in the stargazer 
cerebellum compared to control levels as determined by student's t-test 
(p=0.062). 
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Stargazer levels were determined to be 72 ± 34% of control levels (mean± SEM, 
n=3, p=0.062) (figure 3.8.). 
3 .2.2.2. GABAA receptor subunit a6 
The linear range for the GABAR a6 subunit was calculated to be between 2.5 
and 5 J..lg protein for both control and stargazer cerebella (figure 3.9.). Hence, 5 
J..lg of each control and stargazer cerebellum was compared by immunoblotting, 
probed with anti-GABAR a6 subunit specific antibody at 2 J..lg/ml. 
Figure 3.10. demonstrates a dramatic reduction in the expression levels of the a6 
subunit in the stargazer cerebellum to 39 ± 22% of control levels (n=3, p=0.013). 
3.2.2.3. GABAA receptor subunit J32 
Figure 3 .11. summarises the western blot analysis conducted on serially diluted 
control and stargazer cerebella probed with anti-GABAR J32 subunit specific 
antibody at 0.5 J..lg/ml. The linear range for both control and stargazer cerebella 
was found to lie between 5 and 10 J..lg. Therefore, 5 J..lg of protein for each 
cerebellum was analysed by immunoblotting. 
A significant reduction in the expression ofthe J32 subunit was found in 
stargazer cerebellum, to 45 ± 42% of control levels (p=0.012, n=3) (figure 3.12.). 
3.2.2.4. GABAA receptor subunit J33 
The linear range for the GABAR J33 subunit was found to lie between 2.5 and 5 
J..lg protein for control cerebella and between 5 and 10 J..tg protein for stargazer 
tissue (figure 3.13). 5 J..tg protein of each cerebellum was analysed by western 
blotting, probed with anti-GABAR J33 subunit specific antibody at 0.5 J..lg/ml. 
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lFngure 3.9. Determination of tllne Bineall" nnge tror cerebeiDmr 
expression levels of GABAA receptor a6 subunit in control 
(+/+:+/stg) and stargazer (stg!stg) mutant mice. 
A: Western blot analysis of serially diluted +:+/+/stg and stg/stg 
cerebellar membrane homogenates probed with anti-GABAR a.6 
subunit antibody at a concentration of 1 !J.g/ml. Arrow indicates 
GABAR a.6 immunoreactive band. n=3, immunoblotting repeated 
twice. The immunoreactive band corresponding to the GABAR a.6 
subunit was identified by screening adult mouse forebrain 
membranes and GABAR a.6 subunit immunopurified material by 
western blotting. The anti-GABAR a.6 subunit antibody recognised 
only one band in the GABAR a.6 subunit purified material of ~56 
k:Da, corresponding to the a.6 subunit (data not shown). 
B: Line graph showing the increasing intensity of immunoreactive 
band with increasing protein concentration by western blotting, 
quantified using ImageJ software (see section 2.10.5). Dotted lines 
indicate the linear range for +/+:+/stg and stg/stg membrane 
homogenates. The circled protein concentrations were used for 
subsequent comparison of control and stargazer cerebellar 
membranes. 
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lFigl!Dre 3.:U.O. QliDamtificatfionn Clf cerebeBiar ellpressncm BeveRs off GABAR 
a6 Sl!Dbl!Dnnnll: in cmnll:roD {+/+:+/sll:g) and stargazer (sll:g/stg) m8ce 
A: Western blot analysis of three control and three stargazer cerebella 
probed with anti-GABAR a6 subunit antibody at a concentration of 1 
!lglml. Arrow indicates GABAR a6 immunoreactive band. 
B: Bar graph illustrating the relative levels of a6 subunit expression in 
control and stargazer cerebellum, expressed as a ratio of a6/~-actin. 
Values are mean± SEM ofn=3, immunoblotting repeated twice. Results 
indicate a significant reduction in a6 subunit expression in the stargazer 
cerebellum to 39 ± 22% of control levels as determined by student's t-
test (p=O.Ol3). 
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Figure 3.1lt. Determination of the linear range for cerebellar 
expression levels of GABAA receptor p2 subunit in control (+/+:+/stg) 
and stargazer (stglstg) mutant mice. 
A: Western blot analysis of serially diluted +:+/+/stg and stg/stg 
cerebellar membrane homogenates probed with anti-GABAR ~2 subunit 
antibody at a concentration of0.5 flg/ml. n=3, immunoblotting repeated 
twice. 
B: Line graph showing the increasing intensity of immunoreactive band 
with increasing protein concentration by western blotting, quantified 
using ImageJ software (see section 2.10.5). Dotted lines indicate the 
linear range for +/+:+/stg and stg/stg membrane homogenates. The 
circled protein concentrations were used for subsequent comparison of 
control and stargazer cerebellar membranes. 
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Figure J.D.2. Qanantiflcatio1111 of cerebeRnar exqpressi«m DeveRs of GA..IBlAJR 
p2 subunit in control (+/+:+/stg) and stargazer (stg!stg) mice 
A: Western blot analysis of three control and three stargazer cerebella 
probed with anti-GABAR P2 subunit antibody at a concentration of0.5 
flgfml. 
B: Bar graph illustrating the relative levels of p2 subunit expression in 
control and stargazer cerebellum, expressed as a ratio of P2/p-actin. 
Values are mean± SEM ofn=3, immunoblotting repeated twice. Results 
indicate a significant reduction in p2 subunit expression in the stargazer 
cerebellum to 45 ± 42% of control levels as determined by student's t-
test (p=0.012). 
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1FngWJre J.:nJ. Determftlrnation of the nnnear range tfor cerebellar 
expression Revels of GABAA receptor pJ subunit in controD 
(+/+:+/stg) and stargazer (stg!stg) mutant mice. 
A: Western blot analysis of serially diluted +:+/+/stg and stg/stg 
cerebellar membrane homogenates probed with anti-GABAR ~3 subunit 
antibody at a concentration of0.5 lJ.g/ml. n=3, immunoblotting repeated 
twice. 
B: Line graph showing the increasing intensity of immunoreactive band 
with increasing protein concentration by western blotting, quantified 
using ImageJ software (see section 2.10.5). Dotted lines indicate the 
linear range for +/+:+/stg and stg/stg membrane homogenates. The 
circled protein concentrations were used for subsequent comparison of 
control and stargazer cerebellar membranes. 
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Figure 3.141. Quumtification of cerebeBiaD' expression Bevens of 
GABAR. IJ3 subunit in contD'ol (+/+:+/stg) and staD"gazer (stglstg) 
mice 
A: Western blot analysis of three control and three stargazer cerebella 
probed with anti-GABAR p3 subunit antibody at a concentration ofO.S 
Jlg/ml. 
B: Bar graph illustrating the relative levels ofp3 subunit expression in 
control and stargazer cerebellum, expressed as a ratio of P3/P-actin. 
Values are mean ± SEM of n=6, immunoblotting repeated twice. Results 
indicate no significant reduction in p3 subunit expression in the 
stargazer cerebellum compared to control levels as determined by 
student's t-test (p=0.284). 
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Direct comparison of control and stargazer cerebella revealed no significant 
decrease in the expression levels of the f33 subunit in the stargazer mutant when 
compared to controls (77 ± 42% of control levels, n=6, p=0.283) (figure 3.14). 
3.2.2.5. GABAA receptor subunit y2 
Figure 3.15 shows an example of a western blot performed in order to determine 
the range of cerebellar protein to be applied such that the GABAR y2 subunit 
immunoreactive signal was in the quantitative range for control and stargazer 
cerebellum. The linear range was determined to be between 5 and 10 J..lg protein 
for both control and stargazer cerebella. Hence, 5 J..lg cerebellar protein was 
applied to subsequent immunoblots enabling the comparison ofy2 subunit 
expression between the two mouse strains. 
No significant difference in y2 subunit expression was observed in stargazer 
cerebellum (81 ± 26% of control levels, p=0.06, n=6) relative to controls (100%) 
(figure 3.16). 
3.2.2.6. GABAA receptor subunit o 
The linear range for the GABAR o subunit was determined to lie between 5 and 
10 J..lg protein for both control and stargazer cerebella (figure 3.17.). 10 J..lg 
protein was employed for the direct comparison of GABAR o subunit 
expression. 
Figure 3.18. demonstrates the dramatic reduction in the expression of the o 
subunit (Mr 54 000 Da) observed in stargazer cerebellum compared to control 
(36 ± 21%, p=0.011, n=3). A further immunoreactive band was observed with a 
molecular weight (Mr) of~ 70 000 Da. This probably represents a non-o subunit 
cross-reactive protein, since it was not observed on purified a.6-o subunit-
containing GABARs (data not shown). 
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Figure 3.15. Determination of the linear range for cerebellar 
expression levels of GABAA receptor y2 subunit in control (+/+:+/stg) 
and stargazer (stglstg) mutant mice. 
A: Western blot analysis of serially diluted +:+/+/stg and stg/stg 
cerebellar membrane homogenates probed with anti-GABAR y2 subunit 
antibody at a concentration of2 l!g/ml. n=3, immunoblotting repeated 
twice. 
B: Line graph showing the increasing intensity of immunoreactive band 
with increasing protein concentration by western blotting, quantified 
using ImageJ software (see section 2.10.5). Dotted lines indicate the 
linear range for +/+:+/stg and stg/stg membrane homogenates. The 
circled protein concentrations were used for subsequent comparison of 
control and stargazer cerebellar membranes. 
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1FiguD"e 3.16. Quantification of cere!DeDiar expressio1111 Bevels ofGAB.AR 
y2 subunit in control (+/+:+/stg) and stargazer (stglstg) mice 
A: Western blot analysis of three control and three stargazer cerebella 
probed with anti-GABAR y2 subunit antibody at a concentration of 2 
J.tg/ml. 
B: Bar graph illustrating the relative levels ofy2 subunit expression in 
control and stargazer cerebellum, expressed as a ratio of y2/P-actin. 
Values are mean± SEM ofn=3 with immunoblotting repeated twice. 
Results indicate a significant reduction in y2 subunit expression in the 
stargazer cerebellum to 81 ± 26% of control levels as determined by 
student's t-test (p=0.06). 
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Figure 3.ll7. Determination of the linear range for cerebellar 
expression levels of GABAA receptor 6 subunit in control (+/+:+/stg) 
and stargazer (stg!stg) mutant mice. 
A: Western blot analysis of serially diluted +:+/+/stg and stglstg 
cerebellar membrane homogenates probed with anti-GABAR () subunit 
antibody at a concentration of 1 Jlg/ml. Arrow indicates GABAR () 
immunoreactive band. n=3, immunoblotting repeated twice. 
B: Line graph showing the increasing intensity of immunoreactive band 
with increasing protein concentration by western blotting, quantified 
using lmageJ software (see section 2.10.5). Dotted lines indicate the 
linear range for +/+:+/stg and stglstg membrane homogenates. The 
circled protein concentrations were used for subsequent comparison of 
control and stargazer cerebellar membranes. 
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JFigure 3.11.8. QuantJificatioBB o11' cerebeDiall" expll"essimn BeveRs o11' GABAR 
5 subunit in control (+/+:+/stg) and stargazer (stglstg) mice 
A: Western blot analysis of three control and three stargazer cerebella 
probed with anti-GABAR o subunit antibody at a concentration of 1 
Jlg/ml. Arrow indicates GABAR o immunoreactive band. 
B: Bar graph illustrating the relative levels of o subunit expression in 
control and stargazer cerebellum, expressed as a ratio of 0/~-actin. 
Values are mean± SEM ofn=3, immunoblotting repeated twice. Results 
indicate a significant reduction in o subunit expression in the stargazer 
cerebellum to 36 ± 21% of control levels as determined by student's t-
test (p=0.011). 
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Table 3.2. Quantitative comparison ofGABAR subunit expression in adult 
control and stargazer cerebellum 
GABAR CONTROL STARGAZER PVALUE 
SUBUNIT EXPRESSION EXPRESSION 
LEVELS LEVELS AS 
PERCENTAGE OF 
CONTROL 
(MEAN± SEM) 
a1 100 72±34 0.062 
a6 100 39±22 *0.013 
132 100 45 ±42 *0.012 
133 100 77±42 0.283 
y2 100 81 ±26 0.06 
0 100 36±21 *0.011 
*statistically significant p<0.05. 
Table 3.2. summarises, the expression levels of the GABAR subunits in the 
stargazer cerebellum. The a6, 132 and o subunits were found to be significantly 
reduced in the stargazer cerebellum by semi-quantitative immunoblotting. 
3.2.3. Zolpidem displacement of [Ju] RolS-4513 binding to control and 
stargazer cerebellar membranes 
Previous studies have implied that GABAR abnormalities in the cerebellum of 
stargazer mutant mice may result from compromised maturation of this brain 
region. The aim here is to determine whether GABARs undergo developmental 
transition expected in a normal maturing cerebellum-characterised by type II to 
type I transformation. 
Zolpidem displacement of eH] Ro 15-4513 binding (I 0 nM) to control and 
stargazer cerebellar membranes was conducted to determine the relative 
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proportion of type I and/or type IT binding that may comprise the specific 
benzodiazepine-sensitive (BZ-S) subtype of binding sites. Type I pharmacology 
is indicative of expression of a.1 J3y2 receptors, present in the adult cerebellum. 
Type II pharmacology is conferred by the a.2f3y2, a.3f3y2 and a.5f3y2 subunit-
containing receptors, the predominant subtype expressed in the developing 
cerebellum (see section 1.2.5.). 
Competitive displacement ofeH] Ro15-4513 binding sites (10 nM) with 
zolpidem at concentrations of 1 nM to 10 J.1M revealed no difference in the type 
ofbinding sites present in control and stargazer cerebellar membranes. eHJ 
Ro 15-4513 binding to BZ-S binding sites was completely displaced by zolpidem 
with an ICso of 40 nM and 42 nM for control and stargazer membranes 
respectively, consistent with type I pharmacology (see figure 3.19.) 
3.3. DISCUSSION 
The aim of this chapter was to re-evaluate and extend the previous studies that 
had shown that GABAA receptor subunit expression was compromised in the 
stargazer mutant mouse (Thompson eta/., 1998, Chen eta/., 1999). 
3.3.1. Qualitative differences in GABAR subunit distributions in the 
stargazer mutant, determined by immunohistochemical studies 
Immunohistochemical studies were conducted using subunit-specific antibodies 
to determine the cellular distribution of the GABAA receptor subunits in adult 
control and stargazer mouse cerebella. 
The immunostaining observed matched previously described distributions for 
each of the GABAA receptor subunits in the cerebellum (Pirker eta/., 2000). 
GABAR a. I subunit immunoreactivity was observed in all layers of the 
cerebellar structure to varying degrees, with the predominant immunoreactivity 
in the c_ereb~llar granule cell (CGC) and Purkinje cell layers. 
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Figure 3.19. Zolpidem displacement of [3H] Ro15-4513 binding to 
adult control (+/+:+/stg) and stargazer (stglstg) cerebellar membrane 
bomogenates 
Zolpidem displacement (half log concentrations ranging from 1 nM to 10 
J.1M) of [3H] Ro 15-4513 binding ( 10 nM) to control and stargazer 
cerebellar membranes. n=3 measurements per zolpidem concentration, 
10 cerebella per mouse strain. Data best fit a one-site binding model with 
calculated Hill coefficients (nH) of -0.82 ± 0.07 and -0.85 ± 0.19 for 
control and stargazer respectively. 
125 
"'0 • +/+ :+/stg s:= 
5 100 • stg/stg 
a:l 
M 
..... 
V) 75 
-.:t 
I 
V) 
..... 
0 
~ 50 
,......., 
~ 
M 
.......... 
~ 25 
0 
-10 -9 -8 -7 -6 -5 -4 
log [zolpidem] (M) 
Intense immunoreactivity for the a.6 subunit was observed in the cerebellar 
granule cell layer of the cerebellum in control brain sections, with no specific 
immunostaining detected in either the molecular or Purkinje cell layers. Strong 
immunoreactivity was observed in the cerebellar granule cell layer and to a lesser 
extent in the Bergmann glia cell bodies and processes in the molecular layer for 
the f33 subunit with no specific immunostaining observed in the Purkinje cell 
layer. The most intense immunostaining for the y2 subunit was detected in the 
Purkinje cell layer, with strong immunoreactivity also in the granule cell layer 
and Purkinje cell dendrites of the molecular layer. o subunit immunoreactivity 
was most intense in the cerebellar granule cell layer, with no specific 
immunostaining present in the Purkinje cell or molecular layers. The current 
observations were also in agreement with reported in situ hybridisation data 
(Laurie et al., 1992). CGCs were reported to possess high levels ofa.1, a.6, f32, 
f33, y2 and o GABAR subunits, while Purkinje cells contained a.1, f32, f33 and y2 
mRNAs only. The stellate/basket cells of the molecular layer were found to 
possess a.1, f32 and y2 mRNA only. 
Qualitative decreases in the intensity of immunoreactive staining for the a.6, f32, 
f33 and o subunits were observed uniformly in all cerebellar folia in the cerebellar 
granule cell layer of the stargazer cerebellum. 
3.3.2. Quantitative differences in GABAR subunit expression in the 
stargazer mutant, determined by immunoblotting studies 
During the development of the cerebellum, there is a switch in the expression of 
GABAA receptor subunits, such that the expression of the a.2, a.3 and y1 subunits 
are superceded by the adult GABAR subunit complement, a.1, a.6, f32, f33, y2 and 
o subunits (Laurie et al., 1992~ Thompson & Stephenson., 1994~ Wisden et al., 
1996). In situ hybridisation studies of the adult rat cerebellum show that the 
expression of the a.6 and o subunits occurs postnatally at approximately P6 and 
coiitinuesto nse iniilfadult levefs of e~p~e;sion are r~ached at approximately 
P12 (Laurie et al., 1992). 
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Semi-quantitative western blotting analyses indicated a decrease in the 
expression of GABAR a.6, J32 and cS subunits in the stargazer mutant cerebellum 
to 39 ± 22%, 45 ± 42% and 36 ± 21% of control levels respectively. 
Thompson et a/., in 1998 reported decreases to 23 ± 8% and 3 8 ± 12% of control 
levels in a.6 and J33 expression respectively in the stargazer mutant whereas a.1 
and J32 expression was relatively spared. In the current study, a qualitative 
decrease in J33 subunit expression was observed by immunohistochemistry in the 
stargazer cerebellum. Quantitation of this decrease however revealed a reduction 
in expression to 77 ± 42% of control levels in the stargazer mutant, which failed 
to reach statistical significance (p=0.283, n=6). The discrepancy in the reported 
decreases in J33 subunit expression in the stargazer mutant in the initial study and 
the current investigation can possibly be attributed to differences in the 
background strains used in both studies. The current study utilised the 
appropriate background strain, the C3B6Fe + mouse strain whereas previously the 
C57BL/6J strain was used. Fujikawa et al., in 2000 reported strain variations in 
the survival of cerebellar granule cells in culture under depolarising conditions, 
such that C57BL/6J CGCs did not survive in culture under physiological 
potassium concentrations ( 5 mM), but thrived under depolarising conditions. In 
contrast, CGCs derived from the Balb/C mouse strain survived both 
physiological and depolarising conditions (25 mM). Clearly cerebellar granule 
cells are different depending upon the strain of mouse from which they are 
derived. In this latter context it is interesting to note that C3B6Fe + mouse CGCs 
do survive at 5 mM KCl in vitro. So clearly C57BL/6J is not an ideal background 
strain. 
Quantification of GABAR subunit expression levels in the stargazer mutant 
demonstrated that the levels of the a.6 and cS subunits were reduced to 39 ± 22% 
and 36 ± 21% of control levels, respectively. The a.6 and cS subunits 
preferentially co-assemble into receptors in the cerebellum (Quirk et al., 1994; 
Jeclllingerei ill., 199s;I>o1tl ei a( 2663). 'lienee, it c~~ld be predicted that if a 
reduction in the expression of the a.6 subunit is observed, there may be a 
concomitant reduction in the expression of the cS subunit. This hypothesis is 
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supported by investigations into the effects of the GABAR a.6 subunit knockout 
mouse on other GABAR subunits (Jones et al., 1997). The group report a 
dramatic reduction in the expression of the o subunit protein in the a.6 subunit 
knockout mouse to 25 ± 8% of control levels, as determined by western blot 
analyses. This hypothesis is tested later in this study in chapters 5 and 6. 
Contrary to previous reports where expression of the J32 subunit was relatively 
spared (Thompson et al., 1998), the expression levels of the J32 subunit were 
found to be dramatically decreased to 45 ± 42% of control levels in the stargazer 
cerebellum in the current investigation. However, Jechlinger et al., in 1998 
reported that in the cerebellum, 50-60% of the a.6 subunits co-assemble with the 
J32 subunit, whereas only 20-30% co-assemble with the J33 subunit. Therefore, it 
may be predicted that with a loss of the a.6 subunit in the stargazer mutant, a 
more dramatic loss of expression of the J32 subunit would be observed. We can 
only postulate that this discrepancy is due to an inappropriate background strain 
used in the previous study. 
3.3.3. Is the GABAR profile of the stargazer mutant characteristic of a 
juvenile or adult cerebellum? 
Segal et al., in 1992 proposed that different neurotrophins act at different stages 
of cerebellar granule cell maturation. Brain-derived neurotrophic factor (BDNF) 
was found to be an essential requirement for the survival and maturation of 
immature cerebellar granule cells of the external granule cell layer (EGL) in 
dissociated rat cerebellar granule cell (CGC) cultures but also for the 
commitment of the granule cell to a neuronal phenotype. BDNF expression has 
been reported to be at higher levels in the internal granular layer than the external 
granule cell layer, forming a gradient ofBDNF levels and hence, it has been 
proposed to act as a chemotactic factor, promoting the migration of the CGCs 
from the EGL to internal granule cell layer (IGL) (Borghesani et al., 2002). The 
role ofBDNF as a chemotactic factor in the cerebellum may explain the delay in 
migration ofCGCs in the stargazer mutant mouse, which lacks BDNF expression 
in iile-CGC-layer, as observed by Qiao et~l, 1996, 1998. 
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Investigations into the BDNF knockout mouse (BDNF-t) demonstrate an 
increase in the thickness of the EGL in the mutant when compared to wild-type 
controls, consistent with a slowing of the migration ofCGCs from the EGL to 
IGL, highlighting the role ofBDNF as a motogenic factor (Borghesani et al., 
2002). It might be predicted therefore that in the stargazer mutant differentiation 
of the GABARs may be compromised, such that immature GABAR subunits 
persist in the adult mutant. 
Hashimoto et al., in 1999 reported that stargazer CGCs exhibit 
electrophysiological characteristics that are compatible with an immature stage 
of development, with mossy fibre to granule cell synapses that are devoid of 
AMPAR-mediated excitatory postsynaptic currents (EPSCs). This observation is 
supported by studies on waggler mice, which are allelic to the stargazer, where 
GABARs expressed in Golgi cell to granule cell synapses have immature 
channel kinetics (Chen et al., 1999) that might be explained by the loss of 
GABAR a.6 subunit expression described by Thompson et al., in 1998, which 
would be compatible with immature CGCs. However, in the current study, 
zolpidem displacement of eHJ Ro 15-4513 binding to adult control and stargazer 
cerebellar membranes showed the presence of GABARs with a Type I 
pharmacology (a.1 subunit-containing GABAA receptors) expected to be present 
in adult mature cerebellum. Type II receptors which were clearly absent from 
stargazer are indicative of expression of a.2 and a.J subunit-containing receptors, 
which are predominant in the immature cerebellum. Hence, it can be concluded 
that CGCs of the stargazer mutant differentiate as in control animals at least as 
far as the GABAR profile is concerned. 
3.3.4. Conclusions 
In conclusion, qualitative differences in GABAR subunit expression were 
determined using immunohistochemical techniques. Decreases in the a.6, (32, (33, 
and o subunits were observed in all cerebellar folia of the stargazer mutant 
cerebellum when compar~d to cont{"ols, Ilt~"~?CPJ:~!i~iQpoofth_e .GABAR subunits 
~-"-'-~ --:- ,.,. ~- =-· ·- --~ =-· .. . ~ ~-. - .. ---
were quantified in adult control and stargazer mouse cerebellum and revealed 
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significant decreases in expression of the GABAR a.6, f32 and B subunits in the 
stargazer mutant to 39 ± 22%,45 ± 42% and 36 ± 21% of control levels 
respectively. This study demonstrates that the development of the GABAR 
profile of the stargazer mutant cerebellum is not impaired. The GABAR profile 
expressed in the stargazer cerebellum is not indicative of the immature 
complement of receptors expressed in the developing cerebellum ( a2/a.3/a5 
subunit-containing receptors), as determined by zolpidem displacement of eH] 
Ro 15-4 513 binding, rather, the levels of expression of the a6 and B subunit-
containing GABARs present in the mature cerebellum, are dramatically reduced. 
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CHAPTER 4. GABAA RECEPTOR EXPRESSION IN THE 
CEREBELLUM OF THE STARGAZER MUTANT MOUSE 
4.1. INTRODUCTION 
Chapter 3 reported deficits in the expression of the GABAR subunits in the 
stargazer mutant mouse cerebellum as determined by immunohistochemistry and 
immunoblotting. The expression of the a.6, ~2 and o subunits were found to be 
significantly reduced in the cerebellum of the stargazer mutant to 39 ± 22%, 45 ± 
42%, and 36 ± 21% of control levels respectively. 
The aim of the current chapter was to re-analyse the GABAR expression profile 
by radioligand binding to cerebellar membrane homogenates in the stargazer 
mutant mouse but using the appropriate background strain for control animals. 
C3B6Fe+ mice were utilised in the current study, compared to the C57BL/6J 
strain used in previous investigations, as discussed in section 3.3.2 (Thompson et 
a/., 1998). This work was extended to analyse the distribution and abundance of 
receptor subtypes expressed in the stargazer mutant mouse brain by in situ 
receptor autoradiography. This approach also offered the ability to analyse a-
subunit containing GABAR that is difficult in radioligand binding assays on 
cerebellar membranes. Ultimately this would enable us to evaluate whether 
abnormalities in GABAR subunit expression translate into GABAR deficits in 
the stargazer mutant. 
4.2. RESULTS 
4.2.1. Determination of mouse genotype by genomic PCR screening 
The accurate genotyping of adult (2-6 months old) mice is essential not only for 
the maintenance of the stargazer breeding programme for which heterozygotes 
are required, but is also essential for us to determine whether wild-type(+/+) and 
heterozygote ( +/stg) mice could be combined for control material. Furthermore, 
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it is a necessity for the culture of control (+/+:+/stg) and stargazer (stg/stg) 
primary cerebellar granule neurons. 
Heterozygote mice ( +/stg) were used as breeders producing offspring in 
mendelian ratios of 1 +/+: 2 +/stg: 1 stg/stg. Tail biopsies were obtained from 
adult mice, DNA was isolated and subjected to multiplex polymerase chain 
reaction (PCR) using a combination of primers to yield characteristic amplicons 
of300 base pairs (bp) corresponding to the mutated allele and 600 bp for the 
wild-type allele (as described in methods, section 2.4). The stargazer mutation 
arises from an early viral transposon insertion of 6 kb between introns 2 and 3 of 
the stargazin gene, located on mouse chromosome 15. Therefore, different 
combinations of primers were used to amplify different regions of the gene to 
include the transposon insertion if present (Noebels et al., 1990; Letts eta/., 
1998). 
Heterozygote mice possess one copy of the normal allele ( 600 bp) and one copy 
of the mutated allele (300 bp), hence upon PCR screen, bands ofboth 300 and 
600 bp were visualised by agarose gel electrophoresis. In comparison, a wild-
type mouse possesses two copies of the normal allele and could therefore be 
identified by production of a single PCR product of 600 bp. The stargazer 
mutation is a recessive mutation. Hence, a stargazer mouse possesses two copies 
of the mutated allele and therefore only the 300 bp band can be visualised on an 
agarose gel (see figure 2.1.) 
The validity of the genomic PCR screen was tested by allowing screened 
neonates to mature and observed the resultant progeny following mating of 
heterozygote mice. Neonates that were concluded to be heterozygotes did not 
demonstrate a stargazer phenotype but did go on to produce offspring that 
included stg/stg in mendelian ratios. Wild-type animals did not show any 
characteristics of the stargazer phenotype and produced a single 600 bp PCR 
pJQduct. Stargazer neonates did indeed demonstrate the characteristic head toss 
and cerebellar ataxia predicted ·Ofthe mutant. 
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4.2.2. Radioligand binding to wild-type(+/+) and heterozygote (+/stg) 
cerebellar membranes 
It has been previously reported that +/+ and +/stg animals fail to display any 
differences in any of the electrophysiological or molecular biological parameters 
studied to date and were therefore combined as control tissue (Qiao eta/., 1998; 
Hashimoto eta/., 1999). To establish whether this was suitable for our studies, 
pharmacological analyses were carried out to determine if wild-type and 
heterozygote animals could be grouped as control animals for our future 
experiments. 
4.2.2.1. Cerebellar membrane homogenate preparation 
Original methods developed in the laboratory for the preparation of cerebellar 
membrane homogenates incorporated an initial centrifugation step whereby 
homogenised tissue was spun at I 0 000 g for 12 minutes. The resultant pellet 
containing whole cells and nuclei was discarded and the supernatant was utilised 
for the further preparation of cerebellar membranes. Upon determination of the 
eHJ Rol5-4513 binding (20 nM) present in the pellet, it was found that 42 ± 
11% of total specific binding sites, 39 ± 12% ofbenzodiazepine-sensitive (BZ-S) 
binding sites and 46 ± 10% ofbenzodiazepine-insensitive (BZ-IS) binding sites 
were contained within the pellet and were therefore discarded in the original 
protocol (figure 4.1.). According to Mehta and Ticku (1999) this was because 
cerebellar glomeruli were being spun down in the discarded fraction and 
probably contained CGC receptors which we proposed were compromised by the 
stargazer mutation and hence important for this investigation. Thus we adopted, 
with minor modifications the fractionation method of Mehta and Ticku. 
4.2.2.2. [~ Muscimol 
eH] muscimol acts as a GABA mimeti_9_aJ19ll~mce~binds with.high.affinitytothe · 
•••-- --"-"'--=-~--"~•-,::-=__,.-::::~' ~ •-- - • ..... • -"-'''"'''~~·-•· pC- --
GABA binding site of the GABAA receptor, located at the interface between a. 
and J3 subunits (Korpi eta/., 2002b). 
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IFigUJre 4.1. Comparison of [3H] R.o:D.S-41513 !Dinding in control cerebellar 
membrane preparation versus whole cell pellet 
Bar graph demonstrates radioactivity bound to CHJ Ro15-4513 binding sites (20 
nM) obtained from cerebellar membrane homogenates and pellet discarded in the 
original membrane preparation protocol. Flunitrazepam ( 10 ~ was used to 
define BZ-IS and BZ-S sub-components oftotal specific binding. RolS-1788 (10 
J.1M) was used to define non-specific binding. 
- Total Binding 
- BZ-S 
- BZ-IS 
Cerebellar membranes Whole cell pellet 
.!Figure 4l.2. [3l81] manscnmoR lbindong to wild-type (+/+) and Bneterozygote 
(+/!i!tg) ~erebellar membrane homogenates 
A: Full saturation binding curves to wild-type and heterozygote cerebellar 
membranes using a concentration range of0.5-40 nM em muscimol. 
B: Bar graph to demonstrate the BMAX values calculated for wild-type and 
heterozygote membranes. Results show no significant difference in BMAX, i.e. 
total binding sites, in heterozygote cerebellar membranes ( 104 ± 28%) compared 
to wild-type, p=O. 83. 
C: Table summarising calculated BMAX and Ko values for wild-type and 
heterozygote cerebellar membranes. Data is representative of mean ± SEM for 
n=2 experiments, membranes homogenates prepared from n= 10 cerebella per 
mouse strain. 
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c 
+I+ +/stg 
BMAX (pmoles/mg protein) 2.3 ± 0.4 2.4 ± 0.5 
Kn (nM) 53± 15 65 ± 19 
Consequently, eHJ muscimol will bind with high affinity to all GABAR, 
containing both y2 and o subunits. Interestingly, in autoradiography, the ligand 
has a degree of selectivity for specific GABAR in that it binds specifically to a.6 
subunit containing GABAR either directly or as a consequence of the presence of 
the o subunit (Korpi et al., 2002b). 
Full-saturation eHJ muscimol binding experiments were conducted to compare 
GABAR expression in wild-type(+/+) and heterozygote (+/stg) cerebellar 
membrane homogenates. Figure 4.2. demonstrates eHJ muscimol binding curves 
to cerebellar membranes from wild type and heterozygote animals, using a 
concentration range of 0. 5-40 nM ligand. Binding data was analysed using 
GraphPad prism 3. 0 to construct Rosenthal transformations of the data and 
calculate the maximum number of binding sites per mg protein (BMAX) and the 
dissociation constants (Ko) for each membrane preparation, summarised in figure 
4.2. No significant difference in BMAX for wild type and heterozygote animals 
was found in the current study. The BMAX determined for wild-type and 
heterozygote mice were 2. 3 ± 0.4 pmoles/mg protein and 2.4 ± 0. 5 pmoles/mg 
protein respectively. Ko values calculated for wild-type and heterozygote mice 
were 53± 15 nM and 65 ± 19 nM respectively (figure 4.2). These values are 
contrary to published Ko values for eHJ muscimol binding to mouse cerebellar 
homogenates, which are approximately 4-5 nM (Jones et al., 1997; Tretter eta/., 
2001 ). These results might be explained by the presence of endogenous GABA 
in the membrane preparation, despite the fact that the membrane preparation 
procedure was designed to wash out endogenous, competitive GAB A. Hence, 
calculated Ko values from Rosenthal transformations of the data would be higher 
than expected. Nonetheless, the membranes were prepared identically for each 
strain and the binding curves were practically super-imposable (figure 4.2). 
4.2.2.3. eHJ Ro15-4513 
Ro 15-4513 is a partial inverse agonist at the GABAR, which binds to the BZ 
binding site of the receptor, located on the interface between a. and.Y su~units. 
• .:_ _ ____ .,..,__:;.....--:"::=------ -·-- ·-"·""·-·---·-- -~ --~---- ------- -----
Hence, the presence of they subunit within the GABAR is essential for binding 
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ofRo15-4513. Flunitrazepam (10 J.!M) was used to displace eH] Ro15-4513 
bound to BZ-S GABAR (a1, a2, a3, a5, P and y2 containing), to reveal 
labelling ofBZ-IS GABAR containing the a4 and/or a6 subunits. Ro15-1788 
(10 J.!M) is a competitive antagonist, which competes for specific Ro15-4513 
binding sites, acting to displace eH] Ro 15-4513 from GABAR for which it has 
high affinity, hence revealing non-specific binding. 
In order to assess any differences in the contribution ofy2 containing GABARs 
to the receptor population of wild-type and heterozygote mice, full saturation 
eHJ Ro15-4513 binding studies were conducted in the absence and presence of 
flunitrazepam (10 J.!M) and Ro15-1788 (10 !J.M) to generate total specific, BZ-S 
and BZ-IS parameters. Figure 4.3. shows eHJ Ro15-4513 binding curves to 
cerebellar membranes from wild-type and heterozygote mice using a 
concentration range of0.31-40 nM. 
Calculation ofBMAX and Ko values for wild-type and heterozygote mice 
demonstrated no significant difference in the maximum number of binding sites 
(BMAX), or the affinity of the ligand for its receptor (Ko) between the two 
preparations. BMAX values for total eH] Ro 15-4513 binding for wild-type and 
heterozygote mice were 1.53 ± 0.11 pmoles/mg protein and 1.40 ± 0.05 
pmoles/mg protein respectively. For BZ-S binding, the maximum number of 
binding sites was determined to be 1.09 ± 0.10 pmoles/mg protein and 1.01 ± 
0.05 pmoles/mg protein for wild-type and heterozygote mice respectively. BMAX 
values for BZ-IS binding were 0.43 ± 0.02 pmoles/mg protein for wild-type 
membrane homogenates and 0.39 ± 0.02 pmoles/mg protein for heterozygote 
membrane homogenates. 
In accordance with studies reported by others (Qiao et al., 1998; Hashimoto et 
al., 1999) we have determined that the GABAR pharmacology of wild-type and 
heterozygote animals is identical. Therefore, in all further experiments, both 
genotypes were grouped and used as control animals (+/+:+/stg). 
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Figure 4.3. [~ Ro15-4513 binding to wild-type(+/+) and heterozygote 
(+/stg) cerebellar membrane homogenates 
A: Full saturation binding curves to wild-type cerebellar membranes using a 
concentration range of0.3-40 nM eH] Ro15-4513. Non-specific binding was 
determined in the presence ofRo15-1788 (10 ~- eH] Ro15-4513 binding in 
the presence offlunitrazepam (10 ~'defined benzodiazepine-insensitive (BZ-
IS) binding sites and hence benzodiazepine-sensitive (BZ-S) sites could be 
determined by subtraction ofthe BZ-IS binding sites from total eH] Ro15-4513 
specific binding sites. 
B: Full saturation binding curves to heterozygote cerebellar membranes using a 
concentration range of0.3-40 nM eH] Ro15-4513. 
C: Bar graph to demonstrate the difference in BMAX values calculated for wild-
type and heterozygote membranes. Results show no significant difference in 
BMAX for total specific binding ( 100 ± 8% and 92 ± 9%, p=O.l7), BZ-S binding 
(100 ± 10% and 93 ± 11%, p=18) or BZ-IS binding (100 ± 7% and 91 ± 7%, 
p=0.27) in wild-type or heterozygote membranes respectively. 
D: Table summarising calculated BMAX and Kn values for wild-type and 
heterozygote cerebellar membranes. Data is representative of mean ± SEM for 
n=2 experiments, membranes homogenates prepared from n= 10 cerebella per 
mouse strain. 
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4.2.3. Radioligand binding to control and stargazer cerebellum using eH] 
Muscimol 
4.2.3.1. Cerebellar membranes 
Full saturation binding experiments were conducted using a range of CH] 
muscimol concentrations of0.5-40 nM ligand to control (+/+:+/stg) and stargazer 
(stg/stg) cerebellar membrane homogenates. Results are shown in figure 4.4. A 
significant reduction in BMAX was calculated for the stargazer mutant, which was 
reduced to 70 ± 1 00/o of control levels. No significant difference in Ko values 
were found between the two strains (2.98 ± 0.85 nM and 3.64 ± 0. 74 nM for 
control and stargazer mice respectively), hence the affinity of the ligand for its 
receptor was not altered, rather, the total number of GABAR was found to be 
reduced in the cerebellum of the stargazer mutant mouse when compared to 
controls. 
4.2.3.2. Receptor autoradiography 
Adult control and stargazer tissue sections were subjected to receptor 
autoradiography, using CH] muscimol at a concentration of 20 nM. Non-specific 
binding was determined in the presence of 1 mM GAB A. 
Specific CHJ muscimol binding was observed in the cerebellum, hippocampus, 
cortex, striatum and thalamus (see figure 4.5.). The levels of radioactivity were 
quantified in the cerebellar granule cell layer ofboth control and stargazer 
sections using ImageJ software. CHJ standards of known radioactivities were 
exposed on CHJ hyperfilm for the same length of time as the tissue sections, 
allowing for the construction of a standard curve of radioactivity versus intensity 
of pixels in a gray matter area. Quantification of the levels of radioactivity within 
the cerebellar granule cell layer of control and stargazer tissue sections revealed a 
re<!uction in CHJ muscimol binding in the stargazer mutant to 54 ± 10% of 
control levels (n=6 sections per strain, 10 measurements per section, p<0.01.). 
- -- ------- - ~--- ·- - . -
Non-specific binding was determined to be at background levels of the film. 
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Figure 4.4. eH] muscimol binding to control (+/+:+/stg) and stargazer 
(stglstg) cerebeUar membrane homogenates 
A: Full saturation binding curves to control and stargazer cerebellar membranes 
using a concentration range of0.5-40 nM eHJ muscimol. 
B: Rosenthal transformation of specific eH] muscimol binding data to control 
and stargazer cerebellar membrane homogenates 
C: Bar graph to demonstrate the difference in BMAX values calculated for control 
and stargazer membranes. Results show a reduction to 70 ± 10%, p=0.03 of 
control levels in BMAX, i.e. total binding sites, in stargazer cerebellar membranes. 
D: Table summarising calculated BMAX and Ko values for control and stargazer 
cerebellar membranes. Data is representative of mean ± SEM for n=2 
experiments, membranes homogenates prepared from n= 10 cerebella per mouse 
strain. 
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Figllllre 4.5. [318[] Mllllscimon bhullhng (20 mM) to contron (+/+:+/stg) &lllldl 
stargazer (stg/stg) adult mouse brain sections 
A: Representative control and stargazer autoradiographs demonstrating 
high intensity of radio label in the cerebellar granule cell layer. 
JB: Standard curve of intensity versus radioactivity, constructed using 
ImageJ software to measure the intensity of [3H] standards of known 
radioactivities (see section 2.12.2). 
C: Column graph depicting the calculated radioactivities of the cerebellar 
granule cell layer of 6 control and 6 stargazer tissue sections, 10 
measurements per section from n=2 mouse per strain. 
]!)): Bar graph to demonstrate a significant decrease in PH] muscimol 
binding in the cerebellar granule cell layer of the stargazer mutant 
mouse, to 53± 10% of control levels, p<O.Ol. 
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Hence, it can be concluded from CHJ muscimol binding studies to control and 
stargazer cerebellar membrane homogenates and tissue sections that there is a 
significant reduction in the total number of GABAR in the stargazer mutant 
mouse, to 70 ± 10% of control levels and a reduction in a.6-subunit containing 
GABAR to 54 ± 10% of control levels as determined by receptor 
autoradiography. 
4.2.4. Radioligand binding to control and stargazer cerebellum using en] 
Ro15-4513 
4.2.4.1. Cerebellar membranes 
Radioligand binding studies were conducted using a concentration range of0.31-
40 nM CHJ Ro15-4513 to control and stargazer cerebellar membranes. Upon 
dissection of the resultant binding data into its pharmacological subtypes, it was 
found that the BMAX of total CH] Ro15-4513 binding, representing a.1f3y2, a.6f3y2 
and a.1 a.6f3y2, was reduced to 81 ± 10% of control levels in the stargazer mutant 
(1.01 ± 0.05 and 0.82 ± 0.06 pmoles/mg protein for control and stargazer 
membranes respectively). The BMAX of the BZ-S subtype of receptor, 
corresponding to a.1f3y2 GABAR was reduced to 92 ± 15% of control levels 
(0.71 ± 0.08 and 0.65 ± 0.06 pmoles/mg protein for control and stargazer 
membrane homogenates). The BZ-IS subtype of receptor was dramatically 
reduced to 57 ± 13% of control levels (0.30 ± 0. 76 pmoles/mg protein for 
controls and 0.17 ± 0.02 pmoles/mg protein for stargazer membranes), indicating 
a loss ofa.6f3y2 receptors in the stargazer mutant cerebellum (figure 4.6.). 
4.2.4.2. Receptor autoradiography 
Receptor autoradiography was conducted on adult control and stargazer tissue 
~sections; using CHJ Ro f 5.:4513 at a concentration of 20 nM. 10 J.lM 
·nunitrazepam was· utilised~to defrne BZ~is~6indT~g ~d 10 ~ R~ 15-4513 to 
determine the contribution of non-specific binding. 
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Figure 4.6. eHJ Ro15-4513 binding to control ( +/+:+/stg) and stargazer 
(stglstg) cerebeUar membrane homogenates 
A: Full saturation binding curves to control cerebellar membranes using a 
concentration range of0.3125-40 nM eHJ Ro15-4513. Non-specific binding was 
determined in the presence ofRo15-1788 (10 ~- eHJ Ro15-4513 binding in 
the presence of flunitrazepam (1 0 J!M), defined benzodiazepine-insensitive (BZ-
IS) binding sites and hence benzodiazepine-sensitive (BZ-S) sites could be 
determined by subtraction ofthe BZ-IS binding sites from total eHJ Ro15-4513 
specific binding sites. 
B: Full saturation binding curves to stargazer cerebellar membranes using a 
concentration range of0.3125-40 nM eHJ Ro15-4513. 
C: Rosenthal transformation of total specific eHJ Ro 15-4513 binding data to 
control and stargazer cerebellar membrane homogenates 
D: Rosenthal transformation ofBZ-S eHJ Ro15-4513 binding data to control and 
stargazer cerebellar membrane homogenates 
E: Rosenthal transformation ofBZ-IS CHJ Ro 15-4513 binding data to control 
and stargazer cerebellar membrane homogenates 
F: Bar graph to demonstrate the difference in BMAX values calculated for control 
and stargazer membranes. Results show differences in BMAX for total specific 
binding (100 ± 8% and 81 ± 10%), BZ-S binding (100 ± 14% and 92 ± 15%) or 
BZ-IS binding (100 ± 7% and 57± 13%) in control or stargazer membranes 
respectively. 
G: Table summarising calculated BMAX and Ko values for control and stargazer 
cerebellar membranes. Data is representative of mean ± SEM for n=2 
experiments, membranes homogenates prepared from n=IO cerebella per mouse 
strain. 
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Figure 4.7. Total [3H] Ro15-45Jl3 binding (20 nM) to control 
(+/+:+/stg) and stargazer (stglstg) adult mouse brain sections 
A: Representative control and stargazer autoradiographs demonstrating 
high intensity of radiolabel in the cerebellum, cortex and hippocampus. 
B: Standard curve of intensity versus radioactivity, constructed using 
lmageJ software to measure the intensity of [3H] standards of known 
radioactivities (see Section 2.12.2.) 
C: Column graph depicting the calculated radioactivities of the cerebellar 
granule cell layer of 6 control and 6 stargazer tissue sections, 10 
measurements per section from n=2 mouse per strain. 
D: Bar graph to demonstrate no significant decrease in total [3H] RolS-
4513 binding in the cerebellar granule cell layer of the stargazer mutant 
mouse (90 ± 6% of control levels, p=0.07). 
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A: Representative control and stargazer autoradiographs demonstrating 
high intensity ofradiolabel in the cerebellar granule cell layer. 
Autoradiographic film was processed to achieve the optimum signal in 
the CGC layer. Longer exposure times were required to achieve dentate 
gyrus labelling, see figure 7.3. 
liJ: Standard curve of intensity versus radioactivity, constructed using 
ImageJ software to measure the intensity of [3H] standards of known 
radioactivities (see section 2.12.2). 
C: Column graph depicting the calculated radioactivities of the 
cerebellar granule cell layer of 5 control and 4 stargazer tissue sections, 
10 measurements per section from n=2 mouse per strain. 
D: Bar graph to demonstrate a significant decrease in the BZ-IS subtype 
of PH] Ro15-4513 binding in the cerebellar granule cell layer ofthe 
stargazer mutant mouse to 78 ± 10% of control levels, p=0.03. 
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eHJ Ro 15-4513 binding was predominantly located in the cerebellum, cortex, 
olfactory bulbs and hippocampus. Quantification of the levels of radioactivity 
within the cerebellar granule cell layer of control and stargazer tissue sections 
revealed a slight decrease in total eHJ Ro15-4513 binding in the CGC layer of 
the stargazer mutant that did not however reach statistical significance (90 ± 6% 
of control levels, p=0.07) (figure 4.7.). 
In contrast, BZ-IS eHJ Ro15-4513 binding was located solely in the CGC layer 
in control sections. Interestingly, in the stargazer mutant, BZ-IS binding was also 
observed in the dentate gyrus, an observation discussed in detail in chapter 7. 
Upon quantification of the levels ofBZ-IS binding in the CGC layer, a 
significant decrease to 78 ± 10% of control levels was detected in the stargazer 
mutant, p=0.03 (figure 4.8.). Hence receptor autoradiographic studies also concur 
with radioligand binding studies on cerebellar membrane homogenates such that 
a significant decrease in a.6 subunit-containing GABAR is observed in the 
stargazer mutant cerebellum. 
4. 3. 3. 3. eHJ Flunitrazepam 
eHJ flunitrazepam was employed at a concentration of 5 nM in receptor 
autoradiographic studies on adult control and stargazer tissue sections, in order to 
determine any abnormalities in the BZ-S subtype (a.1J3y2) ofGABAR in the 
stargazer mutant CGC layer. The major areas ofBZ-S expression observed by 
eHJ flunitrazepam binding were noted in the cerebellum, cerebral cortex, 
olfactory bulbs and hippocampus. Quantification of radioactivity in the CGC 
layer of control and stargazer sections revealed a slight increase in BZ-S subtype 
of receptor binding in the stargazer mutant to 113 ± 8% of control levels which 
failed to reach statistical significance (p=0.19) (figure 4.9.). 
4.3. DISCUSSION 
eHtm~c-!moJ acts as a GABA mimetic and hence binds to-the GABA binding--
site <!fJh~_.Q:A.Bi\.R. --~ - -' -0~ -o ~--0~~-
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Figure 41.9. [3H] FB.unitrazepam binding (5 nM) to controB (+/+:+/stg) 
and stargazer (stg!stg) adult mouse brain sections 
A: Representative control and stargazer autoradiographs demonstrating 
high intensity of radio label in the cerebellum, hippocampus and cortex. 
B: Standard curve of intensity versus radioactivity, constructed using 
ImageJ software to measure the intensity of [3H] standards of known 
radioactivities (seeSection 2.12.2.). 
C: Column graph depicting the calculated radioactivities of the 
cerebellar granule cell layer of 6 control and 6 stargazer tissue sections, 
10 measurements per section from n=2 mouse per strain. 
D: Bar graph to demonstrate no significant decrease in [3H] 
flunitrazepam binding in the cerebellar granule cell layer of the stargazer 
mutant mouse (113 ± 8% of control levels, p=0.19). 
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The GABA binding site is situated on the interface between a and J3 subunits. 
Consequently, the ligand binds to all GABAR which in the cerebellum includes 
a.1 (32/3y2, a.6(32/3y2, a.1a.6(32/3y2, a.6(32/3o and a.1a.6(32/3o subunit 
combinations. 
Radioligand binding studies on cerebellar membrane homogenates demonstrated 
a loss of [ 3H] muscimol binding to 70 ± 10% of control levels in the stargazer 
mutant. This indicates either a uniform loss (by 30%) of all GABAR subtypes 
expressed (a.1(3y2, a.6(3y2, a.1a.6(3y2, a.6(3o and a.1a.6(3o) or a selective loss of a 
particular subtype in the stargazer cerebellum. However, receptor 
autoradiography to control and stargazer tissue sections revealed a reduction in 
eHJ muscimol binding to 54 ± 1 0% of control levels in the stargazer mutant. 
Discrepancies in the percentage reductions obtained by both methods can be 
explained a number of ways. Receptor autoradiography allows for the accurate 
quantification of radioactivity within separate layers of the cerebellum, in this 
case, the level of radio ligand binding in the cerebellar granule cell layer was 
determined. In comparison, a cerebellar membrane homogenate is composed of 
the whole structure of the cerebellum, including the Purkinje cell layer, 
molecular layer and CGC layer. As a result, differences in specific GABAR 
subtypes in separate cellular layers may be masked. 
It has been widely reported that eHJ muscimol selectively highlights only certain 
types ofGABAR by receptor autoradiography (Quirk eta/., 1995; Jones eta/., 
1997; Mihalek et al., 1999; Korpi et al., 2002b ). Korpi et al., in 2002b proposed 
that [~ muscimol in autoradiography selectively binds to the GABAR a.6 
subunit-containing subtypes (a.6(3y2+a.6(3o). A lot of evidence has been gathered 
on this disparity in eHJ muscimol binding on membrane preparations and 
receptor autoradiography from studies on knockout animals. Jones et al., in 1997 
reported a complete loss of eH] muscimol binding in the cerebellar granule cell 
layer ofthe a.6 knockout mouse. Korpi et al., in 2002a demonstrated a loss of 
eHJmuscimol biriding in double knockout animals, where the GABAR a.6 and 0 
subunits were absent, but the restoration of ligand binding in the CGC layer in 
the presence of the a.6 subunit, but not the o subunit alone. It was suggested that 
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a factor exists specifically associated with the a.1/a.2/a.3/a.5J3y2 GABAR on 
native membranes that prevents muscimol binding in receptor autoradiography 
(Korpi et al., 2002a). 
The selectivity of eHJ muscimol for the cerebellar a.6 subunit-containing 
GABARs in receptor autoradiography suggests that the loss of CHl muscimol 
binding (54 ± 10% of control levels) in the stargazer mutant is due to a loss of a.6 
subunit-containing receptors in the cerebellar granule cell layer. This is further 
supported by the dramatic reductions in the protein expression of the a.6 and (5 
subunits in the stargazer cerebellum found by western blotting, which were 
reduced to 39 ± 22% and 36 ± 21% of control levels respectively (see section 
3.2.2.). Thompson eta/., in 1998 also reported a dramatic reduction in a.6 subunit 
expression, to 23 ± 8% of control levels. Interestingly the y2 subunit is relatively 
spared (81 ± 26% of control levels). 
CHJ Ro 15-4513 is a partial inverse agonist at the benzodiazepine binding site of 
the GABAR, which is located between the a. andy subunits. Consequently, the 
ligand is selective for y subunit-containing GABAR which in the cerebellum 
include a.1f32/3y2, a.6f32/3y2 and a.1a.6f32/3y2. It is possible to further subdivide 
these GABAR according to their sensitivity to benzodiazepines. The addition of 
flunitrazepam, a benzodiazepine agonist, acts to distinguish the benzodiazepine-
insensitive (BZ-IS) subtype of receptor, namely a.6 subunit-containing GABAR 
in the cerebellum. The benzodiazepine-sensitive subtype of receptor is 
predominantly the a.1 subunit-containing receptors in the cerebellum and can be 
determined by the subtraction of the BZ-IS population of receptors from the total 
level of radio ligand binding obtained. 
Based upon the dramatic reductions in the protein expression of the a.6 subunit 
observed in the stargazer cerebellum by western blotting, it would be predicted 
that this reduction would result in a loss of the BZ-IS subtype of[3H] Ro15-4513 
binding. Radioligand binding to cerebellar membrane homogenates demonstrated 
a reduction to 57± 13% of control levels in BZ-IS binding in the stargazer 
cerebellum. This reduction was also observed in the receptor autoradiographic 
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studies, where a significant decrease in BZ-IS binding was observed in the CGC 
layer of the stargazer mutant, to 78 ± 1 00/o of control levels, p=O. 03. Thompson et 
al., in 1998 also reported a dramatic loss ofthe BZ-IS subtype ofCHJ Ro15-
4513 binding in the stargazer mutant, to 38 ± 10% of control levels. This 
reported loss is significantly greater than the decrease in BZ-IS binding observed 
in the current study. A possible explanation for such a discrepancy is the 
difference in the background strain of mice used in the studies. C57BL/6J 
animals were employed in the initial study, whereas in the current investigations, 
C3B6Fe+ mice were used, which is essentially the background strain of the 
stargazer mutant. Therefore, any differences in reported results may be due to 
strain variability (see section 3.3.2.). 
Determination of the total levels of CHJ Ro 15-4513 binding in control and 
stargazer cerebellum revealed no significant difference between the two strains, 
with calculated reductions to 81 ± 1 0% of control levels in the stargazer mutant 
on cerebellar membranes and to 90 ± 6% by receptor autoradiography. 
Therefore, there is no significant difference in the total number ofy2-containing 
GABAR in the stargazer mutant cerebellum. Western blotting further 
corroborates these findings, which revealed a decrease to 81 ± 26% of control 
levels in y2 subunit protein expression in the stargazer mutant. 
The BZ-S subtype of receptor, representing a1f3y2 GABAR was not significantly 
affected in cerebellar membrane homogenates, being 92 ± 15% of control levels 
in the stargazer mutant. Likewise CHJ flunitrazepam binding which highlights 
the BZ-S subtype of receptor in autoradiography was not significantly different 
in the CGC layer of stargazer compared to controls ( 113 ± 8% of control levels). 
The protein expression levels of the GABAR a1 subunit also concur with the 
BZ-S radioligand binding results, such that no significant difference in the 
expression levels were found between the two mouse strains (72 ± 34% of 
control levels, n=3, p=0.062). 
Poltl et al., in 2003 identified the contributions of each GABAR subtype to the 
mouse cerebellar GABAR population by immunodepletion by immunoaffinity 
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chromatography and western blotting. GABAR y2 subunit containing receptors 
were found to represent 68% of total GABAR in the cerebellum, while GABAR 
()subunit-containing receptors contributed 29% oftotal GABAR with the 
remaining 3% attributable to minor GABAR populations. eH] muscimol when 
used in receptor autoradiography binds to GABAR a.6 subunit-containing 
receptors only (Mihalek eta/., 1999; Korpi eta/., 2002a). Therefore, in the 
cerebellum these would include a.la.6f3y2, a.6f3y2, a.la.6f3B and a.6f3() GABAR, 
which contribute 22%, 7%, 10% and 18% to the total number of GABAR in the 
cerebellum respectively (Poltl eta/., 2003). Hence, by extrapolation, a.la.6f3y2 
and a.6f3y2 contribute 51% of the total GABAR signal obtained by eH] 
muscimol autoradiography. a.la.6f3B and a.6f3B contribute 49% of total signal. 
The BZ-IS subtype ofeH] Ro15-4513 autoradiography was shown to be reduced 
by 22% in the stargazer mutant CGC layer, conferred by a.la.6f3y2 and a.6f3y2. 
Therefore, by extrapolation, this reduction would represent a loss of 11% of the 
total eH] muscimol autoradiography signal. However, eH] muscimol 
autoradiography revealed a 47% decrease in binding in the stargazer CGC layer, 
which is not fully accountable by a loss of 11% ofbinding due to y2 subunit 
containing GABAR. Therefore, it could be predicted that there is a loss of 36% 
of the total signal attributable to () subunit containing GABAR, resulting in a 
73% loss of total() subunit containing GABAR, making this the major subtype 
abnormality so far observed in the stargazer cerebellum. 
In conclusion, possible abnormalities in the GABAR profile of the stargazer 
mutant mouse were determined by radio ligand binding techniques to both 
cerebellar membrane homogenates and tissue sections by receptor 
autoradiography. [~ muscimol binding to cerebellar membranes revealed a 
decrease to 70 ± 10% of control levels, suggesting a loss of total GABAR in the 
stargazer cerebellum. Receptor autoradiography using eH] muscimol, which is 
selective for a.6 subunit-containing receptors, revealed a decrease to 54± 100/o of 
-- - --
controllevels in the CGC layer of the stargazer mutant. Total levels of [3H] 
Ro 15-4513 binding were not found to differ significantly between control and 
stargazer animals. However, upon further pharmacological dissection, the BZ-IS 
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subtype of receptor, conferred by a.6J3y2 and a.1a.6f3y2 receptors was found to be 
reduced to 57± 13% of control levels in cerebellar membrane homogenates and 
to 78 ± 10% of control levels in the CGC layer by receptor autoradiography. By 
difference analysis, ifthere is a dramatic decrease in the total number ofGABAR 
as revealed by a loss of eH] muscimol binding, yet the total level of eH] Ro 15-
4513 binding is unchanged, this implies that the major GABAR abnormality in 
the stargazer mutant cerebellum is due to a deficit of a.6J38 subunit-containing 
GABARs. 
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CHAPTER 5. ARE THE CEREBELLAR GABAA RECEPTOR 
DEFICITS OBSERVED IN STARGAZER MUTANT MICE 
DUE TO COMPROMISED AMPA RECEPTOR 
EXPRESSION? 
5.1. INTRODUCTION 
Previous results of this study identified a dramatic and relatively selective 
reduction in the expression of the cerebellar granule cell-specific GABAA 
receptor (GABAR) a6, o but not y2 subunits in the stargazer mutant mouse 
cerebellum, to 39 ± 22%, 36 ± 21% and 81 ± 26% of control levels, respectively 
(see section 3.3.2.). These observations were compatible with a reduction in CHJ 
muscimol binding by in situ autoradiography to 54 ± I 0% of control levels in the 
stargazer cerebellar granule cell (CGC) layer, suggesting a dramatically lower 
level of expression of a6~o receptors in the stargazer mutant (see section 
4.3.2.2.; 4.4). 
In order to investigate the mechanisms that link failure to express an AMP A 
receptor (AMP AR) trafficking/targeting protein with a selective influence on the 
inhibitory profile of CGCs, it was necessary to utilise a dynamic model system 
which can recapitulate the mechanisms governing GABAR expression and 
trafficking seen in vivo. Since the expression of CGC-specific GABAR subunits 
a6 and o have been shown to be selectively reduced in the stargazer mutant, 
cultured CGCs were utilised in the current study. Furthermore, it has been widely 
reported that the expression of GABAR in vivo can be successfully reproduced in 
cultured cerebellar granule cells (CGCs) {Beattie & Siegel, 1993; Thompson et 
a/., 1994; 1996; Zheng eta/., 1994; Behringer eta/., 1996). 
The majority of previous studies have utilised rat CGCs, which have an absolute 
requirement for depolarising conditions(25 mM-KCl) for survival and 
maintenance in culture, ~as under non-depolarising conditions they rapidly 
undergo apoptosis and degenerate (Gallo eta/., 1987). Gault and Siegel in 1997 
demonstrated that the expression and maintenance of the GABAR o subunit is 
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modulated by KCl-mediated depolarisation in cultured rat CGCs. GABAR 8 
subunit mRNA was not detected in cultures maintained at physiological levels of 
KCl (5 mM). Whereas, following depolarisation with 25 mM KCl which 
activated L-type voltage-gated calcium channels, transcription of the GABAR 8 
gene was increased. In terms of rat CGC development this is in accordance with 
what is observed in vivo, i.e. KCl-mediated depolarisation appears to direct rat 
CGCs along an appropriate path of neuronal development. 
Intriguingly, the contrary appears to apply to mouse CGCs (Mellor eta/., 1998; 
Ives eta/., 2002a). CGCs derived from some mouse strains do not require 
depolarising conditions for survival (Mellor eta/., 1998; Fujikawa eta/., 2000). 
Under basal culture conditions (5 mM KCl) these neurons are electrically active 
(Mellor eta/., 1998). Furthermore, Ives eta/., in 2002 have reported that mouse 
CGCs maintained under 5 mM KCl culture conditions closely mimic the 
developmental expression profile ofGABAR seen in vivo. Interestingly, Mellor 
eta/., in 1998 reported that if mouse CGCs are maintained under depolarising 
conditions (25 mM KCl) for prolonged periods of time (>3 DIV) as used to 
maintain rat CGCs, they become electrically silent, in that they do not exhibit 
spontaneous action potentials, miniature excitatory postsynaptic currents 
(mEPSCs) or miniature inhibitory postsynaptic currents (miPSCs). In addition, 
KCl-mediated depolarisation induced a switch in GABAR subunit expression, 
such that an immature GABAR profile was achieved. Therefore, under KCl-
mediated depolarising conditions, the GABAR profile of mouse CGCs does not 
mirror the expression profile seen in maturing CGCs in vivo (Ives eta/., 2002a). 
Clearly this implies that electrical activity of CGCs is important in orchestrating 
the developmental maturation and expression levels of GABARs, that is 
characterised by the emergence of the a6 and 8 subunits-that are compromised in 
stargazer mutant mice. 
More recently, a number of groups have reported that expression of GABAR 
subunir ffiR:NAs in mouse CGCs is affected by depolarisation following 
activationofionotiopic glutamate receptors (e.g. by kainic acid, a non-NMDA 
receptor agonist) (Engblom eta/., 2003; Martikainen eta/., 2004). However, 
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effects reported on GABAR o subunit expression following kainic acid-treatment 
are controversial. Martikainen et a/., in 2004 reported a reduction in o subunit 
mRNA expression to 28% of control levels following AMP AR activation 
compared to 5K by RT-PCR. In contrast, Engblom et al, in 2003 report no effect 
on GABAR o subunit mRNA levels following kainic acid-mediated 
depolarisation, compared to 5K controls. Observations reporting GABAR o 
subunit mRNA modulation following kainic acid treatment, acting to activate 
AMP AR and kainate receptors are not compatible with our previous observations 
of GABAR o subunit protein expression in the stargazer mutant cerebellum, 
where we observed a significant reduction in GABAR o subunit expression, in a 
CGC which fails to express AMP AR at the cell surface. Is the deficit in AMP AR 
expression in stargazer CGCs responsible for aberrant expression of o subunit-
containing GABARs? 
Previous studies have been unable to distinguish if kainic acid depolarisation-
induced effects on GABAR expression occurred as a consequence of AMP A or 
kainate receptor activation. The stargazer mutant mouse provides an invaluable 
tool to allow for the distinction between the effect of activating each type of 
receptor, CGCs only express T ARPy2 of the family of transmembrane AMP A 
receptor regulatory proteins (T ARPs) and therefore rely exclusively on this 
protein for surface trafficking and targeting of AMP ARs in CGCs. In stargazer 
mice, where T ARPy2 is not expressed, CGCs from this mouse can be regarded as 
AMPAR 'incompetent', but kainate receptor 'competent' (Hashimoto eta/., 
1999), as kainate receptors are relatively unaffected by the mutation (Chen eta/., 
2003). Therefore, only kainate receptors would be activated in response to 
kainic-acid mediated depolarisation in stglstg CGCs whilst CGCs derived from 
control mice are AMP A and kainate receptor competent. 
The aims of this chapter were to firstly characterise the developmental profile of 
mouse cultured CGCs in terms of the GABAR subunits they express and their 
migration'and morphology at different time points in culture. Secondly, to 
determine the effects ofdepolarisation on the GABAR profile and the 
morphology and cellular migration ofCGCs in culture. Finally, to re-investigate 
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the effects ofkainic acid-mediated depolarisation on the expression of the 
GABAR o subunit in culture (Engblom et al., 2003; Martikainen et al., 2004). 
Furthermore, to determine if the effects on o subunit expression observed in vivo 
in the stargazer could be attributed to differential activation of AMP A or kainate 
receptors by comparing expression in control and stargazer CGCs. 
5.2. RESULTS 
In order to study the effects of excitatory inputs on the expression and trafficking 
of the GABAR subunits, it was first necessary to characterise the culture system 
in terms of the development of expression of the GABAR subunits with time in 
vitro, the patterns of maturation, migration and morphology in culture and the 
survival and maintenance of mouse CGCs in response to depolarisation. 
5.2.1. Developmental profile of the morphology and migration of mouse 
CGCs in culture 
Figure 5 .1. depicts the development of mouse CGCs under 5K culture conditions 
with time, in terms of their morphology, migration and cellular arrangement. 
Cerebella were dissected from P6-7 mouse neonates and CGCs cultured from 
them according to standard procedures (see section 2.14). CGCs were fixed with 
4% paraformaldehyde in 0.2 M phosphate buffer at 2 day intervals in culture 
from 1 days in vitro (DIY) to 7 DIY and viewed using a Nikon diaphot 300 
microscope. Images were taken at x200 magnification. 
Figure 5.1.A demonstrates CGCs at I DIY, where the cells had adhered to the 
poly-L-lysine coated surface of the culture dish and had begun to elongate and 
form neuronal processes. At 3 DIY, the CGCs were beginning to form complex 
networks of neuronal processes, with a bipolar morphology characteristic of 
CGCs in culture (see figure 5.l.B). By 5 DIY, there was evidence that the CGCs 
had begun to migrate towards each other to from cellular aggregates, with 
numerous processes extruding from a central oore-of cell bodies (see figure 
S.cl.C}: At7 DIY, theoabundanceofcellular aggregates was greatly increased, 
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Figure 5.1. Development of adult mouse control (+/+:+/stg) cerebellar 
granule cells (CGCs) in culture 
A: CGCs at 1 Day in vitro (DIV). 
B: CGCs at 3 DIV, note the elaboration of neuronal processes. 
C: CGCs at 5 DIV. CGCs begin to migrate towards each other to 
form the cellular aggregates. 
D: CGCs at 7 DIV, note the abundance of cellular aggregates, indicated 
with an arrow. 
with compact aggregates connected by large cables of neuronal processes (see 
figure 5.1.D). 
5.2.2. Developmental expression of GABAR subunits in culture 
The expression ofthe GABAR subunits was determined in CGCs derived from 
P6-7 control ( +/+:+/stg) mouse neonates cultured by standard methods and 
harvested at 2 day intervals from 1 DIV to 9 DIV for western blot analysis. 
5 .2.2.1. GABAR a.l subunit expression 
Figure 5.2.A represents western blot analysis of cultured control CGCs harvested 
at 2 day intervals in vitro and probed with anti-GABAR a.l subunit-specific 
antibody at 1 J..lg/ml. Expression of the a.1 subunit appeared at low levels at 1 
DIV and continued to increase until a plateau was reached at 7 DIV. Two 
immunoreactive bands were highlighted with the anti-GABAR a.1 antibody. The 
higher molecular weight species has previously been shown to correspond to the 
a.1 subunit (Mr 53 000 Da) (Thompson eta/., 1996). The lower molecular weight 
band is likely to be a proteolytically processed fragment of the mature a.1 subunit 
(Duggan eta/., 1991). 
5.2.2.2. GABAR a.6 subunit expression 
Expression of the GABAR a.6 subunit became evident at low levels at 3 DIV and 
increased to plateau at 5-7 DIV. Two further bands were identified by the anti-
GABAR a.6 subunit antibody at 1 J.lg/ml which may represent cross-reacting 
proteins, differentially glycosylated forms of the subunit or in the case of the 
immunoreactive band highlighted at a lower molecular weight than the a.6 
subunit, a degradation product (see figure 5.2.B). 
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Figure 5.2. DeveBopmelllltmllprofnDe for the ell.pressiollll of 
GABAR submnits in cultured cerebellar grallllule ceBis 
Control CGCs cultured under basal conditions (5 mM KCl) 
harvested at 2 day intervals from 1 DIV to 9 DIV and subjected to 
western blot analysis (10 ~g protein per gel lane) using subunit-
specific antibodies compared to adult control cerebellar 
membranes(+/+ cblm). 
A: GABAR a.1 subunit 
B: GABAR a.6 subunit 
C: GABAR ~2 subunit 
D: GABAR ~3 subunit 
E: GABAR o subunit 
F: GABAR y2 subunit 
G: AMP AR GluR2 subunit 
H: TARPy2 
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5.2.2.3. GABAR P2 subunit expression 
Figure 5.2.C demonstrates CGCs subjected to immunoblotting and probed with 
anti-GABAR P2 subunit-specific antibody at 0.5 Jlg/ml. Expression of the P2 
subunit appeared at low levels at 1-3 DIV and increased to reach a peak at 7-9 
DIV. 
5.2.2.4. GABAR P3 subunit expression 
CGCs subjected to immunoblotting and probed with an anti-GABAR P3 subunit-
specific antibody at 0.5 Jlg/ml demonstrated a low level of expression at 1 DIV 
which increased with time in culture, to plateau at 3-5 DIV (see figure 5.2.D). 
5.2.2.5. GABAR o subunit expression 
Expression of the GABAR o subunit appeared at 5 DIV and peaked at 7-9 DIV. 
Immunoblot probed with anti-GABAR o subunit antibody at 1 Jlg/ml highlighted 
an immunoreactive species corresponding to the o subunit (Mr 54 0000 Da) and 
a protein of higher molecular weight which as discussed earlier is most likely a 
cross-reacting, non-o subunit protein (see figure 5.2.E). 
5.2.2.6. GABAR y2 subunit expression 
Figure 5.2.F shows western blot analysis of cultured CGCs probed with anti-
GABAR y2 subunit-specific antibody at 1 Jlg/ml which highlighted one band 
with Mr 45 000-50 000 Da, corresponding to the GABAR y2 subunit. Expression 
of the GABAR y2 subunit appeared at low levels at 1 DIV and increased in 
expression, to peak at 7-9 DIV. 
In order to conduct experiments to compare GABAR subunit modulation 
between control and stargazer CGCs, it was necessary to determine the point at 
which T ARPy2, the AMP AR auxiliary protein ablated in the stargazer mutant, is 
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expressed in a control neuron. Furthermore, to determine the time point in culture 
when expression of AMP AR subunits occurs in control CGCs. 
5.2.2.7. TARPy2 expression 
Western blot analysis of cultured CGCs probed with anti-pan TARP antibody at 
1 J..lg/ml highlighted a single immunoreactive species with a molecular weight of 
I 
approximately 36 000 Da, corresponding to TARPy2. Expression ofTARPy2 
appeared at 3 DIV at low levels and increased in expression to plateau at 7-9 
DIV (see figure 5.2.G). 
5.2.2.8. AMPAR GluR2 subunit expression 
In order to determine the presence of AMP AR subunits in cultured mouse CGCs, 
expression of the GluR2 subunit was characterised by western blotting, using an 
anti-AMP AR GluR2 antibody at 1:500 dilution. Figure 5.2.H shows expression 
of the GluR2 subunit consistently at all time points in culture. 
5.2.2.9. Expression off3-actin in cultured CGCs 
Following the characterisation of the expression of the principal GABAR 
subunits in culture, expression of J3-actin was determined, to ensure that equal 
levels of protein were analysed per time point sample (Figure 5.2.1) 
Western blot analysis of the principal GABAR subunits in culture demonstrated 
markers of mature CGCs, GABAR a.6 and o subunits were expressed at high 
levels in culture between 7-9 DIV, corresponding to P13/14-P15/16, when these 
subunits are expressed in vivo (see figure 1.2.). Cells demonstrated migration in 
culture to form compact cellular aggregates, previously proven to correlate with 
G_AB~_a.6 subunit expression (lves eta/., 2002a). Furthermore, cell viability 
was high at 7 DIV, with the generation of>95% pure primary CGCpopulation. 
Therefore, for all subsequent experiments, CGCs were used for further 
experimentation at 7 DIV. 
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5.2.3. Effects of depolarisation on the migration and maturation of adult 
control (+/+:+/stg) and stargazer (stg!stg) mouse CGCs in culture 
Figure 5.3. demonstrates the cellular arrangement, maturation and morphology of 
control and stargazer CGCs in culture in response to depolarisation mediated by 
KCl and kainic acid (7 DIV). Cerebella were simultaneously dissected from age-
matched control and stargazer mice at P6-7 and cultured by standard methods. 
CGCs were treated at 1 DIV with KCl (fc=25 mM) or kainic acid (100 J.LM), 
fixed with 4% paraformaldehyde in 0.2 M phosphate buffer at 7 DIV and viewed 
under a Nikon diaphot 300 microscope. Images were taken at x200 
magnification. 
Figure 5.3.A&B represent control (A) and stargazer (B) CGCs cultured under 
normal physiological KCl concentrations (5 mM). CGCs derived from both 
mouse strains formed cellular aggregates, connected by thick cables of neuronal 
processes. Upon depolarisation with KCl (fc=25 mM), both control and stargazer 
CGCs responded differently in culture. CGCs failed to migrate towards each 
other to from cellular aggregates, rather they appeared to remain stationary and 
formed a network of neuronal processes (figure 5.3. C&D). This is in agreement 
with, Ives et al., in 2002 who also reported similar patterns of migration of CGCs 
cultured under KCl-mediated depolarising conditions. 
Kainic acid-mediated depolarisation however, appeared to affect the migration of 
CGCs derived from control and stargazer mice differently. Stargazer CGCs more 
closely resembled CGCs cultured under 5 mM KCl conditions, forming compact 
cellular aggregates interconnected by a network of cables of processes (figure 
5.3.F). In comparison, CGCs derived from control animals responded similarly to 
kainic acid-mediated as to KCI-induced depolarisation. Few cellular aggregates 
were observed in control CGCs cultured in the presence ofkainic acid, rather a 
complex network of neuronal processes was evident interspersed with numerous 
cell bodies (figure 5.3.E). 
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Figure 5.3. The effects of culture conditions on the cellular arrangement 
and morphology of cerebellar granule cells (CGCs) in culture 
A&B: CGCs cultured under physiological conditions (5 mM KCl, '5K') 
C&D: CGCs cultured under depolarising conditions (25 mM KCl, '25K') 
E&F: CGCs cultured in the presence ofkainic acid (100 ~M 'Kainate') 
Arrow indicates cellular aggregate. 
Scale bar: 0.05 mm 
5.2.4. Effects of KCI-mediated depolarisation on GABAR subunit expression 
in control and stargazer CGCs. 
Previous findings in the lab have indicated a role for neuronal activity in the 
regulation ofGABAR subunit expression in cultured mouse CGCs (Ives eta/., 
2002a). In order to confirm and extend previous observations, control and 
stargazer CGCs were cultured simultaneously from age-matched littermates, 
treated at 1 DIY with KCl (fc=25 mM) and harvested at 7 DIY for western blot 
analysis. 
5.2.4.1. Control CGCs 
In agreement with previous findings in this lab (Ives eta/., in 2002a), expression 
of the GABAR a.1 subunit protein was found to be dramatically reduced in 
control CGCs cultured under 25K conditions to 7 ± 15% of5K levels (p=0.01). 
Western blot analysis of cultured control CGCs subjected to KCl-mediated 
depolarisation probed with anti-GABAR a.6 subunit-specific antibody revealed a 
dramatic reduction in a.6 subunit expression to 25 ± 1% of 5K levels. Ives eta/., 
in 2002 also reported a dramatic loss of expression of the a.6 subunit in control 
CGCs following KCl-mediated depolarisation (to 3 ± 2% of5K levels). 
Immunoblotting results indicated differential modulation of the expression of the 
GABAR J3 subunits in response to KCl-mediated depolarisation. The expression 
of the J32 subunit was undetectable by immunoblotting following KCl-mediated 
depolarisation (figure 5.4.). In contrast, f33 subunit expression was increased 
dramatically (251 ± 29% of5K levels, p<0.01). These observations are in 
agreement with Ives eta/., in 2002 who reported that the f32 subunit was 
undetectable under 25K conditions while f33 subunit levels were increased to 167 
± 8% of 5K levels. 
To extend previous studies, expression levels of the GABAR y2 and 8 subunits 
were quantified in control CGCs following KCl-mediated depolarisation. A 
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Figure 5.4. Effects of KCI-mediated depolarisation on the expression 
of GABAR subunits in cultured control and stargazer CGCs 
A: Western blot analysis ofGABAR subunit expression in cultured 
control (+/+:+/stg) CGCs (7 DIV) treated in the absence (5K) and 
presence of increased extracellular KCl (25 mM). Note the reduction in 
expression of the GABAR al, a6 and y2 subunits following KCl-
mediated depolarisation. Furthermore, an up-regulation of JB and c) 
subunit expression was observed in response to KCl-mediated 
depolarisation. Data represents mean ± SEM from n=3 cultures as 
presented in figure 5.6. 
B: Western blot analysis ofGABAR subunit expression in cultured 
stargazer (stglstg) CGCs (7 DIY) treated in the absence (5K) and 
presence of increased extracellular KCl (25 mM). Note the reduction in 
expression of the GABAR al, a6 and y2 subunits following KCl-
mediated depolarisation. Furthermore, an up-regulation of f33 and c) 
subunit expression was observed in response to KCl-mediated 
depolarisation. Data represents mean ± SEM from n=3 cultures as 
presented in figure 5. 6. 
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slight reduction in expression ofthe GABAR y2 subunit was observed to 81 ± 
21%, which however failed to reach statistical significance, p=0.36. In contrast, 
the expression of the o subunit protein was dramatically increased to 245 ± 36% 
of 5K levels, p=0.02. 
5.2.4.2. Stargazer CGCs 
A significant reduction in GABAR a1 subunit expression was observed in 
stargazer CGCs upon KCl-mediated depolarisation, to 21 ± 23% of 5K levels 
(p=0.05). GABAR a6 subunit expression was not detectable following KCl-
mediated depolarisation. Regulation of J3 subunit expression was differentially 
modulated in response to KCI-mediated depolarisation, as observed in control 
CGCs, such that expression of the GABAR J32 subunit was undetectable. 
Conversely, expression of the J33 subunit was increased to 246 ± 26% of 5K 
levels (p<0.01). GABAR y2 subunit expression was not significantly different 
from 5K levels, 85 ± 1 00/o, p=0.28 of 5K levels respectively. Under 25 mM KCl 
culture conditions, expression of the o subunit protein was dramatically increased 
in stargazer CGCs (220 ± 47% of5K levels, p<0.01) (figure 5.4.). 
5.2.4.3. GABAR subunit expression following KCI-mediated depolarisation in 
control and stargazer CGCs 
KCI-mediated depolarisation acted to modulate the expression ofGABAR 
subunit expression similarly in both control and stargazer CGCs. Expression of 
the GABAR a1 subunit was dramatically reduced in control and stargazer CGCs, 
to 7 ± 15% and 21 ± 23% of5K levels respectively. GABAR a6 subunit 
expression was also similarly reduced to 25 ± 1% in control CGCs and was 
undetectable in stargazer CGCs. GABAR J3 subunit expression was differentially 
modulated in both control and stargazer CGCs, where (32 subunit expression was 
not detectable upon KCI-mediate depolarisation, while J33 subunit expression 
was dramatically increased to 251 ± 29% and 246 ± 26% of 5K levels in control 
and stargazer CGCs respectively. GABAR y2 subunit expression was reduced to 
81 ± 21% of 5K levels in control CGCs and 85 ± 10% in stargazer CGCs, which 
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did not however reach statistical significance. A dramatic up-regulation of 
GABAR o subunit expression was observed in both control and stargazer CGCs, 
to 245 ± 36% and 220 ± 47% of 5K levels respectively. 
Previous observations in the current study demonstrated a significant reduction in 
GABAR a.6 and o subunit expression in the stargazer mutant CGC layer in vivo 
(see section 3.3.2.). Treatment with increased extracellular KCl (fc=25 mM) 
acted to down-regulate a.6 subunit expression in both control and stargazer CGCs 
in vitro. However, expression of the GABAR o subunit was dramatically up-
regulated in CGCs derived from both mouse strains. Loss of AMP AR expression 
in stargazer mutant CGCs correlates with differential electrical activity of CGCs. 
Comparison ofGABAR expression in control and stargazer CGCs can be 
correlated with comparison of5K (electrically active) and 25K (electrically 
inactive). Therefore, it is possible to conclude that increased extracellular KCl-
mediated depolarisation does not mimic in vivo GABAR subunit regulation in 
the stargazer mutant. However, it is possible to conclude that the downstream 
signalling cascades responsible for inducing regulation of expression of the 
GABAR subunits following KCI-mediated depolarisation are intact in stargazer 
CGCs, as similar GABAR subunit modulation was observed in both mouse 
strains. 
5.2.5. Effects of kainic acid-mediated depolarisation on GABAR subunit 
expression in control and stargazer CGCs. 
The mechanism by which KCI-mediated depolarisation regulates GABAR 
subunit expression has yet to be resolved. However, it was conceivable that 
depolarising KCl concentrations could evoke glutamate release, subsequently 
activating glutamate receptors. Previous studies have reported modulatory effects 
ofkainic acid treatment (non-NMDA receptor agonist) on GABAR subunit 
expression in cultured mouse CGCs (Engblom et al., 2003; Martikainen et al., 
2004). In order to assess the possible contribution of AMP AR/Kainate receptor 
activation on GABAR expression, control and stargazer CGCs were cultured 
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from age-matched littermates, treated at I DIV with kainic acid (100 ~and 
harvested at 7 DIV for immunoblotting. 
5.2.5.1. Control CGCs 
Kainic acid-mediated depolarisation acted to dramatically reduce the levels of 
expression of the GABAR a. I subunit protein in control CGCs to 29 ± 22% of 
5K levels (p<O.Ol). When control CGCs were cultured in the presence of the 
non-NMDA receptor antagonist, CNQX (20 J.LM), kainic acid treatment did not 
act to reduce the expression ofthe a.l subunit in control CGCs (121 ± 21% of5K 
levels, p=0.34). Therefore, it is possible to conclude that kainic acid is acting via 
AMPA and/or kainate receptors to regulate GABAR a. I subunit expression. 
GABAR a.6 subunit expression was reduced to 27 ± 0.3% of 5K levels, in 
control CGCs cultured in the presence ofkainic acid. Kainic acid-mediated 
depolarisation differentially regulated expression of the~ subunits, resulting in 
undetectable levels of GABAR ~2 subunit expression, while a significant 
increase in ~3 subunit protein levels were noted, to 167 ± 30% of 5K levels, 
p=0.04 (see figure 5.5.). Kainic acid-induced depolarisation caused a significant 
reduction in GABAR y2 subunit expression in control CGCs (44 ± 21% of5K 
levels, p=0.03). The effects ofkainic acid-mediated depolarisation resulted in a 
significant increase in expression of GABAR B subunit in control CGCs (246 ± 
40% of5K levels). CGCs cultured in the presence ofkainic acid and CNQX 
resulted in GABAR B subunit expression levels similar to those at 5K (118 ± 
35% of5K levels, p=O.l6). 
5.2.5.2. Stargazer CGCs 
No significant effect on GABAR a. I subunit expression upon kainic acid 
treatment was observed in stargazer CGCs (86 ± 29% of 5K levels, p=0.63). 
GABAR a.6 subunit expression \Vas also not modulated in response to kainic 
acid-mediated depolarisation in stargazer CGCs (100 ± 2% of control levels). ~2 
and ~3 subunit protein levels were unaffected by AMP AR activation, 64 ± 46% 
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Figure 5.5. Effects of kainic acid depolarisation on the expression of 
GABAR subunits in cultured control and stargazer CGCs 
A: Western blot analysis ofGABAR subunit expression in cultured 
control ( +/+:+/stg) CGCs (7 DIV) treated in the absence ( 5K) and 
presence ofkainic acid (100 ~·Note the reduction in expression of the 
GABAR al, a6 and y2 subunits following kainic acid treatment. 
Furthermore, an up-regulation of ~3 and o subunit expression was 
observed in response to AMP AR activation. Data represents mean ± SEM 
for n=3 cultures as presented in figure 5.6. 
B: Western blot analysis ofGABAR subunit expression in cultured 
stargazer (stg/stg) CGCs (7 DIV) treated in the absence (5K) and 
presence ofkainic acid (100 ~·Note the reduction in expression of the 
GABAR y2 subunit following kainic acid treatment. Kainic acid 
treatment did not affect GABAR a 1, a6, ~3 or o expression levels. Data 
represents mean± SEM for n=3 cultures as presented in figure 5.6. 
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and 85 ± 35% of 5K levels, respectively. No effect on expression of the 8 subunit 
was noted in stargazer CGCs (93 ± 61% of5K levels) Kainic acid induced 
depolarisation caused a significant reduction in GABAR y2 subunit expression in 
stargazer CGCs (61 ± 18% of5K levels, p=0.05). Hence, it can be concluded that 
expression of the y2 subunit is modulated by activation of kainate receptors and 
not AMPAR (see figure 5.5.). 
5.2.5.3. GABAR subunit expression following kainate-mediated depolarisation 
in control and stargazer CGCs 
In contrast to the effects ofKCl-mediated depolarisation, kainic acid-mediated 
depolarisation acted to regulate the expression of the GABAR subunits 
differently in control and stargazer CGCs. Expression of the GABAR aJ subunit 
was dramatically reduced in control CGCs (to 29 ± 22% of 5K levels), while no 
significant effect on expression of the subunit in CGCs derived from the 
stargazer mutant were noted (to 86 ± 29% of5K levels). Similarly, GABAR a.6 
subunit expression was reduced in control CGCs (to 27 ± 0.3% of 5K levels), 
which was not reciprocated in stargazer CGCs (to 100 ± 2% of5K levels). 
GABAR ~3 subunit expression levels were increased to 167 ± 30% of 5K levels 
in control CGCs, while protein levels were 85 ± 35% of 5K levels in stargazer 
CGCs. Expression of the GABAR 8 subunit were up-regulated in control CGCs, 
to 246 ± 400/o of 5K levels, which was not observed in stargazer CGCs (93 ± 
61% of 5K levels). Therefore, it is possible to conclude that activation of 
AMPAR in control CGCs resulted in the modulation ofGABAR a.1, a.6, ~3 and 
8 subunit expression levels, since these effects were not observed in stargazer 
CGCs, which are AMP AR-incompetent. 
In contrast, the expression of the GABAR y2 subunit was down-regulated in 
response to kainic acid-mediated depolarisation in both control and stargazer 
CGCs, to 44 ± 21% and 61 ± 18% of5K levels respectively. Hence, it is possible 
to conclude that the regulation of the GABAR y2 subunit occurred as a result of 
kainate receptor activation, since stargazer CGCs are AMP AR-incompetent, and 
kainate receptor-competent. 
162 
JFngure 5.6. IExpressioon of GAJmAA Receptor s1111bmnnts ion contron amll 
stargazer CGCs (7 ][)IV) under polarised! (5K) and depolarisedl (25K 
and Kainate-treated) culture ccmditio1111s. 
CGCs (7 DIV) derived from control (+/+:+/stg) and stargazer (stg/stg) 
mice, in the absence ( 5K) and presence of increased extracellular KCl 
(25K, 25 mM), kainic acid (Ka, 100 ~)or kainic acid (1 00 ~) and 
CNQX (20 !J.M). 10 J..Lg protein per gel lane, data represents n=3 cultures. 
A: Western blot analysis of cultured CGC material probed with anti-
GABAR a1 subunit specific antibody at 1 J..Lg/ml. 
B: Western blot analysis of cultured CGC material probed with anti-
GABAR a6 subunit specific antibody at 2 J..Lg/ml. 
C: Western blot analysis of cultured CGC material probed with anti-
GABAR 132 subunit specific antibody at 0.5 J..Lg/ml. 
D: Western blot analysis of cultured CGC material probed with anti-
GABAR 133 subunit specific antibody at 0.5 J..Lg/ml. 
E: Western blot analysis of cultured CGC material probed with anti-13-
actin specific antibody at 1:2000 dilution. 
F: Western blot analysis of cultured CGC material probed with anti-
GABAR y2 subunit specific antibody at 1 J..Lg/ml. 
G : Western blot analysis of cultured CGC material probed with anti-
GABAR o subunit specific antibody at 1 J..Lg/ml. 
H : Western blot analysis of cultured CGC material probed with anti-13-
actin specific antibody at 1 :2000 dilution. 
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The effects ofKCl-mediated depolarisation on GABAR subunit expression were 
largely mirrored by kainic acid-mediated depolarisation, except in stargazer 
CGCs. Clearly the mechanism by which KCI-mediated depolarisation induces 
effects on GABAR subunit expression are not due to glutamate release and its 
subsequent activation ofnon-NMDA receptors though the downstream signalling 
mechanisms must be very similar. Since these also occur in stargazer CGCs it 
implies that KCI-mediate depolarisation bypasses the requirement for functional 
AMP ARs to induce its effects. These will be discussed later. The only instance 
where KCl-mediated depolarisation and kainic acid-mediated depolarisation do 
not parallel each other is in the case of the GABAR y2 subunit, which is down-
regulated by kainic acid treatment and unaffected by KCI. The y2 subunit appears 
unique in that it is the only subunit which appears to be influenced by kainate 
receptors of the subunits tested, through a mechanism that is not paralleled by 
simple depolarisation. Details of this mechanism are still yet to be resolved. 
5.3. DISCUSSION 
The aim of this chapter was to firstly characterise the mouse CGC culture system 
in terms of their morphological maturation and migration in culture by 
examination ofCGCs at 2 day intervals from 1-7 DIY. Secondly, to determine 
the GABAR expression profile by western blot analysis of mouse control CGCs 
harvested at 2 day intervals from 1-9 DIV to establish whether these would 
constitute a good model system for studying developmental regulation of 
GABAR expression in vitro. The criteria required were that they switch on 
GABAR subunits with a temporal profile as seen in vivo (Laurie et al., 1992) and 
that they expressed T ARPy2 protein. Thirdly, to investigate the modulation of 
expression of GABAR subunits by depolarisation, to confirm and extend 
previously reported effects ofKCl-mediated depolarisation and kainic acid-
induced depolarisation on GABAR subunit expression (Gault and Siegel., 1997, 
1998; Mellor et al., 1998; lves et al., 2002a; Engblom et al., 2003; Martikainen 
et al., 2004). Ultimately the aim here was to establish whether impaired AMP AR 
activity in stargazer CGCs (AMPAR-incompetent and kainate receptor-
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competent) was responsible for the GABAR deficits reported in stargazer 
cerebellum in vivo (see results chapters 3 and 4). 
5.3.1. Characterisation of the cell culture system 
During the maturation of the cerebellum, CGC precursors migrate from the 
external granule cell layer (EGL) to the internal granule cell layer (IGL) and 
once in their adult positions form synapses with glutamatergic mossy fibre 
afferents and GABAergic Golgi II interneurons. Synaptogenesis coincides with a 
developmental switch in the expression of GABAR subunits at P6-7 in vivo, 
from a.2 and a.3 subunits, characteristic of the juvenile GABAR complement, to 
a.1, a.6 and o subunits (Laurie eta/., 1992; Mellor eta/., 1998). Concomitantly 
there is a selective enrichment of the benzodiazepine-insensitive (BZ-IS) subtype 
of GABAR, characteristic of a.6py2 receptors which correlates with the temporal 
up-regulation of the a.6 subunit (Thompson & Stephenson, 1994; Wisden eta/., 
1996). 
Western blot analysis of mouse CGCs cultured under basal SK conditions, 
collected at 2 day intervals from 1-9 DIY demonstrated a developmental increase 
in GABAR a.1, P2 and y2 subunits with time from 1 DIY to plateau at 7-9 DIY, 
in agreement with observations reported in rat CGCs by Thompson & 
Stephenson in 1994. In contrast, expression of the a.6 and o subunits did not 
occur unti13-5 DIY, but also demonstrated a time dependent increase in 
expression, with expression levels reaching a plateau at 7-9 DIY. These findings 
are further supported by the work of Thompson & Stephenson in 1994 who 
demonstrated a time-dependent enrichment ofBZ-IS binding sites in rat CGCs 
with time in culture, corresponding to an increase in GABAR a.6 subunit 
expression. Furthermore, Zheng eta/., in 1994 reported that positive modulation 
of GABA action by diazepam was decreased in rat CGCs from 5-20 DIY, 
corresponding to an increase in expression of a.6 subunit containing receptors. 
At 5-7 DIY, CGCs were shown to have migrated in culture to form compact 
cellular aggregates, interconnected by large cables of neuronal processes, 
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mimicking the migration of CGC precursors from the EGL to the IGL and the 
formation of synapses with glutamatergic mossy fibres in vivo. Hence it can be 
concluded that mouse CGCs cultured under basal conditions (5 mM KCl) 
undergo a maturation process as expected of CGCs in vivo, providing a model 
system with which to study the expression, trafficking and targeting of GABAR 
subunits. 
Furthermore, T ARPy2 protein was expressed by control CGCs at 3-5 DIV as 
expected in vivo. Interestingly, western blot analysis of time point samples 
demonstrated the expression of the AMP AR GluR2 subunit in culture before the 
expression ofT ARPy2, a protein known to be involved in the targeting and 
anchoring of AMPAR at the synapse (Chen et al., 2000). This is an interesting 
observation, as it suggests the production of AMP AR subunits before the 
expression of proteins (T ARPy2) necessary for cell surface trafficking and 
targeting of functional AMP A receptors. Future work would involve western blot 
analysis to determine if there is the presence of other T ARP isoforms, such as 
TARPy4, known to be expressed in CGCs in vivo (Tomita et al., 2003), early in 
the development of CGCs in culture. 
Other groups have also reported minimal expression of AMP AR at the cell 
surface in the absence ofTARPy2 (Chen et al., 2003, Vandenberghe eta/., 
2005). Vandenberghe eta/. in 2005 suggested that this may be explained by 
induction of the unfolded protein response (UPR). The unfolded protein response 
is triggered by accumulation of unfolded and unassembled proteins in the 
endoplasmic reticulum (ER), which leads to the increased transcription of genes 
encoding ER chaperones, such as Ig binding protein (BiP) (Vandenberghe et a/., 
2005). BiP acts to bind to mis-folded or misassembled proteins and helping fold 
and assemble AMP AR. 
Y ~cl_en1Jerghe et al. also demonstrated-that the UPR is induced in stargazer 
~QCs, ExJJr_ession levels of BiP were-found to be increased in stargazer CGCs, 
but not in wild type or heterozygote mice. AMP AR in the stargazer mutant have 
also been reported to show an immature ER-type glycosylation pattern (Tomita 
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eta/., 2003). Furthermore, genistein, a tyrosine kinase inhibitor known to prevent 
full expression of the UPR reduced residual AMP A currents in stargazer CGCs. 
5.3.2. Modulation of the GABAR subunits by depolarisation 
The underlying mechanisms responsible for the temporal regulation of GABAR 
subunit expression are unknown to date, but could result from activation of 
ionotropic glutamate receptors, intrinsic pre-programmed factors or 
environmental cues. However, it has been widely reported that each GABAR 
subunit is independently regulated (Zheng eta/., 1994; Behringer et al., 1996). 
Gault and Siegel in 1997 reported modulatory effects on the expression of the B 
subunit by potassium-mediated depolarisation in rat CGCs. Under 25K 
conditions, the group reported an increase in the expression of the B subunit 
mRNA, proposed to result from activation ofL-type calcium channels and an 
increase in intracellular calcium levels to cause either increased transcription of 
the B subunit gene directly or indirectly by phosphorylation of transcription 
factors. 
In a later study in 1998, the group used rat CGCs maintained at 5 mM potassium 
levels, in the narrow window before cellular degeneration and apoptosis, to show 
that activation ofNMDA receptors causing an influx of calcium also acted to 
increase B subunit mRNA levels. This increase in expression was also increased 
further by removal of the magnesium block from NMDAR which was suggested 
could be removed indirectly by activation ofnon-NMDAR. Increased 
intracellular calcium was proposed to cause activation of transcription factors, or 
immediate early genes to result in increased transcription of B gene. However, we 
have employed the NMDAR antagonist, MK-801 to block calcium influx via 
NMDAR in the presence ofkainic acid and observed no negative modulation of 
the GABAR B subunit (C.L. Thompson, personal communication). 
In the current study, the level of expression of the GABAR B subunit protein was 
found to be dramatically increased in response to KCl-mediated depolarisation in 
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control CGCs (245 ± 36% of5K levels, p=0.02). A number of groups have also 
reported effects ofkainic acid treatment on mouse CGCs to cause depolarisation 
by activation of excitatory inputs via AMP A and kainate receptors. Martikainen 
eta/., 2004 reported an increase in the levels of() subunit mRNA under 25K 
culture conditions, in agreement with Gault and Siegel 1997,1998 and 
observations herein, but a decrease in() subunit mRNA in response to kainic 
acid-mediated depolarisation. The findings of the current study however, 
demonstrated a dramatic increase in GABAR () subunit protein in response to 
kainic acid treatment (246 ± 400/o of 5K levels). This difference in () subunit 
protein and mRNA levels may result from differences in mouse strain utilised in 
each study, as discussed in section 3.3.2. Preliminary results in the laboratory 
suggest an increase in GABAR () subunit mRNA expression following kainic 
acid treatment compared to 5K controls (J.H. lves, personal communication). 
It has been shown previously that under 25K culture conditions, mouse CGCs are 
developmentally arrested in terms of their GABAR profile (Ives eta/., 2002a). 
Ives eta/., in 2002 reported a decrease in GABAR a.6 subunit expression under 
25K culture conditions, correlated with a failure of migration of the cells to form 
cellular aggregates. Immunocytochemistry revealed no a.6 subunit expression 
unless CGCs were arranged in compact cellular aggregates as under basal, 5K 
conditions. Decreased levels of a.6 subunit expression were observed following 
KCI-mediated depolarisation in the current study, but also following kainic acid 
treatment (25 ± 1% and 27 ± 0.3% of 5K levels respectively). These observations 
were also mirrored in the failure of CGCs derived from both control and 
stargazer mice to form cellular aggregates in culture, rather, cells remained 
stationary and formed networks of neuronal processes. 
The reported modulation of the GABAR a.6 subunit in the current study was 
based on western blot analysis of material from one culture, due to the 
degradation of the anti-GABAR a.6 subunit-specific antibody available in the 
laboratory and problems encountered with culturing the CGCs, which was later 
identified as a problem with the trypsin inhibitor used during the protocol. 
Therefore, preliminary results marry with previously reported effects on a.6 
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subunit expression however, further work would be necessary to confirm these 
observations. 
The GABAR B subunit has been shown to preferentially co-assemble with the a.6 
subunit in the cerebellum (Quirk eta/., 1994; Jechlinger eta/., 1998; Sun et al., 
2004). Consequently, it raises the question, that if the expression levels of the a.6 
subunit decrease and the levels of the B subunit increase with kainic acid 
treatment, what is the fate of the B subunit? Is it assembled into receptors? Does 
it reach the cell surface? Which subunits does it co-assemble with? It may be 
possible that expression of an a. subunit normally expressed in immature CGCs 
is increased following kainic acid treatment. Based on our knowledge that B 
preferentially co-assembles with GABAR a.4 and a.6 subunits, the a.4 subunit 
may be inappropriately expressed following kainic acid treatment. This issue is 
addressed in chapter 6. 
Differential regulation of B subunit expression was noted following KCl and 
kainic acid mediated depolarisation of control CGCs, such that increases to 251 ± 
29% and 167 ± 30% of 5K levels in GABAR B3 subunit expression levels were 
observed respectively. In contrast, dramatic reductions in B2 subunit expression 
were observed upon KCl and kainic acid treatment of control CGCs to 
undetectable levels. These findings may reflect co-assembly of the B subunits 
with different a. subunits, suggesting preferential co-assembly of the B2 subunit 
with the a.1 subunit (Benke eta/., 1994). Ives et al., in 2002 similarly reported 
differential modulation of the B subunits in response to KCI-mediated 
depolarisation, such that expression levels ofp3 subunit were increased (167 ± 
50% of 5K levels) whereas, the B2 subunit was undetectable by immunoblotting. 
5.3.3. Mechanisms of GABAR subunit protein modulation in response to 
k_J~inic.acid-mediated depolarisation 
Treatment of cultured mouse CGCs with kainic acid, to cause activation of 
excitatory receptors and hence depolarisation demonstrated differential 
modulation of the principal GABAR subunits in mouse CGCs. The effects 
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observed on the expression of each GABAR subunit varied, such that decreased 
expression of the GABAR a.1, a.6, ~2 and y2 subunits was noted, with an 
increase in the expression of the ~3 and 8 subunits. Kainic acid-mediated 
GABAR subunit modulation was reversed in the presence of CNQX. Therefore, 
it can be concluded that kainic acid was acting via non-NMDA (AMP A and 
kainate) receptors to cause GABAR subunit modulation. GABAR a.1, a.6, ~2, ~3 
and 8 subunits expression levels were modulated in control CGCs only. 
Therefore, AMP AR activation caused the modulation of expression of the above 
subunits. GABAR y2 subunit modulation was observed in both control and 
stargazer CGCs. Therefore, it is possible to conclude that these effects were 
caused by activation of kainate receptors, as it has been previously reported that 
the stargazer mutant possesses no functional AMP A receptors at the cell surface 
(Hashimoto eta/., 1999; Chen eta/., 1999, 2000, 2003). 
5.3.4. Conclusions 
Results of the current investigation indicate that CGCs derived from control and 
stargazer mice follow a pattern of development, as expected of CGCs in vivo, 
thereby providing a model system for the investigation of the factors affecting 
the expression, trafficking and targeting ofthe GABAR subunits. Depolarisation 
either by KCl or kainic acid treatment demonstrated the differential modulation 
of the principal GABAR subunits in mouse CGCs. As previously reported, CGCs 
cultured under 25 mM KCl, demonstrated a decrease in the expression of the 
GABAR subunits indicative of a mature CGC, the a.1 and a.6 subunits (Mellor et 
a/., 1998; lves eta/., 2002a; Engblom eta/., 2003). 
Furthermore, depolarisation mediated by kainic acid treatment also acted to 
decrease a.1 and a.6 subunit expression in control CGCs. However, expression of 
the 8 subunit was found to be dramatically increased under both KCl and kainic 
acid induced depolarisation in control CGCs, but only under KCl-induced 
depolarisation·in stargazer CGCs. Therefore, it is possib~e~t~ co!!Clude that 
activation of AMP A receptors is responsible for initiating the up-regulation of 
the 8 subunit protein. 
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CHAPTER 6. INVESTIGATING THE MECHANISMS 
LINKING AMPA RECEPTOR ACTIVITY TO GABAA 
RECEPTOR EXPRESSION USING CULTURED 
CEREBELLAR GRANULE CELLS 
6.1. INTRODUCTION 
Previous results of this study have demonstrated that the stargazer mutation 
results in compromised expression of a.6(3o GABAA receptors (GABAR) in the 
cerebellar granule cell (CGC) layer, which would be predicted to result in a loss 
of GABAR-mediated, extrasynaptic tonic inhibition. Furthermore, results also 
showed a modulation of expression ofthe GABAR o subunit by activation of 
excitatory inputs in the form of AMP A receptors (AMP AR) in cultured control 
CGCs. 
The aim of the experiments described in this chapter was to further determine the 
mechanism by which activation of AMP A receptors acts to cause modulation of 
the GABAR o subunit in cultured cerebellar granule cells. Secondly, to evaluate 
the effects of depolarisation on the GABAR subtypes expressed in cultured 
control CGCs and finally to investigate the effects of electrical activity on the 
expression ofT ARPy2, the AMP AR auxiliary protein, whose expression is 
ablated by the stargazer mutation. 
6.2. RESULTS 
6.2.1. Modulation of GABAR o subunit expression by depolarisation 
Figure 6.l.A demonstrates western blot analysis of cultured cerebellar granule 
cells, derived from age-matched (P6-7) control and stargazer mice, cultured 
under basal KCl concentrations (5 mM KCl) and under depolarising conditions 
mediated both by increased extracellular KCl (25 rnM KCl}and kainic acid (100 
~) treatment and probed with anti-GABAR o subunit specific antibody. 
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Expression of the o subunit was found to be increased to 245 :1: 36% and 220 :1: 
47% of 5K levels, p<O.OI in control and stargazer CGCs respectively upon KCI-
mediated depolarisation. In contrast, kainic acid-mediated depolarisation caused 
an increase in expression of the o subunit in control CGCs (246 :1: 40"/o of5K 
levels, p=0.02} that was reversed by co-application of the non-NMDA receptor 
antagonist CNQX (20 11M, figure 6.1 A). Expression in stargazer CGCs was 
unaffected (93 :1:61% of5K levels) by kainic acid (100 ~treatment proving 
that AMP A receptor activation plays a role in the modulation of GABAR o 
subunit expression in CGCs (see sections 5.2.4 and 5.2.5.). 
If expression of the GABAR o subunit is increased in control CGCs following 
kainic acid treatment, while its preferential subunit partner, a6 is dramatically 
reduced, it raises the question as to whether the o subunit contributes to 
assembled GABAR under such culture conditions if so, we would expect o to be 
trafficked to the cell surface. 
The next aim was to detennine if the increase in GABAR & subunit expression in 
control CGCs upon AMPAR activation resulted in increased expression of the 
subunit at the cell surface. Subsequently GABAR subunit expression at the CGC 
cell surface and within intracellular compartments was analysed using 
biotinylation assays. Control and stargazer CGCs (7 DIY) were incubated with I 
mgfml sulpholink-NHS-SS-biotin in order to biotinylate cell surface proteins. 
Biotinylated CGCs were subsequently solubil ised using solubilisation buffer (see 
section 2.15), incubated with streptavidin beads to separate out the biotinylated 
cell surface proteins. This allowed for the separation of intracellular proteins 
which are retained in the supernatant, from the cell surface proteins which 
become bound to the streptavidin beads. Surface proteins were then eluted from 
the streptavidin beads by incubation in 2x sample buffer containing 20 mM DTT. 
Samples were then subjected to western blot analysis and probed with anti-
GABAR S subunit specific antibody at I ~glml . 
Figure 6,:J'.B' sh0ws an immunoblot ofbiotinyhited control (+/+:+/stg) and 
stargazer (stgfstg) CGCs 7 DIY cultured under basal culture conditions (5 rnM 
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Figure 6.1. Expression of the GABAR o subannit mmder depoDarisD.ng 
conditions 
A: Western blot analysis of control and stargazer CGCs (7 DIV) 
cultured in the absence ('5K', 5 mM KCl) and presence ('25K', 25 mM) 
of increased extracellular potassium, kainic acid ('Ka', 100 ~or 
kainic acid (100 ~and CNQX ('Ka + CNQX', 20 JJM). Note 
increased 8 subunit expression under 25 mM culture conditions in 
control and stargazer CGCs, but only in control CGCs under kainic acid 
treatment. Data represents n=3 cultures, as in figure 5.6. 
R: Immunoblot of control and stargazer CGCs (7 DIV) cultured in the 
presence and absence ofkainic acid (100 JJM). 'Bound' fraction 
represents protein found at the cell surface. 'Unbound' fraction 
represents proteins located intracellularly. Note the increased expression 
of the GABAR 8 subunit at the cell surface and within the cell interior of 
control CGCs treated with kainic acid (100 ~- n=2 cultures. 
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KCl) and following kainic acid treatment (100 J.LM). Expression ofthe B subunit 
was found to be increased both at the cell surface and intracellularly upon 
AMP AR activation in control CGCs. Expression of GABAR B subunit was 
dramatically reduced in stargazer CGCs (stg/stg) under basal KCllevels both at 
the cell surface and intracellularly compared to control CGCs ( +/+:+/stg). 
However, upon kainic acid treatment ( 100 J.LM), expression of the B subunit was 
undetectable in stargazer CGCs at the cell surface, with minimal amounts 
detected in the intracellular pool. 
6.2.2. Expression of GABAR a subunits under depolarising conditions 
Expression of the principal a subunits detected in cultured mouse CGCs at 7 
DIV, namely GABAR a1 and a6, have previously been quantified following 
KCl and kainic acid-mediated depolarisation in cultured control and stargazer 
mouse CGCs (see section 5.2.4.). Results demonstrated a near total loss of a1 
and a6 subunit protein in control CGCs under 25 mM KCl concentrations (7 ± 
15% and 25 ± 1% of5K levels respectively). AMPAR activation was observed 
also to cause a significant reduction in a1 (29 ± 22% of 5K levels) and a6 (27 ± 
0.3% of 5K levels) subunit expression. These observations imply a dramatic loss 
of the principal GABAR a subunits expected of a mature CGC following 
depolarisation by KCl and kainic acid treatment. Furthermore, if an increase in 
GABAR B subunit expression occurs upon depolarisation, with which a subunit 
is the B subunit co-assembling? 
CGCs derived from P6-7 age-matched control and stargazer mice were cultured 
simultaneously according to standard methods (see section 2.14.). At 1 DIV, 
CGCs were treated with KCl (fc=25 mM), kainic acid (100 JiM) or kainic acid 
(100 J.1M) and CNQX (20 J.LM). CGCs (7 DIV) were harvested for western blot 
analysis to compare total protein expression or following cell surface protein 
oiotinylation-assays in order to compare the proportion of proteins of interest that 
were-expressed afthe CGC surface versus intracellular compartments. 
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lFigure 6.2. Expressimm of tiiBe principal GABAR a subunits in 
cultured control CGCs under depolarising conditions 
Western blot analysis of the principal GABAR a subunits expressed by 
cultured control CGCs in the presence and absence of increased 
extracellular KCl (25 mM), kainic acid ( 100 fJ.M) or kainic acid ( 100 
fJ.M) and CNQX (20 f.J.M). 
A: Note the reduction in a1 subunit expression following 25K and 
kainic acid treatment. 
B: Note the dramatic increase in a4 subunit expression following 25K 
and kainic acid treatment. 
C: Note the dramatic reduction in a6 subunit expression following 25K 
and kainic acid treatment. 
D: Expression off}-actin in the presence and absence of increased 
extracellular KCl (25 mM), kainic acid (100 fJ.M) or kainic acid (100 
fJ.M) and CNQX (20 f.J.M). 
CGCs (7 DIV) were subjected to biotinylation assays to determine the 
relative proportions of proteins of interest that were expressed at the cell 
surface ('Bound') versus that retained within intracellular compartments 
('Unbound'). 
E: Note an increase in a4 subunit expression at the cell surface 
following kainic acid depolarisation. 
F: A dramatic reduction in cell surface expression of the a6 subunit was 
observed following kainic acid treatment. 
G: No non-specific binding ofP-actin was observed in the 'bound' 
fractions following biotinylation. Furthermore, equal protein loading of 
'unbound' fractions was observed. 
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Figure 6.2. A-D summarise western blot analysis of GABAR a subunit 
expression in cultured control CGCs at 7 DIY under basal (5K) and depolarised 
(25K and Kainate-treated) culture conditions. Results demonstrate that a 
dramatic decrease in GABAR cx.l (figure 6.2.A) and cx.6 (figure 6.2.C) subunit 
expression, as reported in section 5.2.4., but a significant increase in GABAR cx.4 
subunit expression occurred following culture under depolarising culture 
conditions (figure 6.2.B). 
Furthermore, western blot analysis of cell surface expressed protein from CGCs 
cultured under 5K and AMP AR-activated conditions revealed that GABAR cx.4 
subunit at the cell surface was increased following kainic acid treatment (figure 
6.2.E), with a concomitant decrease in cx.6 subunit expression at the cell surface 
(figure 6.2.F). Expression of f3-actin was restricted to 'unbound' fractions, 
therefore, cell integrity was maintained throughout the assay as intracellular 
proteins were not biotinylated and no non-specific proteins present in the 
intracellular fraction were bound to the streptavidin beads upon separation of cell 
surface from intracellular proteins (figure 6.2.G). Results therefore suggest an 
up-regulation of expression of the GABAR cx.4 subunit in response to 
depolarisation. Furthermore, since this subunit reaches the neuronal cell surface 
it is probably assembled into a GABAR. 
6.2.3. Radioligand binding to control CGCs (7 DIV) under polarised (5K) 
and depolarised (kainic acid-mediated) culture conditions 
Ives eta/., in 2002 reported a switch in GABAR pharmacological subtypes 
expressed in cultured control CGCs upon depolarisation (25K). The BZ-S 
subtype of GABAR was found to switch from predominantly type I 
pharmacology, compatible with a GABAR profile found in a mature CGC, to 
type II BZ-S pharmacology, predictive ofGABAR cx.2/cx.3/cx.5f3y2. Furthermore, 
an increase in zolpidem-insensitive binding was observed, corresponding to 
increased--expression of cx.5 subunit-containing GABARs. 
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In order to confirm and extend the reported differences in GABAR profiles 
following KCl-mediated depolarisation by Ives et al., in 2002 and determine if 
such rearrangements occur following kainic acid depolarisation, radio ligand 
binding studies were carried out on 7 DIV control CGCs cultured under basal 
polarised ( 5K) and depolarised (25K and Kainic acid-mediated) conditions. 
6.2.3.1. eH] muscimol binding 
em muscimol binding was performed on intact CGCs (7 DIV) cultured under 
5K and kainate-treated conditions. em muscimol was employed at a 
concentration of 40 nM, with non-specific binding determined in the presence of 
0.2 mM GABA. Figure 6.3.A demonstrates that there was no significant 
difference in the amount of ligand bound in pmoles per mg protein between 5K 
and kainate-treated CGCs (0.11 ± 0.05 and 0.11 ± 0.04 pmoles/mg protein, 
respectively n=3, p=0.83) (figure 6.3.A.). em muscimol binds to both y2 and B 
subunit-containing GABAR in cultured CGCs. Therefore, it is possible to 
conclude that the total number of GABAR does not differ under basal, polarised 
and kainate-mediated depolarised culture conditions. 
6.2.3.2. eH] Ro15-4513 binding 
em Ro 15-4513 binding was conducted on intact control CGCs (7 DIY) cultured 
under 5K, 25K and kainate-treated conditions. [~ Ro15-4513 was utilised at a 
concentration of 40 nM, with non-specific binding determined in the presence of 
10 ~ Ro 15-1788. BZ-IS binding was determined in the presence of 10 ~ 
flunitrazepam and BZ-S binding was calculated by subtraction of the BZ-IS 
subtype from total em Ro 15-4513 binding. 
The abundance of eH] Ro 15-4513 binding sites was significantly reduced in 
both 25K and kainate-treated CGCs to 64 ± 14% (0.40 ± 0.07 pmoles/mg protein, 
n=3) and 59± 14% (0.36 ± 0.06 pmoles/mg protein, n=3) of5K levels (0.62 ± 
0.06pmoles/mg protein, n=3) respectively. A significant reduction in the BZ-S 
subtype of binding was also noted in kainate-treated CGCs, to 64 ± 23% 
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Figure 6.3. Radioligand binding to cont~roB (+/+:+/stg) mouse cerebeiBsr 
granule cells (7 DIV) cultured under non-depolarising (5K) and depolarising 
(25K and Kainate-treated) conditions 
A: eHJ muscimol binding to intact cultured control mouse CGCs (7 DIV) 
following 5K and kainate acid ( 100 ~ treatment. Note no significant 
difference in total eHJ muscimol binding between 5K and kainate-treated CGCs, 
p=0.83, n=3. 
B: eHJ Ro 15-4513 binding to intact cultured control mouse CGCs (7 DIV) under 
5K and depolarised (25K and kainate-treated) conditions. Significant reductions 
in total eH] Ro 15-4513 binding were observed in both 25K and kainate-treated 
(100 ~ CGCs (decreased to 64 ± 14% (p=0.008) and 59± 14% (p=0.006) of 
5K levels, respectively). A dramatic reduction in BZ-S subtype of binding in 
kainate-treated CGCs was also observed to 64 ± 23% of 5K levels, p=0.03. 
Notably, a total loss ofBZ-IS subtype of[3H] Ro15-4513 binding was observed 
in 25K CGCs, but no significant difference in kainate-treated CGCs from 5K 
levels (p=O.l 0). 
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25K 0.40 ± 0.07 0.44 ± 0.08 0.00 ± 0.10 
Kainate 0.36 ± 0.06 0.27 ± 0.07 0.09± 0.09 
(0.27 ± 0.07 pmoles/mg protein, n=3) of SK levels (0.43 ± 0.07 pmoles/mg 
protein, n=3). Most notably, a total loss of the BZ-IS subtype ofbinding was 
observed in 25K CGCs, while no significant difference in BZ-IS binding was 
found in kainate-treated CGCs (p=0.10, n=3) (figure 6.3.B). 
6.2.4. Activation of L-type voltage-gated calcium channels following AMP A 
receptor activation leads to an increase in GABAR o subunit expression in 
kainate treated CGCs 
Results of the current investigation have demonstrated that expression of the 
GABAR o subunit in cultured control mouse CGCs is increased by KCl-
mediated depolarisation. Gault and Siegel in 1997 proposed that the increase in 
expression of the GABAR o subunit in response to KCl-mediated depolarisation 
could be blocked by preventing the intracellular calcium influx through L-type 
voltage-gated calcium channels. 
Figure 6.4.A demonstrates the expression of the GABAR o subunit in the 
presence and absence ofkainic acid (100 ~and increasing concentrations of 
nifedipine, an L-type calcium channel blocker (0.1-1 0 J..LM). Results show that if 
calcium entry into the CGC via L-type calcium channels is blocked with 
nifedipine at a concentration of 1-10 ~ the kainic acid induced increase in 
GABAR o subunit protein was inhibited. Nifedipine was employed at a 
concentration of 10 ~ for future experimentation. 
Figure 6.4.B demonstrates the effect of application ofkainic acid (100 ~and 
nifedipine (10 ~applied at 1 DIV, kainic acid acts to activate AMPA 
receptors, causing an influx of calcium via L-type calcium channels, to result in 
an increase in GABAR o subunit expression which can be blocked by treatment 
with nifedipine (10 ~-
Furthermore, figure 6.4.B illustrates that the effect ofnifedipine to completely 
reverse the kainic acid-induced effects on GABAR subunits is not unique to the 
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lFngunre 6.4. Ellpression oJI' tilDe G.AIBAR o sunlbunnt nn tilDe prese~mce oJI' 
kainic acid and nifedipine 
A.: GABAR b subunit expression in the presence ofkainic acid ('Ka', 
100 ~ and dose response treatment with the L-type calcium channel 
blocker, Nifedipine (n=1). 
Lane 1: SK 
Lane 2: SK+Ka (100 ~ 
Lane 3: SK+Ka+Nifedipine (0.1 J.!M) 
Lane 4: SK+Ka+Nifedipine (1 ~ 
Lane 5: SK+Ka+Nifedipine (10 J.1M) 
R Treatment of control CGCs with kainic acid ( 100 JlM) in the 
presence and absence ofnifedipine (10 J.!M) at 1 DIV. Western blots of 
this material were probed with anti-GABAR a1, a4, a6, ~3, b, y2 
subunit-specific antibodies and ~-actin specific antibody. Note the 
reversal of the b and ~3 subunit up-regulation and the partial reversal of 
the a.4 subunit depolarisation-mediated up-regulation in the presence of 
nifedipine (1 0 JlM). 
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JFigmre 6.5. Revernal of kainic mcid depoRarisatnon-medftated URp-
regulation of GABAR o subunit expression with L-type calcium 
channel blockers nifedipine and vernpamil 
A: Control CGCs treated at 1 DIVas detailed below, harvested at 7 DIV, 
and subjected to western blot analysis, probed with anti-GABAR 8 
subunit-specific antibody at 3 ~g/ml. Note the increase in expression of 
the 8 subunit in response to treatment with kainic acid ( 100 ~, which is 
reversed by treatment with L-type calcium channel blockers, nifedipine 
and verapamil (10 ~ (n=1). 
B: Immunoblot as in A, reprobed with anti-~-actin antibody (1 :2000 
dilution) to determine protein loading. 
Lane 1: SK 
2: Kainate treated ( 100 ~ 
3: Kainate and nifedipine (10 ~ 
4: Kainate and verapamil (10 ~ 
5: Kainate and CNQX (20 ~) 
6: SK and Nifedipine 
7: SK and verapamil 
8: SK and CNQX 
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GABAR <5 subunit, as treatment with nifedipine also completely reverses the 
kainic acid-mediated up-regulation of GABAR 133 subunit to 5K levels. 
However, nifedipine treatment acted to only partially reverse the kainate-
mediated up-regulation of GABAR a.4 subunit expression. Furthermore, 
nifedipine treatment did not act to reverse the kainic acid-mediated down 
regulation ofGABAR a.1, a.6 or y2 subunits, thereby suggesting that a number of 
mechanisms are in operation to modulate GABAR subunit expression in 
response to kainic acid-mediated depolarisation. 
In order to further confirm the action of nifedipine, to reverse the kainic acid 
mediated modulation of the GABAR <5 subunit, a further L-type calcium channel 
blocker was employed, verapamil. Control CGCs were treated at 1 DIV with 
kainic acid in the presence or absence ofnifedipine (10 ~), verapamil (10 ~) 
and CNQX (20 ~- CGCs cultured under basal ( 5 mM KCl) culture conditions 
were also treated with each compound, in order to rule out any effects on the 
GABAR (5 subunit in the absence ofkainic acid. Figure 6.5. shows western blot 
analysis demonstrating an increase in GABAR <5 subunit expression upon kainic 
acid treatment, which was inhibited by treatment with nifedipine, verapamil and 
CNQX. None of the drugs were shown to have a major effect on <5 subunit 
expression when applied to 5K CGCs in the absence of kainic acid. Therefore, it 
is possible to conclude that the modulation of the GABAR <5 subunit in response 
to kainic acid mediated depolarisation occurs as a consequence of AMP A 
receptor activation, causing an influx of calcium into the cell via L-type calcium 
channels. 
6.2.5. Effects of depolarisation on TARPy2 expression 
We had earlier shown that TARPy2, the protein ablated in stargazer CGCs, was 
expressed in control CGCs at 3-5 DIV, hence why we have conducted these 
studies at 7 DIV. We decided to investigate whether these depolarisation regimes 
had any affect on T ARPy2 expression, since we assumed that in its presence 
AMPARs wo-uld be expressed and responsive to kainic acid. Figure 6.6.A 
illustrates the effects of both KCI and kainic acid-mediated depolarisation on the 
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lFD.gwure 6.6. Effects of AMJPA recepttor mctivattnoDD oDD ttllne ellpressioDD 
of AMIPA receptor subunit GluR2 and 1'ARPy2 
A: Expression of GluR2 and T ARPy2 following KCl and kainic acid-
mediated depolarisation in control CGCs (7 DIV). Note the reduction in 
molecular weight ofT ARPy2 upon KCl-mediated depolarisation and the 
reduction in expression ofT ARPy2 following kainic acid treatment. 
CGCs (7 DIV) were subjected to biotinylation assays to determine the 
relative proportions of proteins of interest that were expressed at the cell 
surface ('Bound') versus that retained within intracellular compartments 
('Unbound'). 
JB: Expression of the AMP AR GluR2 subunit and T ARPy2 at the cell 
surface of control CGCs following kainic acid treatment ( 100 ~. Note 
the reduction in GluR2 and T ARPy2 expression levels and the reduction 
in molecular weight ofT ARPy2 at the cell surface in kainate-treated 
CGCs. Furthermore, note the reduction in expression ofT ARPy2 
expression intracellularly following AMP AR activation. T ARPy23 
represents the native form of protein, T ARPy2b represents a modified 
form of the protein. 
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expression ofT ARPy2 protein in cultured control CGCs (7 DIY). Upon KCl-
induced depolarisation, the levels of total protein appear unaffected, but 
interestingly the molecular weight ofT ARPy2 was decreased, suggesting either 
dephosphorylation or deglycosylation of the protein. In contrast, kainic acid 
treatment ( 100 J.1M) of CGCs resulted in a near total loss ofT ARPy2 protein 
expression. 
Figure 6.6.B demonstrates western blot analysis ofbiotinylated CGCs cultured 
under basal, polarised (5K) and kainic acid-mediated depolarised conditions (7 
DIY) and probed for the expression ofT ARPy2 and the AMP A receptor subunit, 
GluR2. Results indicate a dramatic decrease in the expression ofT ARPy2 at the 
cell surface upon kainic acid treatment ( 100 ).J.M), with a reduction in molecular 
weight of the protein at the cell surface, correlating with observations following 
KCl- mediated depolarisation. Furthermore, expression of the GluR2 subunit was 
found to be reduced at the cell surface, while total protein levels appeared 
unaffected by depolarisation. 
6.3. DISCUSSION 
Two methods of inducing depolarisation in CGCs were utilised in the current 
study, increasing the extracellular KCllevels to 25 mM and treatment with kainic 
acid (1 00 JlM). By increasing the extracellular KCllevels to 25 mM, this acts to 
alter sodium and potassium ion fluxes and inhibit or potentially reverse outward 
K+ movement. Consequently, this causes a switch in the equilibrium potential for 
K+, causing it to become less negative. As a result, the cell membrane is unable 
to repolarise and the cells become electrically silent. Kainic acid is an ionotropic 
glutamate receptor agonist, hence it acts to activate excitatory AMP A and kainate 
receptors on the cell surface to cause increased permeability to Na+ and K+ ions 
and hence depolarisation. 
Depolarisation mediated by both KCl and kainic acid has been shown to cause 
effects on the expression of the GABAR o subunit (Gault & Siegel1997, 1998; 
Martikainen eta/., 2004). The focus of the current study was to begin to 
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determine the mechanism by which kainic acid-mediated depolarisation acts to 
cause modulation of the B subunit, as previous studies have been unable to 
distinguish between activation of AMP A receptors or kainate receptors. 
Stargazer mutant CGCs provide an invaluable tool, as they do not possess 
functional AMP AR at the cell surface, whereas kainate receptors seem to be 
relatively spared by the mutation (Hashimoto eta/., 1999; Chen eta/., 2000, 
2003). Hence, by comparison of control and stargazer CGCs, it was possible to 
distinguish between activation of different excitatory receptors. 
The aims of the current chapter were to determine the mechanism by which 
activation of AMPA receptors acts to cause modulation of the GABAR B subunit 
in cultured cerebellar granule cells. Secondly, to evaluate the effects of 
depolarisation on the GABAR subtypes expressed in cultured control CGCs and 
finally to investigate the effects of electrical activity on the expression of 
T ARPy2, the AMP AR auxiliary protein, whose expression is ablated by the 
stargazer mutation. Results indicated an increase in GABAR B subunit 
expression following activation of AMP AR by kainic acid treatment in control 
CGCs, which was not observed in CGCs derived from the stargazer mutant. 
Since the stargazer mutant CGCs are essentially AMP AR-incompetent, this 
identified a role for AMP AR activation in the modulation of GABAR subunit 
expression. Biotinylation assays determined that the increased level of GABAR B 
subunit was indeed expressed at the cell surface in cultured control CGCs. 
Radioligand binding studies further supported an up-regulation of B subunit-
containing GABAR following kainic acid treatment, as evidenced by a reduction 
in eH] Ro15-4513 binding (y2 subunit-containing GABAR) in kainic acid 
treated CGCs and no difference in eH] muscimol binding (y2 and B subunit-
containing GABAR). 
Treatment with the L-type calcium channel blockers, nifedipine and verapamil 
implicated the influx of calcium via L-type calcium channels.as a result of 
AMP AR activation to cause the depolarisation induced up-regulation of B 
subunit protein. 
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6.3.1. Is GABAR o subunit assembled into receptors following kainic acid 
depolarisation, when its receptor partner, a.6 is down-regulated? 
Results of the current study indicated a dramatic up-regulation ofGABAR o 
subunit expression upon kainic acid treatment in control CGCs. However, a 
significant reduction in GABAR a.6 subunit expression was also noted, the 
preferential subunit partner for the o subunit in CGCs. Therefore, this raises the 
question as to whether the o subunit is retained intracellularly or if the subunit is 
assembled into receptors and trafficked to the cell surface. 
In order to address this question, biotinylation assays were conducted on control 
CGCs (7 DIV) cultured under basal conditions and in the presence of kainic acid 
(100 ~·Results demonstrated that the GABAR o subunit is indeed expressed 
at the cell surface under both conditions (figure 6.2). Kainic acid-mediated 
depolarisation results in an increase in total GABAR o subunit protein levels, but 
also an increase in GABAR o subunit expression at the cell surface. From 
heterologous cell expression studies, it has been shown that GABAR a. and y 
subunits and presumably o alone are unable to traffick to the neuronal cell 
surface unless co-assembled into a.J3, a.J3y or a.J3o combinations (Connolly eta/., 
1996a, 1996b, 1999a). Therefore, if expression levels of the GABAR o subunit is 
increased at the cell surface following kainic acid treatment, with which a. 
subunit does the o subunit co-assemble? 
6.3.2. Which GABAR a. subunit does the o subunit co-assemble with under 
depolarising conditions? 
6.3.2.1. Kainic acid mediated depolarisation 
Results of the current study demonstrated a dramatic increase in expression of 
the GABAR o subunit upon kainic acid depolarisation. However, total expression 
levels of-the GABAR a.1 and a.6 subunits were significantly reduced upon 
depolarisation to 29 ±-22% and 27 ± 0.3% of 5K levels, with a concomitant 
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decrease in GABAR a.6 subunit expression at the cell surface. Radioligand 
binding studies using eHJ Ro15-4513 indicated that the levels ofBZ-IS binding 
were slightly reduced in kainic acid-depolarised CGCs (0.09 ± 0.09 pmoles/mg 
protein) to 5K CGCs (0.19 ± 0.09 pmoles/mg protein), which however did not 
reach statistical significance (figure 6.3). 
Western blot analysis indicated a dramatic up-regulation of expression of the 
GABAR a.4 subunit upon depolarisation mediated by kainic acid (figure 6.2). 
Biotinylation experiments also revealed a dramatic increase in cell surface 
expression of the a.4 subunit in kainic acid treated CGCs. Therefore, it is possible 
to conclude that under kainic acid depolarisation, there is a selective up-
regulation of a.4 subunit expression. Sur et al., in 1999 reported that in rat 
thalamus there was a preferential co-assembly of a.4 subunits with () subunits. 
lmmunoprecipitations using anti-a.4 serum precipitated 200/o of [3H] muscimol 
binding sites and only 7% of eH] Ro 15-4513 binding sites. 
Consequently, it is possible to suggest that the() subunit preferentially co-
assembles with a.4 subunits under depolarising conditions in CGCs. In support of 
this observation, total eHJ Ro 15-4513 binding was reduced to 59 ± 14% of 5K 
levels, indicating a loss ofy2 subunit-containing GABAR (figure 6.3.B). No 
significant difference in total eHJ muscimol binding was observed in kainate-
treated CGCs, indicating that the total number of GABAR (y2 and () subunit 
containing receptors) does not differ between basal, polarised and kainate-
induced depolarised CGCs (figure 6.3.A). Therefore, it is possible to conclude 
that if the total number ofGABAR is unchanged, while there is a significant 
decrease in y2 subunit containing GABAR, there is an up-regulation of() subunit 
containing GABAR under kainic acid mediated depolarisation. This up-
regulation of GABAR may be in the form of a.4po receptors. In order to test this 
hypothesis, future work would involve immunoprecipitations of a.4 subunit-
containing GABAR from kainate-treated CGCs and probing the precipitated 
material for the presence of the GABAR ()subunit and vice versa. 
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6.3.2.2. KCl-mediated depolarisation 
KCl-mediated depolarisation has also been shown to cause an increase in the 
expression of the GABAR () subunit to 245 ± 36% of 5K levels in control CGCs. 
Furthermore, western blot analysis demonstrated a dramatic reduction in a.1 and 
a.6 subunit expression (7 ± 15% and 25 ± 1% of5K levels respectively). In 
agreement with observations following kainic acid depolarisation, expression of 
the GABAR a.4 subunit was found to be dramatically increased (figure 6.2). 
However, radio ligand binding studies utilising eHJ Ro 15-4513 indicated the 
total loss ofBZ-IS subtype ofGABAR, conferred by GABAR a.6 and a.4 
subunits upon KCl-mediated depolarisation, whereas following depolarisation 
mediated by kainic acid treatment, levels ofBZ-IS binding were unchanged. This 
observation suggests differential regulation of GABAR assembly between 
depolarisation mechanisms. 
6.3.3. Are CGCs cultured under kainic acid-mediated depolarisation 
developmentally arrested in terms of the pharmacology of the BZ-S subtype 
ofGABAR? 
eHJ Ro15-4513 binding studies on basal polarised, KCl and kainic acid-
mediated depolarised CGCs indicated differential modulation of the BZ-S 
subtype of GABAR between depolarisation methods. The levels ofBZ-S binding 
in 25K CGCs was not significantly different from that observed in 5K CGCs. 
However, in kainate-treated CGCs, BZ-S levels of binding were found to be 
reduced to 64 ± 23% of5K levels. Ives et al., in 2002 reported a switch in BZ-S 
subtype pharmacology from type I, conferred by GABAR a.1 subunit expression, 
to type IT pharmacology, indicative of an up-regulation of expression of a.2 and 
a.3 subunits in KCl-mediated depolarised CGCs. Results of the current study are 
in support of these observations, BZ-S subtype of binding was not decreased, 
while expression of the GABAR a.1 subunit was reduced to 7 ± 15% of 5K 
levels, suggesting an alternative a. subunit co-assembles with the GABAR y2 
subunit to.confer BZ-S pharmacology. 
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No evidence of such a switch in BZ-S pharmacology was found in kainate-
treated CGCs. Levels ofBZ-S binding were reduced to 64 ± 23% of5K levels, 
which correlated with a significant reduction in GABAR a.l subunit expression 
(29 ± 22% of 5K levels, p<O.Ol). 
6.3.4. Modulation of GABAR B subunit expression by activation of AMP AR 
to cause calcium influx via L-type calcium channels 
Results of chapter 5 indicated a possible modulation of GABAR B subunit 
expression by kainic acid-mediated depolarisation. Kainic acid is an ionotropic 
glutamate receptor agonist, acting at excitatory AMP A and kainate receptors, to 
cause depolarisation. Comparison of responses observed in control and stargazer 
CGCs indicated a dramatic up-regulation of GABAR B subunit expression in 
control CGCs upon kainic acid treatment, while expression of the subunit in 
stargazer CGCs remained at basal levels (section 5.2.4.). Since stargazer CGCs 
do not possess functional AMP AR at the cell surface, it can be concluded that 
activation of AMP AR by kainic acid treatment results in the positive modulation 
of expression of the GABAR B subunit. 
In order to determine the downstream consequence of activation of AMP AR in 
the mechanism resulting in increased GABAR S subunit expression, the possible 
involvement of calcium influx was investigated. Gault and Siegel in 1997 
reported the involvement of calcium entry via L-type calcium channels in the 
modulation of GABAR S subunit expression following KCl-mediated 
depolarisation. Therefore, in order to test the possibility that such a mechanism 
existed upon kainic acid-mediated depolarisation, calcium influx viaL-type 
calcium channels was blocked by employing two types ofL-type calcium 
channel blocker, nifedipine, a 1,4-dihydropyridine and verapamil, a 
phenylalkylamine at a concentration of 10 J.,LM. 
Results indicated that nifedipine and verapamil reversed the increase in GABAR 
S subunit expression following kainic acid treatment. Furthermore, in order to 
test the specificity of action of the drugs employed on the expression of the S 
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subunit, each compound was applied to CGCs cultured under 5K conditions. 
None of the compounds tested acted alone to cause modulation of the B subunit 
expression. Therefore, the basal, constitutive level of expression of the B subunit 
is independent of AMP AR activity and L-type calcium channel activation (figure 
6.5). 
Therefore it can be concluded that activation of AMP AR causing an increase in 
intracellular calcium levels via L-type calcium channels did act to modulate 
expression levels of GABAR B subunit. 
Further work is necessary to elucidate the exact mechanism by which AMP AR 
mediated, L-type voltage-gated calcium channel-dependent calcium influx 
evokes effects on GABAR B subunit expression. GABAR are subject to 
phosphorylation which can regulate functional desensitisation, open channel 
probability, aggregation of receptors at the synapse and assembly of subunits 
(Swope et al., 1992). The latter two could conceivably result in an apparent 
increase in expression of the phosphorylated subunit. Mckernan et al., in 1996 
reported that there are residues in the GABAR B subunit sequence that are 
predictive substrates for phosphorylation e.g. by protein kinase C. Results of 
biotinylation assays in the current study indicate that phosphorylation of the B 
subunit may occur following kainic acid treatment, as the surface expressed 
protein appeared to have an increased molecular weight when subjected to 
immunoblotting (figure 6.1. ). Dephosphorylation assays on biotinylated, kainate-
treated CGCs would be needed to confirm the above observation. 
Alternatively depolarisation-mediated calcium influx could activate kinases, such 
as protein kinase A, protein kinase C or calcium/calmodulin-dependent kinase II 
(CaMKII) and/or phosphatases, such as PP1 or PP2, which may act to modulate 
the activity of transcription factors, which could cause increased B subunit 
transcription. Gault and Siegel in 1997 and 1998 suggested that the activation of 
tran~cription factors leads to increased GABAR B subunit expression following 
KCI-mediated depolarisation. Indeed initial observations in the lab suggest the 
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up-regulation ofGABAR o subunit mRNA expression in kainate-treated CGCs 
(J.H. Ives, personal communication). 
6.3.5. What are the effects of depolarisation on TARPy2 expression? 
We were intrigued to find that TARPy2 protein expression levels were 
compromised upon kainic acid-mediated depolarisation, furthermore this resulted 
in a decrease in expression ofT ARPy2 at the cell surface. In addition, the 
molecular weight of the protein appeared to be decreased at the cell surface 
(figure 6.6). Expression levels of the total AMPAR subunit GluR2 expressed in 
cultured CGCs were relatively unaffected by kainic acid treatment. However, the 
levels of expression at the cell surface were dramatically reduced (figure 6.6.). 
T ARPy2 has been shown to regulate synaptic AMP AR by two distinct 
mechanisms. The C-terminal tail of the T ARPy2 protein possesses a type I PDZ-
binding domain which has been shown to interact with PDZ proteins, such as 
PSD-95 at the synapse, and hence regulate synaptic targeting of AMPAR (Chen 
eta/., 2000). T ARPy2 also interacts with AMP AR to traffick receptors to the cell 
membrane, an interaction which does not require the PDZ binding domain of the 
protein. Tomita et al., in 2004 reported that neuronal activity acted to increase 
the endocytosis of AMP AR. Furthermore, that depolarisation by increased 
extracellular KCl acted to decrease the surface levels of AMP AR/T ARP 
complexes, in a CNQX sensitive fashion (Tomita eta/., 2004). Endogenous 
agonist at excitatory synapses was also found to disrupt the association of 
AMP AR with T ARPs. Therefore, kainic acid treatment of CGCs would be 
predicted to disrupt the association of GluR2 with T ARPy2 and increase the 
endocytosis of the AMP AR subunit. Consequently, less GluR2 and T ARPy2 
would be expressed at the cell surface. This indeed is what we have shown 
herein, that chronic activation of AMP ARs in a neuronal context results in down-
regulation of AMP AR cell surface expression as well as T ARPy2 expression. We 
assume that during this period of AMP AR activity coincides with GABAR o 
expression. 
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In 2005, Tomita eta/., reported that T ARPy2 is heavily phosphorylated at a set of 
conserved serine residues within its C-terminal tail. This phosphorylation is 
dynamically regulated by synaptic activity, such that activation of CaMKll and 
PKC causes phosphorylation of the protein, while activation ofPPl and PP2B 
causes dephosphorylation. Phosphorylation was shown to facilitate the synaptic 
targeting ofT ARPy2, dependent on the interaction of the C-terminal tail of 
T ARPy2 to PDZ domains ofPSD-95. Therefore, a reduction in the molecular 
weight of stargazin at the cell surface, following depolarisation likely represents 
the dephosphorylation of the protein and the redistribution of receptors between 
synaptic and non-synaptic sites. We have a model system here to test this 
hypothesis. 
6.3.6. Conclusions 
Results of the current study indicated a role for excitatory neurotransmission in 
the modulation of GABAergic inhibition in culture CGCs. Results indicated an 
increase in GABAR B subunit expression following kainic acid-mediated 
depolarisation in control CGCs, which was not observed in CGCs derived from 
the stargazer mutant. Since the stargazer mutant CGCs are essentially AMP AR-
incompetent, this identified a role for AMP AR activation in the modulation of 
GABAR subunit expression. Furthermore, biotinylation assays determined that 
the increased level ofGABAR B subunit was indeed expressed at the cell surface 
in cultured control CGCs. 
Radioligand binding studies demonstrated no significant difference in eH] 
muscimol binding between basal (5K) and kainate-treated CGCs, suggesting that 
the total number of GABAR does not differ between the two treatment groups. 
However, if considered with a reduction in total eH] Ro 15-45 13 binding 
observed in kainate-treated CGCs, indicative of the contribution ofy2 subunit-
containing GABAR, these results further support an increase in B subunit-
containing GABAR in response to kainic acid-mediated depolarisation. 
200 
Treatment with the L-type calcium channel blockers, nifedipine and verapamil 
implicated the influx of calcium viaL-type calcium channels as a result of 
AMP AR activation to cause the depolarisation induced up-regulation of o 
subunit protein. The failure of nifedipine treatment to block the modulation of 
GABAR a 1 and y2 subunit expression also highlighted the existence of a number 
of mechanisms in the regulation of GABAR subunit expression in kainate-treated 
CGCs, further work would be necessary to ascertain the exact nature of such 
mechanisms. 
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Figure 6.6. Schematic representation of the effects of kainic acid-mediated 
depolarisation on the expression of GABAR o subunit and TARPy2 in 
cultured control cerebeiJar granule cells (CGCs) 
Kainic acid depolarisation acts to cause an influx in intracellular calcium via L-type 
voltage-gated calcium channels which results in an increase in cell surface 
expression of o subunit-containing GABAR. Furthermore, depolarisation acts to 
disrupt the association ofT ARPy2 with PSD-95 and results in the internalisation of 
AMP AR and T ARPy2. LTD: Long term depression. 
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CHAPTER 7. GABAA RECEPTOR EXPRESSION IN THE 
DENTATE GYRUS OF THE STARGAZER MUTANT MOUSE 
7 .1. INTRODUCTION 
Cerebellar granule cells of the stargazer mutant are electrically silent as a result 
of failure to express T ARPy2 to cause a deficit in AMP AR expression at mossy 
fibre-granule cell synapses (Chen eta!., 2000). This in tum results in a near total 
ablation of brain-derived neurotrophic factor (BDNF) expression in CGCs and 
compromised TrkB signalling (Qiao eta!., 1996; 1998). 
In contrast, granule cells of the dentate gyrus (DG) are not electrically silent in 
the stargazer mutant. The stargazer mutant exhibits spontaneous bilaterally 
symmetrical 6-7 per second spike-wave discharges (SWDs) in cortical and 
hippocampal brain areas, which represent ~20% of total waking 
electroencephalographic (EEG) activity (Qiao & Noebels, 1993). Onset of 
seizure activity has been shown to occur between postnatal days 16-18 (P 16-18), 
with a frequency of~ 150 bursts per hour (Qiao & Noebels, 1993). The spike-
wave pattern of generalised synchronous activity has been shown to generate 
primarily in the thalamus and neocortex to activate synaptically linked brain 
areas, such as the hippocampus via the dentate gyrus. 
A clear correlation has been shown between the accumulation of continuous 
seizure activity and an increase in mossy fibre sprouting in the inner molecular-
granule cell layer of the dentate gyrus, reported to occur at 4-6 weeks following 
seizure onset (Qiao & Noebels, 1993). No significant cell death of granule cells 
in the dentate gyrus (DG), CA3 pyramidal cells or hilar polymorph cells was 
noted following non-convulsive seizures in the stargazer mutant (Qiao & 
Noebels; 1993), in contrast to convulsive seizure models such as kainic acid 
treatment, -kindling and pentylenetetrazole (PTZ) which are associated with 
cellular injury, death and gliosis (Nahm & Noebels, 1998). Hypersynchronous 
activity has also been shown to induce axonal sprouting in the granule cell-
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molecular layer of the dentate gyrus in these convulsive seizure models (Nahm & 
Noebels, 1998). Chronic depolarisation in convulsive seizure models also results 
in an adaptive modification of inhibitory neurotransmission to balance increased 
excitation, manifesting in alterations in the function, pharmacology, targeting and 
clustering of GABAR (Brooks-kayal et al., 1998; Clark, 1998; Cohen et al., 
2003; Peng et al., 2004). 
Previous results in the laboratory have shown effects of electrical activity on the 
GABAR expression profiles of cultured CGCs (studies described herein and lves 
et al., 2002a) and a subunit specific down-regulation of expression of the 
GABAR a6 and fB subunits to result in a loss ofbenzodiazepine-insensitive 
(BZ-IS) eH] Ro 15-4513 binding in the stargazer mutant (herein and Thompson 
et al., 1998). If a loss of electrical activity and a complete ablation ofBDNF 
expression in stargazer CGCs causes GABAR rearrangements, it could be 
postulated that increased electrical activity and an increase in BDNF expression 
might evoke a reciprocal rearrangement of GABAR in stargazer dentate granule 
cells (DGCs). Furthermore, previous work herein has indicated a possible switch 
in the GABAR profile of the dentate gyrus of the stargazer mutant to favour 
expression ofGABAR with a BZ-IS subtype ofeH] Ro15-4513 pharmacology 
by receptor autoradiography, suggesting an increase in expression of a4(3y2 
GABAR (see section 4.3.3.2; Figure 4.9.). 
The aim of the current chapter was to characterise the expression profile of 
GABAR in control and stargazer DG by a combination of immunohistochemical, 
immunoblotting and radioligand binding techniques to determine any 
abnormalities in GABAR expression in the stargazer DG in response to high 
frequency SWDs and increased BDNF expression (Chaftez et al., 1995; Nahm 
and Noebels, 1998; Koyama et al., 2004; 2005). 
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7 .2. RESULTS 
7.2.1. GABA receptor switch from a4f3o to a4f3y2 in the DG of the stargazer 
mutant mouse 
7 .2.1.1. eH] Muscimol binding 
The relative distribution of eH] muscimol binding (20 nM) was observed to be 
comparable in control and stargazer forebrain tissue sections, with the highest 
levels ofbinding in the hippocampus, cerebral cortex and striatum (figure 7.1.A). 
Quantification ofthe levels of em muscimol binding in the dentate gyrus 
revealed a significant decrease in the levels of binding in the stargazer mutant, to 
79 ± 9% of control levels, n=30, p=0.01 (Figure 7.1. C&D). Since em muscimol 
has been shown to selectively bind only GABAR a6 in autoradiography (or its 
equivalent, a4 in the forebrain) either directly, or as a result of the presence of 
the 0 subunit (Korpi et al., 2002b), a reduction in eHJ muscimol binding 
suggests a loss of a4f3o GABAR in the stargazer mutant DG. 
7.2.1.2. Total em Ro15-4513 binding 
In order to determine any possible abnormalities in expression of y2 subunit-
containing GABAR population, radioligand binding studies were conducted on 
control and stargazer tissue sections, using eH] Ro 15-4513 at a concentration of 
20 nM. Figure 7.2.A demonstrates the mapping of total [3H] Ro15-4513 binding 
sites in control and stargazer tissue sections. The highest intensity of binding was 
observed in the hippocampus and cortex. Figure 7.2.C&D illustrate the 
calculated levels oftotal eH] Ro15-4513 binding in the dentate gyrus which 
revealed no significant difference in the levels of binding between control and 
stargazer tissue sections (104 ± 7% of control levels, p=0.55, n = 30, 6 sections 
per mouse strain, 5 measurements per section). Therefore, it is possible to 
conclude that the total levels ofy2 subunit-containing receptors expressed in the 
dentate gyrus do not differ between control and stargazer mice 
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Figure 7.1. [3H] Muscimol binding (20 nM) to control (+/+:+/stg) and 
stargazer (stglstg) adult mouse dentate gyrus 
A: Representative control and stargazer autoradiographs demonstrating 
high intensity of radio label in the dentate gyrus and cortex. 
B: Standard curve of intensity versus radioactivity, constructed using 
ImageJ software to measure the intensity of pH] standards of known 
radioactivities (see section 2.12.2). 
C: Representative column graph depicting the calculated radioactivities 
of the dentate gyrus of6 control and 6 stargazer tissue sections, 5 
measurements per section from n=2 mice per strain. 
D: Bar graph to demonstrate a significant decrease in [3H] muscimol 
binding in the dentate gyrus of the stargazer mutant mouse, to 79 ± 9% of 
control levels, p=O.Ol. 
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Figure 7.2. Total [3H] Ro15-45JL3 binding (20 nM) to control (+/+:+/stg) 
and stargazer (stglstg) adult mouse dentate gyrus 
A: Representative control and stargazer autoradiographs demonstrating 
high intensity of radio label in the cortex and hippocampus. 
B: Standard curve of intensity versus radioactivity, constructed using 
ImageJ software to measure the intensity of [3H] standards of known 
radioactivities (see section 2.12.2). 
C: Column graph depicting the calculated radioactivities of the dentate 
gyrus of 6 control and 6 stargazer tissue sections, 5 measurements per 
section from n=2 mice per strain. 
D: Bar graph to demonstrate no significant decrease in total PHJ Ro 15-
4 513 binding in the dentate gyrus of the stargazer mutant mouse ( 1 04 ± 7% 
of control levels, p=0.55. 
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7.2.1.3. Benzodiazepine-insensitive (BZ-IS) subtype ofeH] Rol5-4513 binding 
Levels ofBZ-IS subtype ofeH] Ro15-4513 binding were determined in the 
presence of 10 ~ flunitrazepam. Interestingly, BZ-IS binding was not detected 
in control DG, with levels ofbinding not different from background film levels 
(figure 7.3.A). However, this subtype of binding was dramatically up-regulated 
in the stargazer DG which upon quantification yielded -10 nCi/mg gray matter 
radioactivity (p<O.Ol, n=25). An increase in the BZ-IS subtype ofbinding 
suggests an increase in a.4J3y2 (or a.6J3y2) GABAR in the stargazer DG. 
7.2.1.4. Benzodiazepine-sensitive (BZ-S) subtype ofeH] Ro15-4513 binding 
The contribution ofthe BZ-S subtype to total eHJ Ro15-4513 binding was 
determined qualitatively by [3H] flunitrazepam (5 nM) labelling of control and 
stargazer tissue sections. No qualitative differences were noted in the distribution 
of eHJ flunitrazepam binding to control or stargazer sections. The highest levels 
of binding were observed in the hippocampus, cerebral cortex and striatum 
(figure 7.4.A). However, upon quantification ofeH] flunitrazepam binding, the 
gray scale intensities of labelling in the dentate gyrus of control and stargazer 
sections fell above the highest calibration standard available. Consequently, since 
total eH] Ro15-4513 binding is equal to the sum ofBZ-S and BZ-IS binding, the 
relative levels ofBZ-S binding were calculated by the subtraction ofBZ-IS 
binding from total eHJ Ro 15-4513 binding. By this method, the levels ofBZ-S 
binding were calculated to not differ significantly between control and stargazer 
DG (94 ± 6% of control levels, p=0.39). Therefore, it is possible to conclude that 
the levels of a.l/a.2J3y2 GABAR were not different between control and stargazer 
DG. 
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Figure 7.3. [3H] Ro15-4513 B7r:U:S subtype (20 111M in the presence of 
10 JIM tlunitrazepam) binding to control (+/+:+/stg) and stargazer 
(stglstg) adult mouse dentate gyrus 
A: Representative control and stargazer autoradiographs demonstrating 
high intensity of radio label in the dentate gyrus of the stargazer mutant. 
B: Standard curve of intensity versus radioactivity, constructed using 
ImageJ software to measure the intensity of [3H] standards of known 
radioactivities (see section 2.12.2). 
C: Representative column graph depicting the calculated radioactivities 
of the dentate gyrus of 5 control and 5 stargazer tissue sections, 5 
measurements per section from n=2 mice per strain. 
D: Bar graph to demonstrate a significant increase in the BZ-IS subtype 
of PHJ Ro 15-4513 binding in the dentate gyrus of the stargazer 
mutant mouse of control levels, p<O.Ol. 
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mutant mouse (94 ± 6% of control levels). 
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7 .2.2. Immunohistochemical mapping of GABAR subunit expression in the 
DG of control and stargazer mice 
Receptor autoradiography revealed an increase in BZ-IS eHJ Rol5-4513 binding 
in the stargazer DG. Therefore, in order to determine any alterations in the 
distribution and expression levels of GABAR subunits in the stargazer DG, 
GABAR expression was compared in control and stargazer DG by 
immunohistochemistry and quantitative western blotting. 
7 .2.2.1. a.l subunit expression 
Paraformaldehyde perfusion-fixed adult mouse control and stargazer tissue 
sections were probed with anti-GABAR a.l subunit specific antibody at 0.25 
!J.g/ml (see section 2.14 for method). Figure 7.5. demonstrates intense 
immunoreactivity in the stratum oriens, pyramidal cell layer and the stratum 
radiatum of the CAl and CA3. A high level of immunoreactive staining was also 
observed in the hilus and molecular layers of the dentate gyrus, with intense 
staining at the hilar surface of the granule cell layer. No apparent differences 
were noted in the levels of staining in stargazer compared to control tissue 
sections (n=4). 
7.2.2.2. a.4 subunit expression 
GABAR a.4 subunit immunostaining was detected in the pyramidal cell layer of 
the CAl and CA3 and to a lesser extent in the stratum oriens using anti-GABAR 
a.4 subunit specific antibody at 0.5 !J.g/ml (figure 7.6.). The most intense 
immunoreactivity was noted in the molecular layer of the dentate gyrus, with 
staining also observed in the granule cell layer and intemeurons ofthe hilus. No 
immunoreactive staining was observed in the stratum radiatum of the CAl and 
CA3 (n=5-8). A qualitative increase in immunostaining for the GABAR a.4 
subunit was observed in the molecular layer of the dentate gyrus in stargazer 
tissue sections compared to cont~ol sections. 
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Figure 7.5. Immunohistochemical mapping of the GADA A receptor at subunit 
in adult mouse dentate gyrus 
A&B: +/+:+/stg and stg/stg whole hippocampi respectively at x40 magnification 
C&D: +/+:+/stg and stg/stg brain sections respectively at xI 00 magnification 
Note the intense staining in the granule cell layer (GL), molecular layer (ML) and 
hilus (H) of the dentate gyrus (DG) in both control and stargazer tissue sections. 
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Figure 7.6. Immunohistochemical mapping of the GADA A receptor a4 subunit 
in adult mouse dentate gyrus 
A&B: +/+:+/stg and stg/stg whole hippocampi respectively at x40 magnification 
C&D: +/+:+/stg and stg/stg brain sections respectively at x l 00 magnification 
Note the intense staining in the molecular layer (ML) and hilus (H) in control 
dentate gyrus (DG) which is greatly reduced in the molecular layer of the stargazer 
dentate gyrus. 
7.2.2.3. (32 subunit expression 
Anti-GABAR (32 subunit specific antibody was employed at a concentration of 
0.5 J..Lg/ml in order to map the subunit expression in the hippocampus. High levels 
of immunoreactivity were detected in the stratum oriens and stratum radiatum of 
the CAl and to a lesser extent in the stratum oriens and radiatum of the CA3. 
Intense immunoreactivity was observed in the molecular layer of the DG, with 
immunoreactive staining noted in the hilus and granule cell layer (figure 7.7.). 
No immunoreactive staining was noted in the pyramidal cell layer of the CAl or 
CA3 (n=4). An increase in (32 subunit immunoreactivity was noted in the 
molecular layer of the dentate gyrus in stargazer tissue sections compared to 
control levels of staining. 
7.2.2.4. (33 subunit expression 
Figure 7.8. demonstrates immunohistochemical staining of control and stargazer 
tissue sections with anti-GABAR (33 subunit specific antibody at 0.5 J..Lg/ml. 
Intense immunoreactivity was observed in the molecular layer of the dentate 
gyrus, with high levels of staining in the stratum oriens and stratum radiatum of 
the CA3 and to a lesser extent in the stratum oriens and radiatum of the CAl and 
stratum lacunosum moleculare. No immunoreactivity was detected in the hilus or 
granule cell layer of the dentate gyrus or pyramidal cell layer of the CAl and 
CA3 (n=5-8) (figure 7.8.). Increased levels of immunoreactivity were detected in 
the molecular layer of the stargazer mutant tissue sections when compared to 
control sections. 
7.2.2.5. 8 subunit expression 
GABAR 8 subunit immunoreactivity in the hippocampus was determined 
immunohistochemically using anti-GABAR 8 subunit specific antibody at 0.25 
J..Lg/ml In order to visualise immunoreactive staining in the dentate gyrus, tissue 
sections were subjected to antigen retrieval prior to immunohistochemical 
staining, in order to boost specific antibody binding 
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Figure 7.7. Immunohistochemical mapping of the GADA A receptor ~2 subunit 
in adult mouse dentate gyrus 
A&B: +/+:+/stg and stg/stg whole hippocampi respectively at x40 magnification 
C&D: +/+:+/stg and stg/stg brain sections respectively at xlOO magnification 
Note the intense staining in the molecular layer (ML) and hilus (H) in control 
dentate gyrus (DG) which is slightly increased in the molecular layer of the stargazer 
dentate gyrus. 
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Figure 7.8. Immunohistochemical mapping of the GABAA receptor ~3 subunit 
in adult mouse dentate gyrus 
A&B: +/+:+/stg and stg/stg whole hippocampi respectively at x40 magnification 
C&D: +/+:+/stg and stg/stg brain sections respectively at x l 00 magnification 
Note the intense staining in the molecular layer (ML) and hilus (H) in control 
dentate gyrus (DG) which is greatly increased in the molecular layer of the stargazer 
dentate gyrus. 
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Figure 7.9. Immunohistochemical mapping of the GADA A receptor o subunit 
in adult mouse dentate gyrus 
A&B: +/+:+/stg and stg/stg whole hippocampi respectively at x40 magnification 
C&D: +/+:+/stg and stg/stg brain sections respectively at x 100 magnification 
Note the intense staining in the granule cell layer (GL), molecular layer (ML) 
and hilus (H) of control dentate gyrus (DG) which is greatly decreased in 
the molecular layer of the stargazer dentate gyrus. 
(see section 2.13.3. for method). Consistent differences in expression levels of 
the o subunit were not obtained in 5-10 tissue sections. However, in some 
instances expression of the subunit appeared to be reduced in stargazer DG 
compared to controls. The highest levels of immunoreactivity were consistently 
observed in the molecular layer of the dentate gyrus, with high levels in the 
granule cell layer. Immunoreactive staining was also noted in the hilus, stratum 
lacunosum moleculare, stratum oriens of the CAl and pyramidal cell layer of the 
CAl and CA3. No immunoreactive staining was noted in the stratum radiatum of 
the CAl and CA3 or the stratum oriens ofthe CA3 (n=S-10). Figure 7.9. 
demonstrates a qualitative decrease in immunoreactivity in the molecular layer of 
the dentate gyrus in stargazer mutant sections compared to controls. 
7.2.2.6. y2 subunit expression 
Figure 7.10. demonstrates immunohistochemical staining of the hippocampal 
formation using an anti-GABAR y2 subunit-specific antibody at a concentration 
of2 J..Lg/ml. The highest levels of staining were observed in the molecular layer of 
the dentate gyrus and the pyramidal cell layer of the CA2. Immunoreactivity for 
the y2 subunit was also noted in the hilus, dentate granule cell layer and the 
stratum oriens and stratum lacunosum moleculare of the CAl. No differences in 
intensity of staining were noted between control and stargazer sections (n=S-8). 
Table 7.1. summarises the patterns of immunoreactive staining of the GABAR 
subunits in the hippocampus and the qualitative differences observed between 
control and stargazer tissue sections. 
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Figure 7.10. Immunohistochemical mapping of the GADA A receptor "{2 subuni· 
in adult mouse dentate gyrus 
A&B: +/+:+/stg and stg/stg whole hippocampi respectively at x40 magnification 
C&D: +/+:+/stg and stg/stg brain sections respectively at xlOO magnification 
Note the intense staining in the molecular layer (ML) and hilus (H) of control and 
stargazer dentate gyrii (DG). 
Table 7 .1. Quantitative comparison of GABAR subunit expression in adult control and stargazer hippocampus 
STAINING IN 
GABAR CAl CA2 CA3 DG STARGAZER 
SUBUNIT DENT ATE GYRUS 
COMPARED 
so PL SR SLM so PL SR so PL SR H GL ML TO CONTROLS 
aJ. +++ +++ +++ ++ - + + +++ +++ +++ ++ ++ ++ = 
a4 + ++ - + ++ + - + ++ - + + +++ tt 
~2 ++ - ++ ++ + - + + - + ++ + +++ t 
~3 + - + + + - + ++ - ++ - - +++ tt 
8 + + - + - + - - + - + ++ +++ ~ 
y2 + - - + - ++ - - - - + + ++ = 
- ---
L__ --
- -
-
__ L__ 
-- --
L__ 
-- -- - -- ---
+:Weak staining++: Moderate staining+++: Strong staining-: No specific staining. DG: Dentate gyrus, GL: Granule cell layer, H: Hilus, 
ML: Molecular layer, PL: Pyramidal cell layer, SLM: Stratum lacunosum moleculare, SO: Stratum oriens, SR: Stratum radiatum 
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7.2.3. Quantitative western blot analysis of GABAR subunit expression in 
the control and stargazer DG 
Immunohistochemical mapping of GABAR subunits in the dentate gyrus 
consistently revealed a qualitative up-regulation in expression of the a.4, J32 and 
J33 subunits in the stargazer mutant mouse. Consistent changes in the expression 
levels of the GABAR a.1, y2 or 8 subunits were not observed between control 
and stargazer tissue sections. However, in some instances, expression of the 8 
subunit appeared to be reduced in the molecular layer of the stargazer DG 
compared to controls (figure 7.9.). 
In order to determine exact differences in GABAR subunit expression levels, 
western blot analysis was conducted on SDS-solubilised control and stargazer 
DG in order to accurately quantify any differences in expression. 
7.2.3.1. a.4 subunit expression 
Expression of the GABAR a.4 subunit was determined in SDS-solubilised 
control and stargazer DG probed with anti-GABAR a.4 subunit specific antibody 
at 0.5 J...lg/ml. Immunoreactive band intensities were quantified by image 
densiometry using ImageJ software. Results were normalised to J3-actin levels to 
accommodate changes in protein loading. Expression of the a.4 subunit was 
found to be significantly up-regulated in the stargazer mutant DG to 13 7 ± 12% 
of control levels (n=7, p<0.01). 
7.2.3.2. J33 subunit expression 
GABAR J33 subunit expression was determined in control and stargazer DG by 
immunoblotting using anti-GABAR J33 subunit specific antibody at 0.5 J...lg/ml. 
Guantification of expression levels revealed a dramatic up-regulation of 
expression of the subunit in stargazer DG to 139 ± 28% of control levels (n=6, 
p=0.03). 
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Figure 7.11. Quantification of expression ofGABAR a4 and p3 
subunits in control (+/+:+/stg) and stargazer (stglstg) dentate gyrus 
A: Western blot analysis of control and stargazer SDS-solubilised DG 
probed for expression ofGABAR a4, p3, 8, y2, NMDAR NRl, AMPAR 
GluR2 and P-actin. 
B: Quantification of expression of GABAR a4 and P3 subunits in control 
and Stargazer DG. Expression of the a4 and p3 subunits were found to be 
increased to 137 ± 12%, p=0.0003 (n=7) and 139 ± 28%, p=0.026 (n=6) 
of control levels respectively. 
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7 .2.4. Expression of TARPs in the dentate gyrus of control and stargazer 
mice 
Figure 7.12.A demonstrates western blot analysis of forebrain membranes (10 f..l.g 
per lane) from control (+/+:+/stg) and stargazer (stglstg) mice probed with a C-
terminally directed anti-T ARPy2 antibody at a concentration of 4 f..l.g/ml. 
Immunoblot demonstrates the presence of three immunoreactive bands at 36-41 
kDa, ~48 kDa and ~55 kDa. The 36-41 kDa band corresponds to stargazin 
(T ARPy2) protein (Ives eta/., 2004), which was shown to be absent in stargazer 
forebrain membranes. The ~48 and ~55 kDa bands correspond in molecular 
weight to TARPs y4 and y8 respectively (Sharp eta/., 2001). Interestingly, both 
the 48 and 55 kDa immunoreactive species were present in both control and 
stargazer forebrain membranes. 
Heterologous expression of the T ARP isoforms in human embryonic kidney 293 
cells (HEK-293) and subjected to western blot analysis carried out by other lab 
members revealed that the anti-T ARPy2 antibody recognised T ARPy3 and y8 and 
can therefore be referred to as an anti-pan T ARP antibody. 
Immunohistochemical staining of paraformaldehyde-perfusion fixed control and 
stargazer tissue sections using an anti-pan T ARP antibody at 0.5 f..l.g/ml indicated 
differential staining of the dentate gyrus (DG). Figure 7.12.B&C demonstrates 
intense immunoreactivity in the CAl, with a high level of staining in the CA3 
and dentate gyrus in control tissue sections (B). Expression ofTARP isoforms in 
the CAl and CA3 were found to be reduced in stargazer tissue sections with a 
more profound reduction in staining observed in the DG, suggesting a loss of 
TARP isoform expression in the hippocampus of the stargazer mutant mouse (C). 
In order to determine the identity of the T ARP isoforms expressed in the dentate 
gyrus, the brain structure was dissected from control tissue, SDS-solubilised and 
silfijectecfto- western blot analysis probed with anti-pan TARP antibody at 4 
g/ "~~~- ~­ll m. 
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A: Control and stargazer forebrain membranes subjected to western blot 
analysis and probed for the expression of stargazin using anti-T ARPy2 
antibody directed to the C-terminus at 4 Jlg/ml. Expression ofTARPy2 
(36-41 kDa) was only detected in control forebrain material. 
A number of immunoreactive bands were detected in both control and 
stargazer forebrain membranes of -55 kDa, -48 kDa and 36-41 kDa. 
lffi&C: Immunohistochemical mapping ofTARPs in the dentate gyrus 
of control (B) and stargazer (C) tissue sections using anti-pan T ARP 
antibody at 0.5 Jlg/ml. Note the reduction in intensity of staining in the DG 
ofthe stargazer mutant.(Courtesy ofP. Tiwari). 
]!): Western blot analysis of control DG probed with anti-pan T ARP antibody 
at 4 Jlg/ml. Notice the absence ofT ARPy2 expression in control DG. 
(Courtesy ofP. Donoghue). 
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Figure 7 .12.0 demonstrates the presence of a single immunoreactive species 
expressed in control DG with a molecular weight of ~55 kDa, corresponding to 
TARPy8. Stargazin (TARPy2) protein expression was demonstrated in control 
cerebellar membranes, which was absent in stargazer cerebellar membranes 
AND control DG. 
7 .2.5. Quantification of TARP y8 expression in the dentate gyrus of the 
control and stargazer mice 
Figure 7.13.A demonstrates quantitative western blot analysis of control and 
stargazer DG probed for the expression ofT ARPy8. Expression ofT ARPy8 was 
found to be reduced to 77±1% of control levels in the stargazer DG (n=2). In 
order to determine if the immunoreactive species (~55 kDa), corresponding to 
T ARPy8 was an AMP AR interacting protein, DG were dissected from control 
animals, triton X-1 00 solubilised and immunoprecipitated using anti-pan T ARP 
antibody (100 J..Lg). Figure 7.13.C illustrates the co-immunoprecipitation of 
AMPAR GluR2 subunit with anti-pan TARP antibody 55kDa immunoreactive 
species. Therefore it is possible to conclude that T ARPy8 does function as an 
AMP AR interacting protein in the dentate gyrus. 
7.3. DISCUSSION 
7.3.1. GABAR plasticity in the dentate gyrus of the stargazer mutant 
Inhibitory GABAergic networks adapt to changes in the strength of their 
excitatory inputs. Results herein identify that cerebellar granule cells of the 
stargazer mutant mouse in vivo demonstrate a loss of GABAR a.6 and o subunit 
expression, to result in a significant reduction in eH] muscimol binding to 70 ± 
10% of control levels (see section 4.3.2.1.). This selective loss ofGABAR 
subtype occurs as a consequence of the stargazer mutation, to cause a failure to 
express-TARPy2 and a near complete ablation of AMP AR expression at the 
mossy. fibre-granule cell synapse: Hence, a loss of excitatory input in vivo causes 
an adaptation in GABAR expression in the cerebellar granule cell layer. 
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Figure 7.13. Expression of'fARPy8 in stargazer dentate gyrus 
A: Western blot analysis of control and stargazer DG material probed with 
anti-pan T ARP antibody at 4 ~glml. 
B: lmmunoprecipitation of control DG Triton-soluble material with anti-pan 
T ARP antibody ( 100 ~g), demonstrating the association ofT ARPy8 with 
AMPAR GluR2 subunit.(Courtesy ofP. Donoghue). 
DG: Dentate gyrii, IP: Immunoprecipitated protein, UB: Unbound material. 
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In contrast, the dentate gyrus of the stargazer mutant receives high frequency ( 6-
7 Hz) spike-wave discharges, which could be postulated to cause the reverse 
response to that seen in the CGC layer of the mutant, where excitatory inputs are 
reduced, which is indeed what was observed. 
In the current study, the levels of GABAR a.4 and f33 subunits were found to be 
significantly increased in the DG of the stargazer mutant compared to controls 
(figure 7.11). Furthermore, the levels ofBZ-IS CH1 Ro15-4513 binding were 
shown to be up-regulated in the stargazer DG, indicative of a.4f3y2 GABAR, a 
subtype ofbinding not observed in the control DG (figure 7.2.1.3.). Expression 
of the BZ-S subtype of binding was not significantly affected, represented by 
a.1/a.2f3y2 GABAR in the DG, highlighting the specificity of the GABAR switch 
observed in the stargazer DG. 
The a.4 subunit has been reported to preferentially co-assemble with the GABAR 
o subunit in the thalamus of control mice (Sur eta/., 1999), unless the ability to 
form GABAR containing the o subunit is compromised, as in the o knockout 
mouse, where a.4f3o receptors are replaced by a.4f3y2 GABAR (Mihalek et al., 
1999; Korpi eta/., 2002a; Sun eta/., 2004). In the current study, the levels of 
CH1 muscimol binding in the stargazer DG were significantly reduced, to 79 ± 
9% of control levels. CH1 muscimol in autoradiography highlights a.4f3o 
GABAR in the forebrain (Korpi et al. 2002b ). Therefore, it is possible to 
conclude that a.4f3y2 GABAR arise in the DG of the stargazer mutant, at the 
expense of a.4f3o GABAR. 
Immunohistochemical studies indicated a possible down-regulation of expression 
of the GABAR o subunit in the molecular and granule cell layers of the stargazer 
DG (figure 7.9.). A reduction in the expression of the o subunit would have been 
in agreement with the reduction in CH1 muscimol binding observed in the 
stargazer DG. Furthermore, if the y2 and o subunits compete for assembly with 
the a.4-subunit in the forebrain, a reduction in o subunit expression would also 
favourtheup•regulation ofBZ-IS subtype ofbinding observed in the stargazer 
DG. However, this result was variable between sections immunohistochemically 
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stained foro subunit immunoreactivity. Further experiments were conducted to 
examine the possible role of age or gender in the variability in o immunostaining 
observed. Gender could be a factor influencing o subunit expression, as the levels 
of the 6 subunit have been shown to fluctuate with the oestrus cycle in female 
rats (Griffiths eta/., 2005). However, none of these factors could explain the 
variability observed (data not shown). No variability was observed in 
autoradiographic studies in that all stargazer DG sections showed the GABAR 
subtype switch. Therefore, further studies using a dynamic cell system would be 
required to determine how the switch from a.4f36 to a.4f3y2 GABAR occurs in the 
stargazer. 
7 .3.2. Is the GABAR plasticity observed in the stargazer DG as a 
consequence of the mutation in the failure ofT ARPy2 expression, or in 
response to the hyper-excitability entering the dentate gyrus? 
The effects observed on GABAR expression could be postulated to occur as a 
consequence of failure to express T ARPy2 in the thalamocortical pathways 
resulting in seizure activity entering the hippocampus (Qiao and Noebels., 1993). 
Conversely, ifTARPy2 is normally expressed in the DG acting to regulate 
inhibitory networks in the control hippocampus, the stargazer hippocampus 
would therefore experience hyper-excitability. 
Previous studies have reported the expression ofT ARPy2 isoform in the 
cerebellum, CA3, dentate gyrus, cerebral cortex, thalamus and olfactory bulb 
(Sharp eta/., 2001; Tomita eta/., 2003). Western blot analysis of control and 
stargazer forebrain membranes, probed with anti-T ARPy2 antibody revealed that 
the 36-41 kDa band which corresponds to TARPy2 in molecular weight and was 
observed in control cerebellar membranes, was absent from stargazer forebrain. 
Surprisingly, two other immunoreactive bands at -48 and -55 kDa were 
observed in both control and stargazer forebrain (figure 7. 12. ). Upon further 
characterisation of the antibody by other lab members, by recombinant 
expression of the T ARP isoforrns in HEK-293 cells, it was revealed that the 
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antibody cross-reacted with T ARPy3 and y8 and could therefore be referred to as 
a pan-T ARP antibody. 
In order to confirm the identity of the immunoreactive species highlighted by the 
anti-pan TARP antibody, the dentate gyrus was excised from control and 
stargazer forebrain and subjected to western blot analysis. Results demonstrated 
that indeed the T ARPy2 isoform was not expressed in control DG, rather the 
immunoreactive band at ~55 kDa was the prominent immunoreactive species. 
Further analysis using an anti-TARPy8 specific antibody revealed that the ~55 
kDa band corresponded to T ARPy8, the levels of which were reduced to 77 ± 1% 
of control levels in the stargazer mutant DG, consistent with immunostaining 
differences observed using the anti-TARP antibody (figure 7.12.). Furthermore, 
immunoprecipitation assays using the anti pan-T ARP and T ARPy8 antibodies 
confirmed that T ARPy8 does indeed interact with the AMP AR GluR2 subunit in 
the control DG (figure 7.13.). 
Consequently it is possible to conclude that the mossy fibre sprouting, down-
regulation ofTARPy8 and GABAR rearrangements occur as a consequence of 
failed TARPy2 expression elsewhere in the stargazer mutant brain. 
7.3.3. What are the implications for a switch to BZ-IS subtype of GABAR? 
A switch from expression of the 8 subunit-containing GABAR to y2 subunit-
containing GABAR has the potential to result in a switch in location of receptor 
from extrasynaptic to synaptic location. Therefore, resulting in an adaptation in 
inhibitory response to accommodate increased hyper-excitability entering the DG 
to maintain cell viability. In the stargazer mutant, mossy fibre release of zinc and 
glutamate to give high extracellular zinc concentrations acts on zinc-insensitive 
GABAR. Unlike in temporal lobe epilepsy models, where a switch to 8 subunit-
containing GABAR which are zinc sensitive causes blockade of the GABA 
response·and zinc-mediated failure of inhibition, acting to promote seizure 
generation(Cohen eta/., 2003). 
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The GABAR switch observed in the current study is not uniform in all absence 
epilepsy models, but rather is unique to the stargazer mutant. Autoradiographic 
studies were carried out on tottering mouse tissue sections, where no increased 
BZ-IS binding was observed in the dentate gyrus (data not shown). A possible 
explanation for such a difference between absence models, when the tottering 
mouse DG experiences the same SWDs, but at a lower burst frequency is that 
there is a threshold level of excitability required to cause rearrangements of 
GABAR profile, not reached in the tottering mouse. 
7 .3.4. Conclusions 
In conclusion, the current study has demonstrated a switch in GABAR 
expression from a4J3B to a4f3y2 in the stargazer DG. This switch was not 
observed in autoradiographic studies in the tottering mutant, hence it can be 
concluded that this GABAR rearrangement is not a common feature of absence 
epilepsy models. The switch was found not to be caused by the failure to express 
T ARPy2 in the stargazer DG, rather can be predicted to occur as a consequence 
of hyper-excitability and failed T ARP y2 expression elsewhere in afferent 
pathway (thalamocortical networks), as the DG does not normally express 
T ARPy2, T ARPy8 appears to be the predominant T ARP in control mouse DG. 
The switch from extrasynaptic (o subunit-containing GABAR) to potentially 
synaptic (y2 subunit-containing GABAR) location ofGABAR may provide a 
homeostatic mechanism which neurons can employ to balance increased 
excitatory inputs. 
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CHAPTER 8. SUMMARY AND FUTURE WORK 
The stargazer mutant mouse is an animal model of human absence epilepsy and 
cerebellar ataxia. The stargazer mutation results in the complete ablation of 
expression ofT ARPy2, an AMP A receptor auxiliary subunit. Results of the 
current study provide evidence for the involvement ofT ARPy2 in the regulation 
of expression and trafficking of specific GABAA receptor (GABAR) subtypes in 
the cerebellum and hippocampal formation. 
Qualitative differences in GABAR subunit expression were determined using 
immunohistochemical techniques. Decreases in the a.6, J32, J33, and B subunits 
were observed in all cerebellar folia of the stargazer mutant cerebellum when 
compared to controls. The expression of the GABAR subunits were quantified in 
adult control and stargazer mouse cerebellum and revealed decreases in 
expression of the GABAR a.6, J32, J33 and B subunits in the stargazer mutant to 
39 ± 22%,45 ± 42%, 77 ± 42% and 36 ± 21% of control levels respectively. The 
abnormal GABAR profile expressed in the stargazer cerebellum is not a 
consequence of failed cerebellar maturation as an immature complement of 
receptors were not found to be expressed in adult stargazer (e.g. a.2/a.3/a.5 
subunit-containing receptors), as determined by zolpidem displacement of eH] 
Ro15-4513 binding. This demonstrates that the development of the GABAR 
profile of the stargazer mutant cerebellum is not impaired, rather, the levels of 
expression of the a.6 and B subunit-containing GABARs present in the mature 
cerebellum, are dramatically reduced. 
Possible abnormalities in the GABAR profile of the stargazer mutant mouse 
were determined by radioligand binding techniques to both cerebellar membrane 
homogenates and tissue sections by receptor autoradiography. eH] muscimol 
binding to cerebellar membranes revealed a decrease to 70 ± 10% of control 
levels, a loss of30% of total GABAR (y2 and B containing subpopulations) in the 
stargazer cerebellum. Receptor autoradiography using eH] muscimol, which is 
selective for a.6 subunit-containing receptors, revealed a d~crease to 54± 100/o of 
control levels in the CGC layer of the stargazer mutant indicating that the loss of 
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GABAR is entirely accommodated by the loss of CGC-specific a6J3y2 and a6J3o 
GABAR subtypes. Total levels ofeH] Ro15-4513 binding were not found to 
differ significantly between control and stargazer animals. However, upon 
further pharmacological dissection, the BZ-IS subtype of receptor, conferred by 
a6J3y2 and a1a6J3y2 receptors was found to be reduced to 57± 13% of control 
levels in cerebellar membrane homogenates and to 78 ± 10% of control levels in 
the CGC layer by receptor autoradiography. By difference analysis, if there is a 
dramatic decrease in the total number ofGABAR as revealed by a loss ofeH] 
muscimol binding, and the total level of eH] Ro 15-4513 binding is not changed, 
the loss of GABAR must be due to a dramatic loss of a6J3o receptors reduced by 
76%. In CGCs, activation of o-subunit containing GABARs mediates >95% of 
the total GABAR-mediated inhibition in these neurons (Cope eta/., 2005). Thus 
in stargazer CGCs we would estimate a loss of 78% of GAB A-mediated 
inhibition potential. 
CGCs derived from control and stargazer mice follow a pattern of development, 
as expected of CGCs in vivo, thereby providing a model system for the 
investigation of the factors affecting the expression, trafficking and targeting of 
the GABAR subunits. Depolarisation either by KCl or kainic acid treatment 
demonstrated the differential modulation of the principal GABAR subunits in 
mouse CGCs. As previously reported, CGCs cultured under 25 mM KCl, 
demonstrated a decrease in the expression of the GABAR subunits indicative of a 
mature CGC, the a1 and a6 subunits (Mellor eta/., 1998; Ives eta/., 2002a; 
Engblom eta/., 2003). 
Furthermore, depolarisation mediated by kainic acid treatment also acted to 
decrease a1 and a6 subunit expression in control CGCs. However, expression of 
the o subunit was found to be dramatically increased under both KCl and kainic 
acid-induced depolarisation in control CGCs, but only under KCl-induced 
depolarisation in stargazer CGCs. The studies described herein demonstrated that 
AMP AR activation resulted in L-type voltage-gated calcium channel-dependent 
up-regulation of GABAR o subunit expression and cell surface trafficking which 
was not detected in CGCs derived from stargazer animals. Offering a partial 
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explanation for the abnormalities observed in vivo. The KCl-mediated 
depolarisation studies do however indicate that the signalling pathways linking 
depolarisation to GABAR B subunit up-regulation are still intact in the CGCs of 
the stargazer. 
Future work would involve blocking downstream signalling pathways following 
calcium influx through L-type voltage-gated calcium channels, using pathway 
inhibitors ofPKA, PKC, CaM Kinases, MAP kinase, in order to further dissect 
the signalling pathways involved in the modulation of GABAR subunit 
expression and trafficking in cultured CGCs. Furthermore, the levels of GABAR 
subunit rnRNA present in 5K and kainate CGCs needs to be quantified, to 
determine if increased transcription of the GABAR B subunit gene was 
responsible for increased GABAR B subunit expression. In addition, cultured 
control CGCs treated in the absence (5 mM KCl) and presence of increased 
extracellular KCl (25 mM) or kainic acid (I 00 J.!M) could be 
immunofluorescently stained with anti-GABAR B subunit-specific and L-type 
voltage-gated calcium channel-specific antibodies to determine where the 
increased expression of the B subunit localises within the CGC following 
depolarisation and furthermore if the B subunit co-localises with L-type voltage-
gated calcium channels. 
Conflicting reports exist as to the electrical activity of mouse CGCs under 5K 
culture conditions. Mellor eta/., in 1998 reported that CGCs maintained under 
5K culture conditions were electrically active in that they exhibited spontaneous 
action potentials, mEPSCS and miPSCs. Engblom eta/., in 2003 reported that no 
spontaneous action potentials were observed in CGCs cultured under 5K 
conditions. Hence, the cells were considered to be electrically silent. The group 
suggested that the conflicting reports resulted from differences in the age of the 
CGCs in culture. Mellor eta/. recorded electrical activity in mouse CGCs at 15 
DIY. In contrast, the neurons recorded from by Engblom eta/. were at 7 DIV, 
suggesting that the necessary features for spontaneous electrical activity, such as 
functional synapses and voltage-gated sodium channels were less developed at 7-
8DIV. 
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Results of the current study, are in support ofEngblom et al., as CGCs employed 
in current investigations were also utilised at 7 DN. Upon treatment of CGCs 
cultured under basal conditions ( 5 mM KCl) with CNQX (20 JJM), the levels of 
for example the 8 subunit protein observed by western blotting would be 
expected to be lower than that obtained in untreated cells if the CGCs were 
spontaneously active, which was not the case for the GABAR 8 subunit. CGCs 
are a good model system to begin to study mechanisms of trafficking and 
targeting of GABAR, but the whole cerebellar circuitry is not intact, therefore, in 
order to study the system as a whole, it would be necessary to employ cerebellar 
slices. 
The current study has also demonstrated a switch in GABAR expression from 
a.4J38 to a.4J3y2 in the stargazer dentate gyrus (DG). This switch was not 
observed in autoradiographic studies in the tottering mutant. Hence it can be 
concluded that this GABAR rearrangement is not a common feature of absence 
epilepsy models. The switch was found not to be caused by the failure to express 
T ARPy2 in the stargazer DG, rather can be predicted to occur as a consequence 
of hyper-excitability and failed T ARPy2 expression elsewhere in afferent 
pathway (thalamocortical networks), as the DG does not normally express 
T ARPy2, but T ARPy8 is the predominant T ARP in control mice. The switch 
from extrasynaptic (8 subunit-containing GABAR) to synaptic (y2 subunit-
containing GABAR) location of GABAR provides a homeostatic mechanism 
which neurons can employ to balance increased excitatory inputs. 
Future work would involve electrophysiological studies on control compared to 
stargazer dentate granule cells (DGGCs ), to determine if the proposed decrease 
in a.4J38 GABAR in the stargazer DGGCs is evident by a loss of tonic currents. 
Lesion of the thalamocortical pathway in the control mouse would allow for the 
quantification of GABAR subunit levels in the DG, to determine if the GABAR 
switch observed in the stargazer mutant occurs as a result of failed T ARPy2 
expression elsewhere in the afferent pathway. 
240 
In conclusion, the results of this study support the hypothesis that neural 
networks in both the cerebellum and the hippocampus are able to undergo 
homeostatic GABAergic plasticity in response to alterations in excitatory inputs. 
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Appendix 1. Expression of the GABAR a6 subunit in response to 
depolarisation in cultured CGCs (7 DIV) 
A: Quantification of expression levels of the GABAR a6 subunit in response 
to depolarisation mediated by increased extracellular KCl (25 mM) and kainic 
acid treatment (I 00 J.lM). n= 1 
B: Quantification of expression levels of the GABAR a6 subunit in response 
to depolarisation mediated by increased extracellular KCl (25 mM) and kainic 
acid treatment (100 J.lM), including data as presented in figure 5.6, n=2. 
C: Summary of quantification ofGABAR a6 subunit expression levels. Note 
a significant reduction in GABAR a6 subunit expression in response to KCl 
and kainic acid mediated depolarisation in control CGCs (13 ± 0.5% and 16 ± 
2% of5K levels respectively, p<0.05). In contrast, GABAR a6 subunit 
expression was not detectable in stargazer CGCs upon KCl-mediated 
depolarisation whereas expression levels were not affected by kainic acid-
mediated depolarisation (82 ± 16% of 5K levels, p=0.20). 
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Appendix 2. Dentate granule cells of the stargazer mutant mouse exhibit 
reduced tonic currents and decreased potentiation in response to 
neurosteroids compared to age-matched control mice 
GABAR-mediated tonic currents were significantly lower in the dentate 
granule cells of stargazer mice (6-8 week old male mice) compared to control 
animals (3.5 ± 0.7 pA vs 7.5 ± 0.2 pA respectively; n = 4-5; P<0.05). Dentate 
granule cells from the stargazer mutant exhibited decreased potentiation of 
tonic currents in response to the neurosteroid, THDOC (1 00 nM), ( 11.1 ± 
2.6pA vs 19.8 ± l.OpA; n = 4-5; P<0.05), correlating with a loss ofthe GABAR 
8 subunit-containing, neurosteroid-sensitive subtype of GABAR. 
Conducted by W.M.K Connelly and G. Lees of the Department of 
Pharmacology & Toxicology, Otago School of Medical Sciences, University of 
Otago, PO Box 913, Dunedin, New Zealand. 
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